{ "_id" : { "$oid" : "5b5d132f747304045b282d10" }, "title" : "第十一版块", "text" : "基础综合", "content" : [{ }, { "text" : "第一篇  生理学", "guide" : [{ "text" : "执业医师考试——本篇约占临床执业医师考试的6.34%，出题量约为38题。其中细胞的基本功能、血液循环、呼吸、消化为考试重点，相关知识点穿插于内科学、外科学等考点之中，故复习重心应放于内、外、妇、儿，回顾性学习基础部分！" }], "content" : [{ "title" : "第一章", "text" : "细胞的基本功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、细胞膜的物质转运功能", "alignment" : "left" }, { "text" : "（1）单纯扩散<br>（2）易化扩散<br>（3）主动转运<br>（4）出胞和入胞　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、细胞的兴奋性和生物电现象", "alignment" : "left" }, { "text" : "（1）静息电位和动作电位及其产生机制<br>（2）兴奋性与兴奋的引起，阈值、阈电位和动作电位的关系<br>（3）兴奋在同一细胞上传导的机制和特点", "alignment" : "left" }] }, { "content" : [{ "text" : "三、骨骼肌的收缩功能", "alignment" : "left" }, { "text" : "（1）骨骼肌神经-肌接头处的兴奋传递<br>（2）骨骼肌的兴奋-收缩耦联　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、细胞膜的物质转运功能", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 小分子物质的跨膜转运方式：单纯扩散、易化扩散、主动转运", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "单纯扩散", "alignment" : "left" }, { "text" : "易化扩散", "alignment" : "left" }, { "text" : "主动转运", "alignment" : "left" }] }, { "content" : [{ "text" : "定义", "alignment" : "left" }, { "text" : "是指脂溶性小分子物质从细胞膜的高浓度一侧向低浓度一侧移动的过程", "alignment" : "left" }, { "text" : "指非脂溶性或脂溶性低的物质在膜蛋白介导下，由膜的高浓度侧向低浓度侧转移的过程", "alignment" : "left" }, { "text" : "指物质依靠膜上的泵蛋白，逆浓度（或电位）梯度通过细胞膜的过程", "alignment" : "left" }] }, { "content" : [{ "text" : "转运物质", "alignment" : "left" }, { "text" : "O<sub>2. </sub>CO<sub>2. </sub>N<sub>2. </sub>H<sub>2</sub>O、乙醇、尿素、甘油等", "alignment" : "left" }, { "text" : "葡萄糖进入红细胞、K<sup>+</sup>、Na<sup>+</sup>、Cl<sup>-</sup>、Ca<sup>2+</sup>", "alignment" : "left" }, { "text" : "肠及肾小管吸收葡萄糖、钠泵、钙泵、H<sup>+</sup>-K<sup>+</sup>泵", "alignment" : "left" }] }, { "content" : [{ "text" : "转运方向", "alignment" : "left" }, { "text" : "物质从高浓度一侧向低浓度一侧移动", "alignment" : "left" }, { "text" : "物质从高浓度梯度或高电位梯度一侧移向低梯度的一侧", "alignment" : "left" }, { "text" : "逆浓度差或电位差移动", "alignment" : "left" }] }, { "content" : [{ "text" : "转运过程", "alignment" : "left" }, { "text" : "无载体、通道参与", "alignment" : "left" }, { "text" : "需离子通道或载体的帮助", "alignment" : "left" }, { "text" : "需转运蛋白形成的泵的参与", "alignment" : "left" }] }, { "content" : [{ "text" : "能耗", "alignment" : "left" }, { "text" : "不耗能，依靠浓度差", "alignment" : "left" }, { "text" : "不耗能，属于被动转运", "alignment" : "left" }, { "text" : "耗能，由膜或其所属细胞供能", "alignment" : "left" }] }, { "content" : [{ "text" : "终止条件", "alignment" : "left" }, { "text" : "细胞膜两侧浓度相等或者电化学势能差为0", "alignment" : "left" }, { "text" : "细胞膜两侧浓度相等或者电化学势能差为0", "alignment" : "left" }, { "text" : "由“泵”调节", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 易化扩散的两种形式", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "经通道易化扩散", "alignment" : "left" }, { "text" : "经载体易化扩散", "alignment" : "left" }] }, { "content" : [{ "text" : "介导方式", "alignment" : "left" }, { "text" : "通道蛋白", "alignment" : "left" }, { "text" : "载体蛋白", "alignment" : "left" }] }, { "content" : [{ "text" : "转运方向", "alignment" : "left" }, { "text" : "顺浓度或电位梯度进行", "alignment" : "left" }, { "text" : "顺浓度梯度进行", "alignment" : "left" }] }, { "content" : [{ "text" : "转运速度", "alignment" : "left" }, { "text" : "快（10<sup>6</sup>～10<sup>8</sup>个离子/秒）", "alignment" : "left" }, { "text" : "慢（10<sup>2</sup>～10<sup>5</sup>个离子或分子/秒）", "alignment" : "left" }] }, { "content" : [{ "text" : "特点", "alignment" : "left" }, { "text" : "1. 离子通道具有离子选择性和门控特性<br>2. 通道有开放和关闭两种不同状态<br>3. 无饱和现象", "alignment" : "both" }, { "text" : "1. 载体与溶质的结合具有化学结构特异性<br>2. 竞争性抑制<br>3. 饱和现象", "alignment" : "both" }] }, { "content" : [{ "text" : "物质举例", "alignment" : "left" }, { "text" : "K<sup>+</sup>、Na<sup>+</sup>、Cl<sup>-</sup>、Ca<sup>2+</sup>的快速移动", "alignment" : "left" }, { "text" : "葡萄糖、氨基酸、核苷酸等的跨膜转运", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "3. 主动转运的分类及特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "主动转运分类", "alignment" : "left" }, { "text" : "原发性主动转运", "alignment" : "left" }, { "text" : "继发性主动转运", "alignment" : "left" }] }, { "content" : [{ "text" : "转运方向", "alignment" : "left" }, { "text" : "逆浓度梯度或化学梯度进行", "alignment" : "left", "colSpan" : 2 }] }, { "content" : [{ "text" : "是否耗能", "alignment" : "left" }, { "text" : "必须消耗能量", "alignment" : "left", "colSpan" : 2 }] }, { "content" : [{ "text" : "能量来源", "alignment" : "left" }, { "text" : "钠-钾泵、钙泵、质子泵等直接分解ATP供能", "alignment" : "left" }, { "text" : "所需的驱动力并不直接来自ATP的分解，而是利用原发性主动转运所形成的某些离子的浓度梯度进行转运", "alignment" : "left" }] }, { "content" : [{ "text" : "举例", "alignment" : "left" }, { "text" : "钠-钾泵将钠移出细胞外，钾移入细胞内", "alignment" : "left" }, { "text" : "葡萄糖、氨基酸在小肠和肾小管的吸收；神经末梢在突触间隙摄取肽类神经递质；Na<sup>+</sup>-H<sup>+</sup>交换、Na<sup>+</sup>-Ca<sup>+</sup>交换", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "4. 大分子物质的跨膜转运方式：出胞与入胞", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "出胞", "alignment" : "left" }, { "text" : "入胞", "alignment" : "left" }] }, { "content" : [{ "text" : "定义", "alignment" : "left" }, { "text" : "指胞质内的大分子物质以分泌囊泡的形式排出细胞的过程", "alignment" : "left" }, { "text" : "指大分子物质或物质团块借助于细胞膜形成吞噬泡或吞饮泡的方式进入细胞的过程", "alignment" : "left" }] }, { "content" : [{ "text" : "特点", "alignment" : "left" }, { "text" : "细胞排出大分子物质", "alignment" : "left" }, { "text" : "大分子物质进入细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "举例", "alignment" : "left" }, { "text" : "主要见于细胞的分泌活动：<br>内分泌腺细胞将合成的激素分泌到血液、组织液；外分泌腺细胞将酶原、粘液分泌到腺管的管腔中；神经纤维末梢突触囊泡内神经递质的释放", "alignment" : "both" }, { "text" : "主要见于细胞外某些团块物质进入细胞的过程：<br>部分多肽类激素、抗体、运铁蛋白、LDL、病毒、大分子营养物质等", "alignment" : "both" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "5. 几种常见物质的跨膜转运方式", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "葡萄糖从肠腔内、肾小管吸收", "alignment" : "left" }, { "text" : "继发性主动转运（伴Na<sup>+</sup>的重吸收）", "alignment" : "left" }] }, { "content" : [{ "text" : "葡萄糖被红细胞、脑细胞摄取", "alignment" : "left" }, { "text" : "经载体易化扩散", "alignment" : "left" }] }, { "content" : [{ "text" : "带电离子（Na<sup>+</sup>、K<sup>+</sup>、Ca<sup>2+</sup>）顺浓度（电位）转运", "alignment" : "left" }, { "text" : "经通道易化扩散", "alignment" : "left" }] }, { "content" : [{ "text" : "带电离子（Na<sup>+</sup>、K<sup>+</sup>、Ca<sup>2+</sup>）逆浓度（电位）转运", "alignment" : "left" }, { "text" : "主动转运", "alignment" : "left" }] }, { "content" : [{ "text" : "水分子", "alignment" : "left" }, { "text" : "单纯扩散、经通道易化扩散", "alignment" : "left" }] }, { "content" : [{ "text" : "单胺类、肽类递质、碘摄取", "alignment" : "left" }, { "text" : "继发性主动转运", "alignment" : "left" }] }, { "content" : [{ "text" : "气体分子（O<sub>2. </sub>CO<sub>2. </sub>NH<sub>3. </sub>N<sub>2</sub>）、乙醇、尿素", "alignment" : "left" }, { "text" : "单纯扩散", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "二、细胞的兴奋性和生物电现象", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 静息电位：静息时，细胞质膜两侧存在着外正内负的电位差，称为静息电位。静息电位约为－80到－90mV，是钾平衡电位（主要成分）、少量钠内流和生电性钠钾泵活动的综合反映，故其接近于钾平衡电位。" }, { "type" : "h2", "alignment" : "left", "text" : "2. 动作电位：动作电位可双向传导，动作电位传递不易疲劳，不易受环境因素影响，无衰减性，“全或无”式传导。动作电位升支是由膜对钠通透性增大，超过了对钾的通透性，钠向膜内易化扩散形成。动作电位下降支由钠通道失活，钾通道开放，钾外流形成。" }, { "type" : "h2", "alignment" : "left", "text" : "3. 钠泵的主要生理功能有：(1)维持细胞内外钠、钾浓度差。(2)维持胞内渗透压和细胞容积。(3)建立钠的跨膜浓度梯度，为继发性主动转运的物质提供势能储备。(4)钠泵活动形成的跨膜浓度梯度为细胞发生电活动前提条件。" }, { "type" : "h2", "alignment" : "left", "text" : "4. 细胞电活动几个常见概念", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "极化", "alignment" : "left" }, { "text" : "指静息状态下，细胞膜电位外正内负的状态", "alignment" : "left" }] }, { "content" : [{ "text" : "超极化", "alignment" : "left" }, { "text" : "指细胞膜静息电位向膜内负值增大的方向转变", "alignment" : "left" }] }, { "content" : [{ "text" : "去极化或除极化", "alignment" : "left" }, { "text" : "指细胞膜静息电位向膜内负值减小的方向转变", "alignment" : "left" }] }, { "content" : [{ "text" : "反极化", "alignment" : "left" }, { "text" : "去极化致零电位后，膜电位进一步变为正值", "alignment" : "left" }] }, { "content" : [{ "text" : "复极化", "alignment" : "left" }, { "text" : "指细胞去极化后，再向静息电位方向恢复的过程", "alignment" : "left" }] }, { "content" : [{ "text" : "阈值", "alignment" : "left" }, { "text" : "指引起动作电位的最小刺激强度", "alignment" : "left" }] }, { "content" : [{ "text" : "阈电位", "alignment" : "left" }, { "text" : "指造成细胞膜对Na<sup>+</sup>通透性突然加大的临界膜电位。", "alignment" : "left" }] }, { "content" : [{ "text" : "阈刺激", "alignment" : "left" }, { "text" : "刺激强度为阈值的刺激", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "三、骨骼肌的收缩功能", "content" : [{ "type" : "common", "alignment" : "left", "text" : "兴奋-收缩偶联指的是电活动传导至神经肌肉接头后，骨骼肌的电兴奋转化为肌纤维的机械运动的过程。是将电兴奋过程和机械收缩联系起来的中介过程，其中介因子是钙离子，结构基础是三联管结构。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "骨骼肌的兴奋收缩偶联主要过程为：", "content" : [{ "type" : "common", "alignment" : "left", "text" : "(1)肌膜上的动作电位沿横管传向肌细胞深处，并激活三联管上的L型钙通道。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "(2)L型钙通道的变构或钙离子的内流→激活终末池RYR→钙离子释放→胞质中钙离子浓度升高近百倍→与肌钙蛋白结合→肌肉收缩。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "(3)胞质内钙离子浓度升高的同时激活肌质网上的钙泵→回收钙离子→钙离子浓度降低→肌肉舒张。" }] }] }] }] }] }] }, { "title" : "第二章", "text" : "血液", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、血液的组成与特性", "alignment" : "left" }, { "text" : "（1）内环境与稳态<br>（2）血量、血液的组成、血细胞比容<br>（3）血液的理化特性　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、血细胞及其功能", "alignment" : "left" }, { "text" : "（1）红细胞生理：红细胞的数量、生理特性和功能、<br>造血原料及其辅助因子<br>（2）白细胞生理：白细胞总数和分类计数，白细胞的<br>生理特性及功能<br>（3）血小板生理：血小板的数量，血小板的生理特性<br>及其功能　", "alignment" : "both" }] }, { "content" : [{ "text" : "三、血液凝固、抗凝和纤溶", "alignment" : "left" }, { "text" : "（1）血液凝固的基本步骤<br>（2）主要抗凝物质的作用，纤维蛋白溶解系统及其功<br>能", "alignment" : "both" }] }, { "content" : [{ "text" : "四、血型", "alignment" : "left" }, { "text" : "（1）血型与红细胞凝集反应<br>（2）ABO血型系统和Rh血型系统<br>（3）输血原则　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、血液的组成与特性", "content" : [{ "type" : "common", "alignment" : "left", "text" : "正常成年人的体液量约占体重的60%，其中约2/3（约占体重40%）分布于细胞内，称为细胞内液，余1/3（约占体重20%）分布于细胞外，称为细胞外液。细胞外液中约3/4（约占体重15%）分布于细胞间隙内，称为组织间液或组织液，其余1/4（约占体重5%）位于血管中不断循环流动，称为血液。" }] }, { "type" : "h1", "text" : "二、血细胞及其功能", "content" : [{ "type" : "common", "alignment" : "left", "text" : "三种血细胞的比较", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "红细胞（RBC）", "alignment" : "left" }, { "text" : "白细胞（WBC）", "alignment" : "left" }, { "text" : "血小板（PLT）", "alignment" : "left" }] }, { "content" : [{ "text" : "正常值范围", "alignment" : "left" }, { "text" : "男（4.0～5.5）×10<sup>12</sup>/L<br>女（3.5～5.0）×10<sup>12</sup>/L", "alignment" : "both" }, { "text" : "（4.0～10.0）×10<sup>9</sup>/L", "alignment" : "left" }, { "text" : "（100～300）×10<sup>9</sup>/L", "alignment" : "left" }] }, { "content" : [{ "text" : "主要功能", "alignment" : "left" }, { "text" : "运输O<sub>2</sub>及CO<sub>2</sub>；缓冲作用；免疫作用", "alignment" : "left" }, { "text" : "防御功能", "alignment" : "left" }, { "text" : "生理性止血", "alignment" : "left" }] }, { "content" : [{ "text" : "寿命", "alignment" : "left" }, { "text" : "120天", "alignment" : "left" }, { "text" : "难确定", "alignment" : "left" }, { "text" : "7～14天", "alignment" : "left" }] }, { "content" : [{ "text" : "生成调节", "alignment" : "left" }, { "text" : "造血原料（蛋白质、维生素B<sub>12</sub>，叶酸，Fe<sup>2+</sup>），EPO，性激素等", "alignment" : "left" }, { "text" : "集落刺激因子（CSF）", "alignment" : "left" }, { "text" : "血小板生成素（TPO）", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "三、血液凝固、抗凝和纤溶", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 内、外源性凝血途径的比较", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "内源性凝血途径", "alignment" : "left" }, { "text" : "外源性凝血途径", "alignment" : "left" }] }, { "content" : [{ "text" : "产生条件", "alignment" : "center" }, { "text" : "血管损伤或试管内凝血", "alignment" : "left" }, { "text" : "组织损伤", "alignment" : "left" }] }, { "content" : [{ "text" : "凝血因子分布", "alignment" : "center" }, { "text" : "全部存在于血液中", "alignment" : "left" }, { "text" : "存在于血液和组织中", "alignment" : "left" }] }, { "content" : [{ "text" : "启动因子", "alignment" : "center" }, { "text" : "血管内膜下胶原纤维或异物激活FⅫ", "alignment" : "left" }, { "text" : "组织损伤产生FⅢ", "alignment" : "left" }] }, { "content" : [{ "text" : "共同途径", "alignment" : "center" }, { "text" : "FX", "alignment" : "left" }, { "text" : "FX", "alignment" : "left" }] }, { "content" : [{ "text" : "不同因子", "alignment" : "center" }, { "text" : "FⅧ、FⅨ、FⅪ、FⅫ", "alignment" : "left" }, { "text" : "FⅢ、FⅦ", "alignment" : "left" }] }, { "content" : [{ "text" : "激活FX的复合物", "alignment" : "center" }, { "text" : "FⅨa-FⅧa-Ca<sup>2+</sup>复合物", "alignment" : "left" }, { "text" : "FⅢ-FⅦa复合物", "alignment" : "left" }] }, { "content" : [{ "text" : "凝血速度", "alignment" : "center" }, { "text" : "较慢（约数分钟）", "alignment" : "left" }, { "text" : "较快（约十几秒）", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 几种特殊的凝血因子", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "FⅣ", "alignment" : "left" }, { "text" : "为Ca<sup>2+</sup>，其余因子均为蛋白质", "alignment" : "left" }] }, { "content" : [{ "text" : "FⅢ", "alignment" : "left" }, { "text" : "组织因子，存在于组织，其余凝血因子均存在于新鲜血浆中", "alignment" : "left" }] }, { "content" : [{ "text" : "FⅡ、FⅦ、FⅨ、FⅩ", "alignment" : "left" }, { "text" : "合成需VitK参与，称为依赖VitK的凝血因子<br>（2. 7. 9. 10）", "alignment" : "both" }] }, { "content" : [{ "text" : "FⅧ", "alignment" : "left" }, { "text" : "最不稳定", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "3. 常见抗凝物质特性", "content" : [{ "type" : "h4", "alignment" : "left", "text" : "1）肝素于体内外均能立即发挥抗凝作用，已广泛应用于临床防治血栓形成。肝素有抗凝作用和抗栓作用，抗凝作用通过增强抗凝血酶3（AT-3）的作用而抑制凝血酶（Ⅱa因子）的作用，抗栓作用是通过抑制X因子的激活抑制血小板聚集。而低分子肝素则主要以抗栓作用为主，故临床上的出血副作用较普通肝素少。", "content" : [{ "type" : "h4", "alignment" : "left", "text" : "2）华法林为体内抗凝剂，是维生素K的拮抗剂，抑制FⅡ、FⅦ、FⅨ、FⅩ的合成，起体内抗凝作用，枸橼酸钠为体外抗凝剂，可去除血浆中的Ca2+而起抗凝作用。" }] }] }] }, { "type" : "h1", "text" : "四、ABO血型", "content" : [{ "type" : "common", "alignment" : "left", "text" : "根据红细胞膜上是否存在A抗原和B抗原，可将血液分成A、B、AB、O 四种血型。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "ABO血型的分型", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "血型", "alignment" : "left" }, { "text" : "红细胞上的抗原（凝集原）", "alignment" : "left" }, { "text" : "血清中的抗体（凝集素）", "alignment" : "left" }] }, { "content" : [{ "text" : "A型", "alignment" : "left" }, { "text" : "A", "alignment" : "left" }, { "text" : "抗B", "alignment" : "left" }] }, { "content" : [{ "text" : "B型", "alignment" : "left" }, { "text" : "B", "alignment" : "left" }, { "text" : "抗A", "alignment" : "left" }] }, { "content" : [{ "text" : "AB型：", "alignment" : "left" }, { "text" : "A+B", "alignment" : "left" }, { "text" : "无", "alignment" : "left" }] }, { "content" : [{ "text" : "O型", "alignment" : "left" }, { "text" : "无A，无B", "alignment" : "left" }, { "text" : "抗A+抗B", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "输血原则：在准备输血时，首先必须鉴定血型，保证供血者与受血者的ABO血型相合，输血最好坚持同型输血。即使在ABO系统血型相同的人之间进行输血，输血前也必须进行交叉配血试验。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "对于生育年龄的妇女和需要反复输血的患者，还必须使供血者与受血者的Rh血型相合，特别要注意Rh阴性受血者产生抗Rh抗体的情况。" }] }] }] }] }] }] }, { "title" : "第三章", "text" : "血液循环", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、心脏的泵血功能", "alignment" : "left" }, { "text" : "（1）心动周期的概念；心脏泵血的过程和机制<br>（2）心脏泵血功能的评价：每搏输出量、每分输出量、射<br>血分数、心指数、心脏做功<br>（3）心脏泵血功能的调节：每搏输出量和心率对心输出量<br>的影响", "alignment" : "both" }] }, { "content" : [{ "text" : "二、心肌的生物电现象和生理特性", "alignment" : "left" }, { "text" : "（1）工作细胞和自律细胞的跨膜电位及其形成机制<br>（2）心肌的兴奋性、自动节律性和传导性和收缩性<br>（3）正常心电图的波形及生理意义", "alignment" : "left" }] }, { "content" : [{ "text" : "三、血管生理", "alignment" : "left" }, { "text" : "（1）动脉血压的形成、正常值和影响因素<br>（2）中心静脉压及影响静脉回流的因素<br>（3）微循环的组成及作用<br>（4）组织液的生成及其影响因素", "alignment" : "left" }] }, { "content" : [{ "text" : "四、心血管活动的调节", "alignment" : "left" }, { "text" : "（1）神经调节：心交感神经、心迷走神经、交感缩血管神经<br>的功能<br>（2）心血管反射：颈动脉窦和主动脉弓压力感受性反射<br>（3）体液调节：肾素-血管紧张素系统、肾上腺素和去甲肾<br>上腺素、血管内皮产生的血管活性物质的功能", "alignment" : "both" }] }, { "content" : [{ "text" : "五、器官循环", "alignment" : "left" }, { "text" : "冠脉循环的血流特点和血流量的调节", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、心脏的泵血功能", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 心动周期中常见心脏部位压力及容积改变的特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "左心室", "alignment" : "left", "rowSpan" : 3 }, { "text" : "压力最高", "alignment" : "left" }, { "text" : "快速射血期末", "alignment" : "left" }] }, { "content" : [{ "text" : "容积最小", "alignment" : "left" }, { "text" : "等容舒张期末", "alignment" : "left" }] }, { "content" : [{ "text" : "容积最大", "alignment" : "left" }, { "text" : "心房收缩期末", "alignment" : "left" }] }, { "content" : [{ "text" : "主动脉", "alignment" : "left", "rowSpan" : 3 }, { "text" : "压力最高", "alignment" : "left" }, { "text" : "快速射血期末", "alignment" : "left" }] }, { "content" : [{ "text" : "压力最低", "alignment" : "left" }, { "text" : "等容收缩期末", "alignment" : "left" }] }, { "content" : [{ "text" : "血流量最大", "alignment" : "left" }, { "text" : "快速射血期", "alignment" : "left" }] }, { "content" : [{ "text" : "室内压升高最快", "alignment" : "left", "colSpan" : 2 }, { "text" : "等容收缩期", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 心脏泵血功能评定", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "指标", "alignment" : "center" }, { "text" : "定义", "alignment" : "center" }, { "text" : "正常值", "alignment" : "center" }] }, { "content" : [{ "text" : "每搏输出量", "alignment" : "center" }, { "text" : "指一侧心室在一次心搏中输出的血液量", "alignment" : "center" }, { "text" : "70ml", "alignment" : "center" }] }, { "content" : [{ "text" : "每分输出量", "alignment" : "center" }, { "text" : "指一侧心室每分钟射出的血液量，为搏出量×心率", "alignment" : "center" }, { "text" : "男为4.5～6.0L/min<br>女比男低10%", "alignment" : "center" }] }, { "content" : [{ "text" : "心指数", "alignment" : "center" }, { "text" : "以单位体表面积计算的心输出量。即心输出量/体表面积", "alignment" : "center" }, { "text" : "3.0～3.5L/（min·㎡）", "alignment" : "center" }] }, { "content" : [{ "text" : "射血分数", "alignment" : "center" }, { "text" : "是指搏出量占心室舒张末期容积的百分比", "alignment" : "center" }, { "text" : "55%～65%", "alignment" : "center" }] }, { "content" : [{ "text" : "左室每搏功", "alignment" : "center" }, { "text" : "搏出量（L）×（平均动脉压－6mmHg）×13.6×9.807/1000", "alignment" : "center" }, { "text" : "0.803J", "alignment" : "center" }] }, { "content" : [{ "text" : "每分功", "alignment" : "center" }, { "text" : "心室每分钟收缩射血所做的功", "alignment" : "center" }, { "text" : "60.2J/min", "alignment" : "center" }] }] }] }] }, { "type" : "h1", "text" : "二、心肌的生物电现象和电生理特性", "content" : [{ "type" : "common", "alignment" : "left", "text" : "快反应细胞：构成浦肯野纤维的浦肯野细胞为快反应细胞，动作电位特点为去极化速度和幅度大，兴奋传导速度快。心房、心室肌细胞也属于快反应细胞。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "慢反应细胞：窦房结及房室结细胞动作电位特点为去极化速度和幅度小，兴奋传导速度慢，为慢反应细胞。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "工作细胞：包括心房和心室肌细胞。心室肌细胞动作电位由去极化和复极化两个过程或五个时期组成，即0期（快速去极期）、1期（快速复极初期）、2期（平台期）、3期（快速复极末期）和4期（完全复极期，或静息期）。心室肌细胞动作电位形成主要依赖快钠通道开放，钠离子内流增加产生。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "心室肌收缩特点：1.同步收缩；2.不发生强直收缩；3.对细胞外钙依赖性。心室肌有效不应期特别长，可使心室肌不发生强直性收缩。心室肌有效不应期主要由绝对不应期及局部反应期组成，电位区间包括0期到3期膜电位（－55mV～－60mV），其中2期平台期可受钙、钠、钾离子轻微变化影响时长，故有效不应期长短主要受2期长短影响。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "自律细胞：包括房室束、束支、浦肯野细胞、房室结和窦房结。窦房结P细胞膜缺乏钠通道，其动作电位0期产生主要依赖L型钙通道，动作电位没有平台期，只有0、3. 4期，而4期可发生自动去极化，自动去极化是自律细胞产生自动节律性兴奋的基础。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "心肌细胞具有兴奋性、传导性、自律性和收缩性等四种基本生理特性。" }] }] }] }] }] }] }, { "type" : "h1", "text" : "三、血管生理", "content" : [{ "type" : "common", "alignment" : "left", "text" : "收缩压、舒张压、脉压等的概念及正常值", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "收缩压", "alignment" : "left" }, { "text" : "心室收缩时，主动脉压升高，在收缩期的中期达到最高值，此时的动脉血压称为收缩压。", "alignment" : "left" }, { "text" : "100～120mmHg", "alignment" : "left" }] }, { "content" : [{ "text" : "舒张压", "alignment" : "left" }, { "text" : "心室舒张时，主动脉压下降，在心舒末期动脉血压的最低值称为舒张压。", "alignment" : "left" }, { "text" : "60～80mmHg", "alignment" : "left" }] }, { "content" : [{ "text" : "脉压（脉搏压）", "alignment" : "left" }, { "text" : "收缩压和舒张压的差值", "alignment" : "left" }, { "text" : "30～40mmHg", "alignment" : "left" }] }, { "content" : [{ "text" : "平均动脉压", "alignment" : "left" }, { "text" : "一个心动周期中每一瞬间动脉血压的平均值称为平均动脉压。约为舒张压与1/3脉压之和。", "alignment" : "left" }, { "text" : "90mmHg", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "四、心血管活动的调节", "content" : [{ "type" : "common", "alignment" : "left", "text" : "心交感神经节后神经元末梢释放的递质为去甲肾上腺素，与心肌细胞膜上的β型肾上腺素能受体结合，导致心率加快，房室传导加快，心肌收缩力增强，这些效应分别成为正性变时作用、正性变传导作用和正性变力作用。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "心迷走神经节后纤维末梢释放的递质为乙酰胆碱，作用于心肌细胞膜的M型胆碱能受体，具有负性变时、变力和变传导作用。" }] }] }] }, { "title" : "第四章", "text" : "呼吸", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、肺通气", "alignment" : "left" }, { "text" : "（1）肺通气原理：肺通气的动力和阻力<br>（2）基本肺容积和肺容量<br>（3）肺通气量与肺泡通气量", "alignment" : "left" }] }, { "content" : [{ "text" : "二、肺换气和组织换气", "alignment" : "left" }, { "text" : "肺换气和组织换气的过程及其影响因素", "alignment" : "left" }] }, { "content" : [{ "text" : "三、气体在血液中的运输", "alignment" : "left" }, { "text" : "（1）氧和二氧化碳在血液中的运输形式<br>（2）血氧饱和度、氧解离曲线及影响因素", "alignment" : "left" }] }, { "content" : [{ "text" : "四、呼吸运动的调节", "alignment" : "left" }, { "text" : "化学因素对呼吸的调节", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、肺通气", "content" : [{ "type" : "common", "alignment" : "left", "text" : "呼吸运动的直接动力是肺泡与外界环境之间的压力差，原动力是呼吸肌的收缩和舒张引起的节律性呼吸运动。" }, { "type" : "h2", "alignment" : "left", "text" : "1. 呼吸运动与参与肌肉", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "呼吸气肌", "alignment" : "center" }, { "text" : "主要吸气肌—膈肌、肋间外肌；主要呼气肌—肋间内肌、腹肌", "alignment" : "left" }] }, { "content" : [{ "text" : "平静呼吸", "alignment" : "center" }, { "text" : "吸气是主动的，呼气是被动的", "alignment" : "left" }] }, { "content" : [{ "text" : "用力呼吸", "alignment" : "center" }, { "text" : "吸气、呼气都是主动的", "alignment" : "left" }] }, { "content" : [{ "text" : "腹式呼吸", "alignment" : "center" }, { "text" : "以膈肌舒缩活动为主", "alignment" : "left" }] }, { "content" : [{ "text" : "胸式呼吸", "alignment" : "center" }, { "text" : "以肋间外肌舒缩活动为主", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "用力呼吸时，吸气及呼气均为主动过程，吸气由膈肌、肋间外肌、辅助吸气肌参与；呼气时，吸气肌舒张，还有腹肌及肋间内肌参与收缩。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "平静呼吸时，吸气为主动过程，呼气为被动过程，吸气由膈肌、肋间外肌收缩完成；呼气由膈肌、肋间外肌舒张完成。" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 肺通气量与肺泡通气量指标", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "指标", "alignment" : "center" }, { "text" : "定义", "alignment" : "center" }, { "text" : "成人正常值", "alignment" : "center" }] }, { "content" : [{ "text" : "肺通气量", "alignment" : "center" }, { "text" : "是指每分钟呼出或吸入的气体总量", "alignment" : "left" }, { "text" : "6～9L", "alignment" : "center" }] }, { "content" : [{ "text" : "最大随意通气量", "alignment" : "center" }, { "text" : "尽力做深快呼吸时，每分钟呼出或吸入的最大气体量", "alignment" : "left" }, { "text" : "150L", "alignment" : "center" }] }, { "content" : [{ "text" : "解剖无效腔", "alignment" : "center" }, { "text" : "每次吸入的气体，一部分留在呼吸道，不参与肺泡与血液间的气体交换，这部分气道的容积称为解剖无效腔", "alignment" : "left" }, { "text" : "150ml", "alignment" : "center" }] }, { "content" : [{ "text" : "肺泡无效腔", "alignment" : "center" }, { "text" : "进入肺泡内的气体，因血流在肺内分布不均匀而不能都与血液进行气体交换，未能发生交换的这部分肺泡容量称肺泡无效腔", "alignment" : "left" }, { "text" : "—", "alignment" : "center" }] }, { "content" : [{ "text" : "生理无效腔", "alignment" : "center" }, { "text" : "解剖无效腔+肺泡无效腔", "alignment" : "left" }, { "text" : "—", "alignment" : "center" }] }, { "content" : [{ "text" : "肺泡通气量", "alignment" : "center" }, { "text" : "真正有效的气体交换量<br>（潮气量－无效腔气量）×呼吸频率。", "alignment" : "both" }, { "text" : "每次呼吸仅使肺内气体更新1/7", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "3. 肺容积和肺容量概念", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "肺总量", "alignment" : "left" }, { "text" : "肺所能容纳的最大气体量，由肺活量和残气量组成", "alignment" : "left" }] }, { "content" : [{ "text" : "深吸气量", "alignment" : "left" }, { "text" : "是指从平静呼吸呼气末做最大吸气时，所能吸入的气体量，是衡量最大通气潜力的重要指标", "alignment" : "left" }] }, { "content" : [{ "text" : "功能余气量", "alignment" : "left" }, { "text" : "平静呼气末尚存在于肺内气体量称为功能余气量，其意义为缓冲呼吸过程中肺泡气PO<sub>2</sub>和PCO<sub>2</sub>的变化幅度", "alignment" : "left" }] }, { "content" : [{ "text" : "余气量", "alignment" : "left" }, { "text" : "指最大呼气末尚存在于肺内不能呼出的气体量", "alignment" : "left" }] }, { "content" : [{ "text" : "补吸气量", "alignment" : "left" }, { "text" : "指平静吸气末，再尽力吸气所能吸入的气体量，反映吸气的储备量", "alignment" : "left" }] }, { "content" : [{ "text" : "补呼气量", "alignment" : "left" }, { "text" : "指平静呼气末，再尽力呼气所能呼出的气体量，反映呼气的储备量", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "二、肺换气和组织换气", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肺换气以气体扩散方式进行，气体分子从压力高处向压力低处发生净转移，因此气体交换的关键是交换部位两侧的气压差，是气体交换的动力。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肺泡表面活性物质的功能有：1. 降低肺泡表面张力，有助于肺泡稳定性；2. 减少肺泡组织液生成，防止肺水肿；3. 降低吸气阻力，减少吸气做功；4. 防止肺不张，可使肺顺应性变大，减少肺弹性阻力。" }] }] }, { "type" : "h1", "text" : "三、气体在血液中的运输", "content" : [{ "type" : "common", "alignment" : "left", "text" : "CO2在血液中的运输形式有两种，一种为物理溶解，约占5%，余为化学结合，其中88%与碳酸氢盐结合，余下7%与氨基甲酰血红蛋白结合。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "O2在血液中的运输包括物理溶解（占1.5%）及化学结合（与氧合血红蛋白结合，占98.5%）。" }] }] }, { "type" : "h1", "text" : "四、呼吸运动的调节", "content" : [{ "type" : "common", "alignment" : "left", "text" : "化学感受器的分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "外周化学感受器", "alignment" : "left" }, { "text" : "中枢化学感受器", "alignment" : "left" }] }, { "content" : [{ "text" : "部位", "alignment" : "left" }, { "text" : "颈动脉体（主要调节呼吸）<br>主动脉体（主要调节循环）", "alignment" : "both" }, { "text" : "延髓腹外侧浅表部位的头端、尾端（中间区不具备化学感受器）", "alignment" : "left" }] }, { "content" : [{ "text" : "感受器", "alignment" : "left" }, { "text" : "颈动脉体I型细胞", "alignment" : "left" }, { "text" : "生理刺激是脑脊液和局部细胞外液中的H<sup>+</sup>", "alignment" : "left" }] }, { "content" : [{ "text" : "特点", "alignment" : "left" }, { "text" : "1. 适宜刺激物为H<sup>+</sup>、PaCO<sub>2. </sub>PaO<sub>2</sub>；<br>2. 感受的是PaO<sub>2</sub>，而不是O<sub>2</sub>；<br>3. 对PCO<sub>2</sub>的突然增高的调节反应快", "alignment" : "both" }, { "text" : "1. 适宜的刺激物为H<sup>+</sup>、CO<sub>2</sub>；<br>2. 对缺O<sub>2</sub>不敏感，但对H<sup>+</sup>的敏感性高；<br>3. 对PCO<sub>2</sub>的突然增高的调节反应慢", "alignment" : "both" }] }, { "content" : [{ "text" : "生理功能", "alignment" : "left" }, { "text" : "在机体低O<sub>2</sub>时，维持对呼吸的驱动", "alignment" : "left" }, { "text" : "调节脑脊液的H<sup>+</sup>浓度<br>使中枢系统有一定的稳定性", "alignment" : "both" }] }] }] }] }] }, { "title" : "第五章", "text" : "消化和吸收", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、胃肠神经体液调节的一般规律", "alignment" : "left" }, { "text" : "（1）胃肠的神经支配及其作用<br>（2）胃肠激素及其作用", "alignment" : "left" }] }, { "content" : [{ "text" : "二、口腔内消化", "alignment" : "left" }, { "text" : "（1）唾液的性质、成分和作用<br>（2）唾液分泌的调节", "alignment" : "left" }] }, { "content" : [{ "text" : "三、胃内消化", "alignment" : "left" }, { "text" : "（1）胃液的性质、成分和作用<br>（2）胃液分泌的调节<br>（3）胃的运动：胃的容受性舒张和蠕动，胃排空及其控制", "alignment" : "left" }] }, { "content" : [{ "text" : "四、小肠内消化", "alignment" : "left" }, { "text" : "（1）胰液和胆汁的性质、成分及作用<br>（2）小肠的运动形式，回盲括约肌的功能", "alignment" : "left" }] }, { "content" : [{ "text" : "五、大肠内消化", "alignment" : "left" }, { "text" : "排便反射", "alignment" : "left" }] }, { "content" : [{ "text" : "六、吸收", "alignment" : "left" }, { "text" : "小肠的吸收功能：吸收的条件和方式，食物中主要成分的吸收", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、胃肠神经体液调节的一般规律", "content" : [{ "type" : "common", "alignment" : "left", "text" : "消化道内副交感节后纤维主要为胆碱能纤维，兴奋时释放乙酰胆碱，通过激活M受体，可使消化道收缩，腺体分泌增多，而消化道括约肌松弛。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "支配消化道的交感神经兴奋时，消化运动减弱，腺体分泌抑制、血流减少，而消化道括约肌却收缩。" }] }] }, { "type" : "h1", "text" : "二、口腔内消化", "content" : [{ "type" : "common", "alignment" : "left", "text" : "唾液中水约占99%，有机物主要是黏蛋白，还有免疫球蛋白、唾液淀粉酶、溶菌酶等，无机物为各种离子。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "唾液分泌部位为唾液腺（腮腺、颌下腺、舌下腺），唾液的渗透压随分泌率的变化而有所不同，在最大分泌率时渗透压可接近血浆。" }] }] }, { "type" : "h1", "text" : "三、胃内消化", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 胃的分泌腺及其分布与功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "分泌腺或细胞", "alignment" : "left" }, { "text" : "分布部位", "alignment" : "left" }, { "text" : "主要功能", "alignment" : "left" }, { "text" : "分泌性质", "alignment" : "left" }] }, { "content" : [{ "text" : "贲门腺", "alignment" : "left" }, { "text" : "胃与食管连接处", "alignment" : "left" }, { "text" : "黏液细胞分泌稀薄的碱性黏液", "alignment" : "left" }, { "text" : "外分泌", "alignment" : "left", "rowSpan" : 4 }] }, { "content" : [{ "text" : "泌酸腺", "alignment" : "left" }, { "text" : "胃底、胃体", "alignment" : "left" }, { "text" : "壁细胞分泌盐酸和内因子；主细胞分泌胃蛋白酶原；颈黏液细胞分泌黏液", "alignment" : "left" }] }, { "content" : [{ "text" : "幽门腺", "alignment" : "left" }, { "text" : "幽门部", "alignment" : "left" }, { "text" : "分泌碱性黏液", "alignment" : "left" }] }, { "content" : [{ "text" : "上皮细胞", "alignment" : "left" }, { "text" : "胃的所有区域", "alignment" : "left" }, { "text" : "分泌粘稠黏液", "alignment" : "left" }] }, { "content" : [{ "text" : "G细胞", "alignment" : "left" }, { "text" : "胃窦部", "alignment" : "left" }, { "text" : "分泌胃泌素和ACTH样物质", "alignment" : "left" }, { "text" : "内分泌", "alignment" : "left", "rowSpan" : 3 }] }, { "content" : [{ "text" : "δ细胞", "alignment" : "left" }, { "text" : "胃底、胃体和胃窦", "alignment" : "left" }, { "text" : "分泌生长抑素", "alignment" : "left" }] }, { "content" : [{ "text" : "肠嗜铬细胞", "alignment" : "left" }, { "text" : "胃泌酸区黏膜内", "alignment" : "left" }, { "text" : "合成和释放组胺", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 胃液的成分及其主要生理功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "胃液成分", "alignment" : "center" }, { "text" : "分泌细胞", "alignment" : "center" }, { "text" : "主要功能", "alignment" : "center" }] }, { "content" : [{ "text" : "盐酸（胃酸）", "alignment" : "center" }, { "text" : "壁细胞", "alignment" : "left" }, { "text" : "1.激活胃蛋白酶原；<br>2.促使蛋白质的变性，使之易吸收；<br>3.杀灭细菌；<br>4.促进小肠铁钙吸收；<br>5.促进促胰液素、缩胆囊素的释放，促进胰液、胆汁、小肠液分泌，可抑制胃酸分泌（负反馈抑制）", "alignment" : "both" }] }, { "content" : [{ "text" : "胃蛋白酶原", "alignment" : "center" }, { "text" : "主细胞为主，黏液颈细胞、黏液细胞", "alignment" : "left" }, { "text" : "水解蛋白质生成胨、多肽及氨基酸；<br>已被激活的胃蛋白酶可自我激活胃蛋白酶原（正反馈）", "alignment" : "both" }] }, { "content" : [{ "text" : "胃的粘液", "alignment" : "center" }, { "text" : "上皮细胞、黏液颈细胞、贲门腺、幽门腺", "alignment" : "left" }, { "text" : "1.润滑作用；<br>2.保护胃黏膜；<br>3.为中性或弱碱性，降低胃酸度；<br>4.减慢H<sup>+</sup>向胃壁扩散速度。", "alignment" : "both" }] }, { "content" : [{ "text" : "碳酸氢盐", "alignment" : "center" }, { "text" : "胃黏膜非泌酸细胞", "alignment" : "left" }, { "text" : "黏液—碳酸氢盐屏障保护胃黏膜免受H<sup>+</sup>及胃蛋白酶对胃黏膜的伤害", "alignment" : "left" }] }, { "content" : [{ "text" : "内因子", "alignment" : "center" }, { "text" : "壁细胞", "alignment" : "left" }, { "text" : "与维生素B<sub>12</sub>结合，促进回肠对其吸收，缺乏可致巨幼细胞性贫血", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "胃排空的调节：十二指肠可通过肠-胃反射抑制胃排空，促胰液素、缩胆囊素、抑胃肽等可抑制胃运动。迷走-迷走反射及壁内神经丛反射为胃内促进胃排空的因素。" }] }] }] }, { "type" : "h1", "text" : "四、小肠内消化", "content" : [{ "type" : "common", "alignment" : "left", "text" : "小肠的特点：小肠内面黏膜存在环状皱裂、绒毛和微绒毛，可使小肠的吸收面积比同样长短的圆筒吸收面积增加约600倍，食物在小肠停留时间较长，且在小肠内已被消化为适于吸收的小分子物质，这些都为小肠在吸收中发挥作用的有利条件。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "神经及胃肠激素对胰液分泌的调节", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "迷走神经兴奋", "alignment" : "left" }, { "text" : "促胰液素（胰泌素）", "alignment" : "left" }, { "text" : "缩胆囊素（CCK、促胰酶素）", "alignment" : "left" }] }, { "content" : [{ "text" : "刺激因素", "alignment" : "left" }, { "text" : "食物", "alignment" : "left" }, { "text" : "胃酸最强、蛋白质分解产物次之、糖类最弱", "alignment" : "left" }, { "text" : "蛋白分解产物最强、脂肪酸次之、糖类最弱", "alignment" : "left" }] }, { "content" : [{ "text" : "作用部位", "alignment" : "left" }, { "text" : "胰腺腺泡细胞（主要分泌胰酶）", "alignment" : "left" }, { "text" : "胰腺导管细胞（主要分泌水分及碳酸氢盐）", "alignment" : "left" }, { "text" : "胰腺腺泡细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "分泌特点", "alignment" : "left" }, { "text" : "少量水分、碳酸氢盐，大量酶", "alignment" : "left" }, { "text" : "大量水分、碳酸氢盐，少量酶", "alignment" : "left" }, { "text" : "少量水分、碳酸氢盐，大量酶", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "胰液主要由腺泡细胞分泌的胰酶及导管细胞分泌的碳酸氢根及水分组成，每日分泌量在1～2升，pH约为8.0左右，胰液有很强的消化能力，可中和进入十二指肠的胃酸，保护肠黏膜免受强酸的侵蚀，弱碱环境可为小肠内多种消化酶提供最适宜的pH环境。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肠激酶可使胰蛋白酶原转变为胰蛋白酶。能将胰蛋白酶原转变为胰蛋白酶的物质有肠激酶、胃酸、胰蛋白酶本身及组织液等，最重要的为肠激酶。胃酸可使胃蛋白酶原转变为胃蛋白酶。" }] }] }] }] }] }, { "type" : "h1", "text" : "五、吸收", "content" : [{ "type" : "common", "alignment" : "left", "text" : "铁的吸收是一个主动的过程，吸收部位主要在小肠上部。铁以Fe2+的形式通过主动转运，从小肠上部吸收，维生素C及胃酸可促进铁的吸收。大多数维生素都在小肠上段吸收，但维生素B12在回肠被其主动吸收。十二指肠对钙的吸收能力最强。" }] }] }, { "title" : "第六章", "text" : "能量代谢", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、能量代谢", "alignment" : "left" }, { "text" : "（1）影响能量代谢的因素<br>（2）基础代谢率", "alignment" : "left" }] }, { "content" : [{ "text" : "二、体温", "alignment" : "left" }, { "text" : "（1）体温的概念及其正常变动<br>（2）体热平衡：产热和散热<br>（3）体温调节：温度感受器，体温调节中枢，调节机制，<br>调定点学说", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、能量代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "成年人在饥饿24h内靠消耗体内储备的肝糖原供能。脂肪酸在人体耗尽储备肝糖原后，由脂肪分解产生供能；肌蛋白是在人体处于某些特殊情况下，如长期不能进食或体力极度消耗时分解供能。ATP是直接供能物质，最先消耗，糖原其次消耗，再次脂肪，最后蛋白质。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "基础代谢率：基础状态（清醒、安静、不受肌肉活动、精神紧张、食物及环境温度等因素影响时的状态）下单位时间的能量代谢。基础代谢率与体表面积成正比，与体重不成比例关系。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "影响基础代谢率最主要的就是甲状腺激素，甲亢时升高，甲减时降低。" }] }] }] }, { "type" : "h1", "text" : "二、体温", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 产热和散热", "content" : [{ "type" : "common", "alignment" : "left", "text" : "安静时肝脏是主要产热器官，运动时骨骼肌是主要的产热器官。人体的主要散热部位是皮肤。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "人体的几种散热方式", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "4种散热形式", "alignment" : "left" }, { "text" : "特点", "alignment" : "left" }] }, { "content" : [{ "text" : "辐射散热", "alignment" : "left" }, { "text" : "皮肤温度＞环境温度，以发射红外线的形式传热，散热量取决于皮肤与环境温差及机体有效散热面积", "alignment" : "left" }] }, { "content" : [{ "text" : "传导散热", "alignment" : "left" }, { "text" : "皮肤温度＞环境温度，热量直接传给与之接触的物体，散热量取决于皮肤与环境温差及物体的导热性能，如冰帽、冰袋", "alignment" : "left" }] }, { "content" : [{ "text" : "对流散热", "alignment" : "left" }, { "text" : "皮肤温度＞环境温度，以风的形式将热量带走，散热量取决于皮肤与环境温差及风速", "alignment" : "left" }] }, { "content" : [{ "text" : "蒸发散热", "alignment" : "left" }, { "text" : "环境温度＞皮肤温度时，唯一有效的散热方式，分不感蒸发和发汗，通过体表水分蒸发带走热量，如临床上用酒精擦拭降温", "alignment" : "left" }] }] }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 体温调节", "content" : [{ "type" : "common", "alignment" : "left", "text" : "体温调节的基本中枢在下丘脑。下丘脑的视前区—下丘脑前部（PO/AH）中的某些温度敏感神经元不仅感受局部脑温的变化，而且能对下丘脑以外的部位，如中脑、延髓、脊髓，以及皮肤、内脏等处的温度变化发生反应。PO/AH为体温调节中枢整合机构的中心部位。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "体温调定点学说认为，体温的调节类似于恒温器的调节。如果某种原因使调定点向高温侧移动，发热初期体温低于新的调定点水平，则机体出现皮肤血管收缩、减少散热，随即出现寒战等产热反应，直至体温上升至新调定点。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "外源性致热源不能直接作用于体温调节中枢，需通过内源性致热源发挥作用，如病原微生物及其产物。内源性致热源由中性粒细胞、嗜酸粒细胞和单核巨噬细胞所释放，又称为白细胞致热源，可通过血脑屏障直接作用于体温调节中枢，使体温调定点上升，导致产热增加，散热减少，体温上升。" }] }] }] }] }] }, { "title" : "第七章", "text" : "尿的生成和排出", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、肾小球的滤过功能", "alignment" : "left" }, { "text" : "（1）肾小球的滤过率和滤过分数<br>（2）影响肾小球滤过作用及其影响因素　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、肾小管与集合管的转运功能", "alignment" : "left" }, { "text" : "（1）对Na<sup>+</sup>、Cl<sup>-</sup>、水、HCO<sub>3</sub><sup>-</sup>、葡萄糖和氨基酸的重吸收<br>（2）对H<sup>+</sup>、NH<sub>3</sub>和NH<sub>4</sub><sup>+</sup>的分泌　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、尿生成的调节", "alignment" : "left" }, { "text" : "（1）小管液中溶质的浓度<br>（2）神经和体液调节：肾交感神经，抗利尿激素，肾素-<br>血管紧张素-醛固酮系统　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、血浆清除率", "alignment" : "left" }, { "text" : "血浆清除率的概念、计算方法及其应用", "alignment" : "left" }] }, { "content" : [{ "text" : "五、尿的排放", "alignment" : "left" }, { "text" : "（1）排尿反射<br>（2）正常和异常尿量，低渗尿和高渗尿的概念　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、肾小球的滤过功能", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肾小球滤过率是指单位时间内（每分钟）两肾生成的超滤液。正常成年人的肾小球滤过率平均值为125ml/min，正常成人两肾每天生成的超滤液达180L。" }] }, { "type" : "h1", "text" : "二、肾小管与集合管的转运功能", "content" : [{ "type" : "common", "alignment" : "left", "text" : "正常成人两肾每天生成的超滤液达180L，终尿仅1.5L左右。超滤液中的水分约99%都被肾小管和集合管重吸收。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肾小管中，近端小管是Na+、Cl-和水重吸收的主要部位。Na+的重吸收主要受醛固酮的调节，水的重吸收主要受抗利尿激素的调节。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "HCO3-是以CO2形式重吸收，肾小管对HCO3-重吸收优先于Cl-的重吸收，若HCO3-滤过量超过H+的分泌量，多余部分随尿排出。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肾小管和集合管上皮细胞均可分泌H+，NH3主要以扩散的方式进入小管液，与H+结合形成NH4+，随尿排出。" }] }] }] }] }, { "type" : "h1", "text" : "三、尿生成的调节", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 常见与尿液生成相关的现象及其意义", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "常见现象", "alignment" : "left" }, { "text" : "生理意义", "alignment" : "left" }] }, { "content" : [{ "text" : "1. 糖尿病病人多尿；<br>2. 正常人大量进食葡萄糖后多尿；<br>3. 静脉注射高渗葡萄糖、甘露醇后多尿", "alignment" : "both" }, { "text" : "渗透性利尿", "alignment" : "left" }] }, { "content" : [{ "text" : "大量饮清水后多尿（水利尿）", "alignment" : "left" }, { "text" : "血浆晶体渗透压下降", "alignment" : "left" }] }, { "content" : [{ "text" : "大量饮用等渗盐水后尿量不少", "alignment" : "left" }, { "text" : "体液量增加，渗透压不高（无高渗尿）", "alignment" : "left" }] }, { "content" : [{ "text" : "失水、禁水后少尿", "alignment" : "left" }, { "text" : "血浆晶体渗透压升高", "alignment" : "left" }] }, { "content" : [{ "text" : "大量出汗、严重呕吐或腹泻后少尿", "alignment" : "left" }, { "text" : "血浆晶体渗透压升高，抗利尿激素分泌增加", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "尿液生成受肾内自身调节、神经调节和体液调节。肾脏可以产生缓激肽，促进肾小动脉舒张，抑制集合管对Na+和水的重吸收；肾脏还可以产生PGE2和PGI2，舒张小动脉，增加肾血流，抑制近端小管和髓袢升支粗段对Na+的重吸收。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "抗利尿激素又名血管升压素，主要由下丘脑视上核分泌，作用于肾脏远曲小管和集合管，使其对水通透性增加，进而对水重吸收增加，尿量减少，血压升高。中枢性尿崩症是由于抗利尿激素分泌不足致尿量增多。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "促进抗利尿激素释放的最重要因素为血浆晶体渗透压升高。大量出汗时，人体水分丢失过多，会使血浆晶体浓度相对升高，血浆晶体渗透压升高，刺激下丘脑视上核分泌抗利尿激素，促进水的重吸收，使尿量减少。" }] }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 血管升压素及醛固酮对尿量生成的作用", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "血管升压素（抗利尿激素、ADH）", "alignment" : "left" }, { "text" : "醛固酮", "alignment" : "left" }] }, { "content" : [{ "text" : "生成部位", "alignment" : "left" }, { "text" : "下丘脑视上核（主要）、室旁核（少量）合成，", "alignment" : "left" }, { "text" : "肾上腺皮质的球状带合成和释放", "alignment" : "left" }] }, { "content" : [{ "text" : "作用部位", "alignment" : "left" }, { "text" : "远曲小管、集合管", "alignment" : "left", "colSpan" : 2 }] }, { "content" : [{ "text" : "作用机制", "alignment" : "left" }, { "text" : "增加作用部位对水通透性", "alignment" : "left" }, { "text" : "增加作用部位对水、钠重吸收，增加对钾排放", "alignment" : "left" }] }, { "content" : [{ "text" : "作用结果", "alignment" : "left" }, { "text" : "水重吸收增加，尿量减少，血压升高", "alignment" : "left" }, { "text" : "保钠排钾，对水、氯重吸收增加", "alignment" : "left" }] }, { "content" : [{ "text" : "生成因素", "alignment" : "left" }, { "text" : "血浆晶体渗透压增高（最重要）<br>血容量减少（次重要）<br>恶心、疼痛、应激、低血糖等", "alignment" : "both" }, { "text" : "血钠下降、血钾升高，肾素—血管紧张素作用均可使醛固酮生成增加", "alignment" : "left" }] }] }] }] }] }, { "title" : "第八章", "text" : "神经系统的功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、突触传递", "alignment" : "left" }, { "text" : "（1）经典突触的传递过程，兴奋性突触后电位与抑制性突<br>触后电位及其产生的原理<br>（2）中枢兴奋传播的特征<br>（3）外周神经递质和受体：乙酰胆碱及其受体；去甲肾上<br>腺素及其受体　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、神经反射", "alignment" : "left" }, { "text" : "（1）反射与反射弧<br>（2）非条件反射和条件反射<br>（3）反射活动的反馈调节：负反馈和正反馈　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、神经系统的感觉分析功能", "alignment" : "left" }, { "text" : "（1）感觉的特异投射系统和非特异投射系统<br>（2）内脏痛与牵涉痛　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、脑电活动", "alignment" : "left" }, { "text" : "正常脑电图的波形及其意义　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、神经系统对姿势和躯体运动的调节", "alignment" : "left" }, { "text" : "（1）骨骼肌牵张反射<br>（2）低位脑干对肌紧张的调节<br>（3）小脑的主要功能<br>（4）基底神经节的运动调节功能　", "alignment" : "left" }] }, { "content" : [{ "text" : "六、神经系统对内脏活动的调节", "alignment" : "left" }, { "text" : "（1）交感和副交感神经系统的功能<br>（2）脊髓、低位脑干和下丘脑对内脏活动的调节　", "alignment" : "left" }] }, { "content" : [{ "text" : "七、脑的高级功能", "alignment" : "left" }, { "text" : "（1）大脑皮层的语言中枢<br>（2）大脑皮层功能的一侧优势　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、突触传递", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 神经纤维传导兴奋的特点与突触传递、中枢兴奋传递的特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "神经纤维传导兴奋特点", "alignment" : "left" }, { "text" : "突触传递特点", "alignment" : "left" }, { "text" : "中枢兴奋传播特点", "alignment" : "left" }] }, { "content" : [{ "text" : "双向性<br>完整性<br>绝缘性<br>相对不疲劳性", "alignment" : "both" }, { "text" : "单向传导<br>突触延搁<br>易疲劳<br>对内环境变化敏感", "alignment" : "both" }, { "text" : "单向传布<br>中枢延搁<br>易疲劳<br>对内环境变化敏感<br>后发放", "alignment" : "both" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 抑制性与兴奋性突触后电位的比较", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "兴奋性突触后电位（EPSP）", "alignment" : "left" }, { "text" : "抑制性突触后电位（IPSP）", "alignment" : "left" }] }, { "content" : [{ "text" : "神经递质（作用于突触后膜）", "alignment" : "left" }, { "text" : "兴奋性", "alignment" : "left" }, { "text" : "抑制性", "alignment" : "left" }] }, { "content" : [{ "text" : "后膜电位变化", "alignment" : "left" }, { "text" : "去极化", "alignment" : "left" }, { "text" : "超极化", "alignment" : "left" }] }, { "content" : [{ "text" : "突触后膜对刺激的兴奋性", "alignment" : "left" }, { "text" : "兴奋性增高", "alignment" : "left" }, { "text" : "兴奋性降低", "alignment" : "left" }] }, { "content" : [{ "text" : "产生机制", "alignment" : "left" }, { "text" : "递质作用于突触后膜，突触后膜对钠和钾通透性增高，导致突触后膜去极化", "alignment" : "left" }, { "text" : "后膜对氯通透性增强，氯内流，超极化；钾通透性增高及钠、钙通道关闭", "alignment" : "left" }] }, { "content" : [{ "text" : "离子流向", "alignment" : "left" }, { "text" : "钠大量内流，钾少量外流", "alignment" : "left" }, { "text" : "氯大量内流，钾少量外流", "alignment" : "left" }] }, { "content" : [{ "text" : "特点", "alignment" : "left" }, { "text" : "可以总和，为局部电位", "alignment" : "left" }, { "text" : "可以总和，为局部电位", "alignment" : "left" }] }, { "content" : [{ "text" : "对突触后神经元影响", "alignment" : "left" }, { "text" : "易兴奋", "alignment" : "left" }, { "text" : "更不易兴奋", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "突触前抑制的结构基础是轴突—轴突突触，表现为突触前膜被兴奋性递质去极化，使膜电位绝对值变小，释放的兴奋性递质减少，导致突触后兴奋性突触后电位（EPSP）减小，最终降低突触后神经元兴奋性。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "突触后抑制都由抑制性中间神经元释放抑制性递质，使突触后神经元产生IPSP而引起，包括传入侧支性抑制和回返性抑制。" }] }] }] }] }, { "type" : "h1", "text" : "二、神经反射", "content" : [{ "type" : "common", "alignment" : "left", "text" : "非条件反射：先天/少数的/固定/低级/（基础）防御反射、食物反射、性反射", "content" : [{ "type" : "common", "alignment" : "left", "text" : "条件反射：后天/无数的/可消退/高级" }] }] }, { "type" : "h1", "text" : "三、神经系统的感觉分析功能", "content" : [{ "type" : "common", "alignment" : "left", "text" : "特异投射系统：有点对点的投射关系，引起特异的感觉。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "非特异投射系统：弥散地投射到大脑皮层广泛区域，维持和改变其兴奋状态，但不产生特异的感觉。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "耳蜗为听觉感受器，能将机械振动转换为听神经纤维的神经冲动，与听觉有关。半规管、椭圆囊、球囊是前庭器官，为位置感受器，在保持身体的平衡中起重要作用。" }] }] }] }, { "type" : "h1", "text" : "四、脑电活动", "content" : [{ "type" : "common", "alignment" : "left", "text" : "正常人4种脑电波及其意义等", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "δ波", "alignment" : "left" }, { "text" : "θ波", "alignment" : "left" }, { "text" : "α波", "alignment" : "left" }, { "text" : "β波", "alignment" : "left" }] }, { "content" : [{ "text" : "常见部位", "alignment" : "left" }, { "text" : "颞叶、枕叶", "alignment" : "left" }, { "text" : "颞叶、顶叶", "alignment" : "left" }, { "text" : "枕叶", "alignment" : "left" }, { "text" : "额叶、顶叶", "alignment" : "left" }] }, { "content" : [{ "text" : "出现条件", "alignment" : "left" }, { "text" : "婴幼儿正常脑电波；成人熟睡时", "alignment" : "left" }, { "text" : "少年正常脑电波；成人困倦时", "alignment" : "left" }, { "text" : "成人安静闭目清醒", "alignment" : "left" }, { "text" : "成人活动时", "alignment" : "left" }] }, { "content" : [{ "text" : "意义", "alignment" : "left" }, { "text" : "高幅慢波<br>同步化，抑制状态", "alignment" : "both" }, { "text" : "高幅慢波<br>同步化，抑制状态", "alignment" : "both" }, { "text" : "高幅慢波<br>同步化，抑制状态", "alignment" : "both" }, { "text" : "低幅慢波<br>去同步化，兴奋状态", "alignment" : "both" }] }] }] }] }, { "type" : "h1", "text" : "五、神经系统对姿势和躯体运动的调节", "content" : [{ "type" : "common", "alignment" : "left", "text" : "牵张反射是指骨骼肌受外力牵拉时引起受牵连的同一肌肉收缩的反射活动，包括腱反射和肌紧张。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肌紧张是维持躯体姿势最基本的反射活动，是姿势反射的基础。对侧伸肌反射是一种姿势反射，在保持躯体平衡中有重要意义。屈肌反射具有保护意义，不属于姿势反射。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "腱反射和肌紧张的比较", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "腱反射（动态牵张反射）", "alignment" : "left" }, { "text" : "肌紧张（静态牵张反射）", "alignment" : "left" }] }, { "content" : [{ "text" : "性质", "alignment" : "left" }, { "text" : "位相性牵张反射", "alignment" : "left" }, { "text" : "紧张性牵张反射", "alignment" : "left" }] }, { "content" : [{ "text" : "定义", "alignment" : "left" }, { "text" : "快速牵拉肌腱发生的牵张反射", "alignment" : "left" }, { "text" : "缓慢持续牵拉肌腱发生的牵张反射", "alignment" : "left" }] }, { "content" : [{ "text" : "作用", "alignment" : "left" }, { "text" : "肌肉的快速收缩，产生动作", "alignment" : "left" }, { "text" : "受牵拉肌肉紧张性收缩，阻止被拉长", "alignment" : "left" }] }, { "content" : [{ "text" : "感受器", "alignment" : "left" }, { "text" : "肌梭", "alignment" : "left" }, { "text" : "肌梭", "alignment" : "left" }] }] }] }] }] }] }, { "type" : "h1", "text" : "六、神经系统对内脏活动的调节", "content" : [{ "type" : "common", "alignment" : "left", "text" : "被狗撵后，瞳孔、心跳、呼吸、肠蠕动、腺体变化=交感神经变化", "content" : [{ "type" : "common", "alignment" : "left", "text" : "夜间睡觉时，瞳孔、心跳、呼吸、肠蠕动、腺体变化=迷走神经变化" }] }] }] }, { "title" : "第九章", "text" : "内分泌", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、下丘脑的内分泌功能", "alignment" : "left" }, { "text" : "（1）下丘脑与垂体之间的功能联系<br>（2）下丘脑调节肽", "alignment" : "left" }] }, { "content" : [{ "text" : "二、垂体的内分泌功<br>能", "alignment" : "left" }, { "text" : "（1）腺垂体和神经垂体激素<br>（2）生长素的生物学作用及其分泌调节", "alignment" : "left" }] }, { "content" : [{ "text" : "三、甲状腺激素", "alignment" : "left" }, { "text" : "（1）生物学作用<br>（2）分泌调节", "alignment" : "left" }] }, { "content" : [{ "text" : "四、与钙、磷代谢调节有关的激素", "alignment" : "left" }, { "text" : "（1）甲状旁腺激素的生物学作用及其分泌调节<br>（2）降钙素的生物学作用及其分泌调节<br>（3）维生素D<sub>3</sub>的生物学作用及其生成调节", "alignment" : "left" }] }, { "content" : [{ "text" : "五、肾上腺糖皮质激素", "alignment" : "left" }, { "text" : "（1）生物学作用<br>（2）分泌调节", "alignment" : "left" }] }, { "content" : [{ "text" : "六、胰岛素", "alignment" : "left" }, { "text" : "（1）生物学作用<br>（2）分泌调节", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、下丘脑的内分泌功能", "content" : [{ "type" : "common", "alignment" : "left", "text" : "下丘脑调节肽：促甲状腺激素释放激素（TRH）、促性腺激素释放激素（GnRH）、生长激素抑制激素（SS）、生长激素释放激素（GHRH）、促肾上腺皮质激素释放激素（CRH）、促黑素细胞激素释放因子（MRF）、促黑素细胞激素抑制因子（MIF）、催乳素释放肽（PRP）、催乳素释放抑制因子（PIF）。" }] }, { "type" : "h1", "text" : "二、垂体的内分泌功能", "content" : [{ "type" : "common", "alignment" : "left", "text" : "腺垂体主要分泌7种激素，其中促甲状腺激素（TSH）、促肾上腺皮质激素（ACTH）、黄体生成素（LH）、卵泡刺激素（FSH）均有各自的靶腺，分别作用于甲状腺、肾上腺皮质和性腺。" }] }, { "type" : "h1", "text" : "三、甲状腺激素", "content" : [{ "type" : "common", "alignment" : "left", "text" : "甲状腺激素是胎儿和新生儿脑发育的关键激素，是影响神经系统发育最重要的激素，亦是促进生长发育必不可少的因素。甲状腺激素可增加组织耗氧量，促进产热；促进婴幼儿脑和骨的发育；增加糖原分解和糖异生；提高神经系统的兴奋性。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "几种常见激素的主要生理作用", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "激素名称", "alignment" : "left" }, { "text" : "主要生理作用", "alignment" : "left" }] }, { "content" : [{ "text" : "生长激素", "alignment" : "left" }, { "text" : "促进生长发育（不能促进神经系统发育）", "alignment" : "left" }] }, { "content" : [{ "text" : "甲状腺激素", "alignment" : "left" }, { "text" : "促进生长发育（促进神经系统发育）", "alignment" : "left" }] }, { "content" : [{ "text" : "胰岛素", "alignment" : "left" }, { "text" : "降低血糖，促进脂肪、蛋白质合成", "alignment" : "left" }] }, { "content" : [{ "text" : "降钙素", "alignment" : "left" }, { "text" : "降低血钙、血磷", "alignment" : "left" }] }, { "content" : [{ "text" : "甲状旁腺激素", "alignment" : "left" }, { "text" : "升血钙、降血磷", "alignment" : "left" }] }, { "content" : [{ "text" : "醛固酮", "alignment" : "left" }, { "text" : "保钠、保水，排钾", "alignment" : "left" }] }] }] }] }] }, { "type" : "h1", "text" : "四、与钙、磷代谢调节有关的激素", "content" : [{ "type" : "common", "alignment" : "left", "text" : "调节钙磷代谢的激素", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "甲状旁腺激素（PTH）", "alignment" : "left" }, { "text" : "降钙素（CT）", "alignment" : "left" }, { "text" : "1,25—二羟维生素D<sub>3</sub>", "alignment" : "left" }] }, { "content" : [{ "text" : "生成部位", "alignment" : "left" }, { "text" : "甲状旁腺主细胞分泌", "alignment" : "left" }, { "text" : "甲状腺C细胞（甲状腺滤泡旁细胞）分泌", "alignment" : "left" }, { "text" : "由7—脱氢胆固醇转化而来，或动物食物中获取", "alignment" : "left" }] }, { "content" : [{ "text" : "作用部位", "alignment" : "left" }, { "text" : "肾、骨", "alignment" : "left" }, { "text" : "肾、骨", "alignment" : "left" }, { "text" : "广泛分布，主要为小肠、骨、肾", "alignment" : "left" }] }, { "content" : [{ "text" : "主要作用", "alignment" : "left" }, { "text" : "升血钙、降血磷", "alignment" : "left" }, { "text" : "降血钙、降血磷", "alignment" : "left" }, { "text" : "升血钙、升血磷", "alignment" : "left" }] }, { "content" : [{ "text" : "作用机制", "alignment" : "left" }, { "text" : "促进骨钙入血；<br>促进近端小管对钙吸收；<br>抑制近端小管对磷吸收", "alignment" : "both" }, { "text" : "抑制破骨细胞活动；<br>促进骨组织中钙磷沉积；<br>抑制肾小管对钙磷吸收", "alignment" : "both" }, { "text" : "促进小肠对钙和磷的吸收；<br>调节骨钙的沉积和释放；<br>促进肾小管对钙磷吸收", "alignment" : "both" }] }, { "content" : [{ "text" : "调节机制", "alignment" : "left" }, { "text" : "血钙浓度（最重要），血磷浓度，正常人日节律波动", "alignment" : "left" }, { "text" : "血钙浓度（主要因素）", "alignment" : "left" }, { "text" : "维生素D、血钙浓度、血磷浓度，PTH促进其分泌，雌激素影响其生成", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "五、肾上腺糖皮质激素", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肾上腺皮质激素包括由球状带分泌的盐皮质激素（醛固酮），由束状带分泌的糖皮质激素（皮质醇），以及由网状带分泌的性激素及少量糖皮质激素，分别调节水盐平衡、物质代谢、性器官发育等。" }] }, { "type" : "h1", "text" : "六、胰岛素", "content" : [{ "type" : "common", "alignment" : "left", "text" : "胰高血糖素由胰岛A细胞分泌；胰岛素由胰岛B细胞分泌；胰岛素可作用于胰岛A细胞，抑制胰高血糖素分泌。" }] }] }, { "title" : "第十章", "text" : "生殖", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、男性生殖", "alignment" : "left" }, { "text" : "睾酮的生理作用及其分泌调节", "alignment" : "left" }] }, { "content" : [{ "text" : "二、女性生殖", "alignment" : "left" }, { "text" : "（1）雌激素、孕激素的生理作用<br>（2）卵巢和子宫周期性变化的激素调节", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "雌激素和孕激素的不同作用比较", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "部位", "alignment" : "left" }, { "text" : "雌激素", "alignment" : "left" }, { "text" : "孕激素", "alignment" : "left" }] }, { "content" : [{ "text" : "子宫肌", "alignment" : "left" }, { "text" : "增加子宫平滑肌对缩宫素的敏感性", "alignment" : "left" }, { "text" : "降低子宫平滑肌兴奋性及其对缩宫素的敏感性（保胎）", "alignment" : "left" }] }, { "content" : [{ "text" : "子宫内膜", "alignment" : "left" }, { "text" : "促进子宫内膜增殖和修复", "alignment" : "left" }, { "text" : "限制子宫内膜增殖，使增殖期转化为分泌期", "alignment" : "left" }] }, { "content" : [{ "text" : "宫颈", "alignment" : "left" }, { "text" : "使宫颈口松弛，扩张", "alignment" : "left" }, { "text" : "使宫颈口闭合", "alignment" : "left" }] }, { "content" : [{ "text" : "输卵管", "alignment" : "left" }, { "text" : "增强输卵管的节律性收缩", "alignment" : "left" }, { "text" : "抑制输卵管的节律性收缩", "alignment" : "left" }] }, { "content" : [{ "text" : "阴道上皮", "alignment" : "left" }, { "text" : "使阴道上皮增生角化", "alignment" : "left" }, { "text" : "使阴道上皮脱落", "alignment" : "left" }] }, { "content" : [{ "text" : "乳房", "alignment" : "left" }, { "text" : "促进乳腺管增生，乳头、乳晕着色", "alignment" : "left" }, { "text" : "促进乳腺小叶发育及腺泡发育", "alignment" : "left" }] }, { "content" : [{ "text" : "代谢作用", "alignment" : "left" }, { "text" : "促进水钠潴留；<br>加速蛋白质合成，促进生长；促进骨的成熟及骨骺愈合", "alignment" : "both" }, { "text" : "促进水钠排泄", "alignment" : "left" }] }] }] }] }] }] }, { "text" : "第二篇  生物化学", "guide" : [{ "text" : "执业医师考试——本篇约占临床执业医师考试的3%，出题量约为18题。其中三大物质的相关知识点（物质合成、代谢等）为考试重点，考试题量不大，但知识点较繁杂，重点理解记忆即可。" }], "content" : [{ "title" : "第一章", "text" : "蛋白质的结构与功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、氨基酸与多肽", "alignment" : "left" }, { "text" : "（1）氨基酸的结构与分类<br>（2）肽键与肽链　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、蛋白质的结构", "alignment" : "left" }, { "text" : "（1）一级结构<br>（2）二级结构<br>（3）三级和四级结构　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、蛋白质结构与功能的关系", "alignment" : "left" }, { "text" : "（1）蛋白质一级结构与功能的关系<br>（2）蛋白质高级结构与功能的关系　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、蛋白质的理化性质", "alignment" : "left" }, { "text" : "蛋白质的等电点、沉淀和变性　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、氨基酸与多肽", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 组成体内蛋白质的20种氨基酸的分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "非极性脂肪族氨基酸", "alignment" : "left" }, { "text" : "甘氨酸、丙氨酸、缬氨酸、亮氨酸、异亮氨酸、脯氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "极性中性氨基酸", "alignment" : "left" }, { "text" : "丝氨酸、半胱氨酸、蛋氨酸、天冬氨酸、谷氨酰胺、苏氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "酸性氨基酸", "alignment" : "left" }, { "text" : "天冬氨酸、谷氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "碱性氨基酸", "alignment" : "left" }, { "text" : "赖氨酸、精氨酸、组氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "芳香族氨基酸", "alignment" : "left" }, { "text" : "苯丙氨酸、色氨酸、酪氨酸", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 有特殊特点的氨基酸", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "赖氨酸", "alignment" : "left" }, { "text" : "含2个氨基的氨基酸", "alignment" : "left" }] }, { "content" : [{ "text" : "谷氨酸、天冬氨酸", "alignment" : "left" }, { "text" : "含2个羧基的氨基酸", "alignment" : "left" }] }, { "content" : [{ "text" : "脯氨酸、羟脯氨酸", "alignment" : "left" }, { "text" : "为亚氨基酸，脯氨酸为容易使肽链走向形成折角的氨基酸", "alignment" : "left" }] }, { "content" : [{ "text" : "同型半胱氨酸、鸟氨酸", "alignment" : "left" }, { "text" : "天然蛋白质中不存在的氨基酸", "alignment" : "left" }] }, { "content" : [{ "text" : "瓜氨酸", "alignment" : "left" }, { "text" : "不出现于蛋白质中的氨基酸", "alignment" : "left" }] }, { "content" : [{ "text" : "色氨酸、酪氨酸", "alignment" : "left" }, { "text" : "在280nm处有特征性吸收峰的氨基酸", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "3. 氨基酸的其他分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "必需氨基酸", "alignment" : "left" }, { "text" : "缬氨酸、异亮氨酸、亮氨酸、苯丙氨酸、蛋氨酸、色氨酸、苏氨酸、赖氨酸（写一两本单色书来）", "alignment" : "left" }] }, { "content" : [{ "text" : "支链氨基酸", "alignment" : "left" }, { "text" : "缬氨酸、异亮氨酸、亮氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "一碳单位", "alignment" : "left" }, { "text" : "丝氨酸、色氨酸、组氨酸、甘氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "含硫氨基酸", "alignment" : "left" }, { "text" : "半胱氨酸、胱氨酸、蛋氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "生酮氨基酸", "alignment" : "left" }, { "text" : "亮氨酸、赖氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "生糖兼生酮氨基酸", "alignment" : "left" }, { "text" : "异亮氨酸、苯丙氨酸、酪氨酸、色氨酸、苏氨酸", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "二、蛋白质的结构与功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "一级结构", "alignment" : "left" }, { "text" : "二级结构", "alignment" : "left" }, { "text" : "三级结构", "alignment" : "left" }, { "text" : "四级结构", "alignment" : "left" }] }, { "content" : [{ "text" : "定义", "alignment" : "left" }, { "text" : "蛋白质分子中氨基酸排列顺序", "alignment" : "left" }, { "text" : "蛋白质分子中某一段肽键的局部空间结构", "alignment" : "left" }, { "text" : "整条肽键中所有原子在三维空间的排布位置", "alignment" : "left" }, { "text" : "蛋白质分子中各亚基的空间排布", "alignment" : "left" }] }, { "content" : [{ "text" : "表现形式", "alignment" : "left" }, { "text" : "肽键", "alignment" : "left" }, { "text" : "α-螺旋、β-折叠、β-转角、无规则卷曲", "alignment" : "left" }, { "text" : "结构域、分子伴侣", "alignment" : "left" }, { "text" : "亚基", "alignment" : "left" }] }, { "content" : [{ "text" : "维系键", "alignment" : "left" }, { "text" : "肽键（主要）、二硫键（次要）", "alignment" : "left" }, { "text" : "氢键", "alignment" : "left" }, { "text" : "疏水键、盐键、氢键、范德华力", "alignment" : "left" }, { "text" : "氢键、离子键", "alignment" : "left" }] }, { "content" : [{ "text" : "意义", "alignment" : "left" }, { "text" : "为蛋白质空间构象和特异性功能的基础，但非决定空间构象的唯一因素", "alignment" : "left" }, { "text" : "由一级结构决定，在蛋白质中存在2～3个模块，发挥特殊生理功能", "alignment" : "left" }, { "text" : "分子量较大的蛋白质常可折叠成多个结构较紧密的区域，并各行其功能", "alignment" : "left" }, { "text" : "含有四级结构的蛋白质，单独的亚基一般无功能", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "三、蛋白质的理化性质蛋白质的等电点、沉淀和变性", "content" : [{ "type" : "common", "alignment" : "left", "text" : "蛋白质变性后溶液粘度增加，溶解度降低，结晶能力消失、生物活性丧失，易被蛋白酶水解。蛋白质变性后空间构象被破坏，但一级结构不受影响，部分蛋白质变性后可以复性。蛋白质水解时，一级结构被破坏，所有蛋白质水解后均不能复性。" }] }] }, { "title" : "第二章", "text" : "核酸的结构与功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、核酸的基本组成单位——核苷酸", "alignment" : "left" }, { "text" : "（1）核苷酸分子组成<br>（2）核酸（DNA和RNA）　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、DNA的结构与功能", "alignment" : "left" }, { "text" : "（1）DNA碱基组成规律<br>（2）DNA的一级结构<br>（3）DNA双螺旋结构<br>（4）DNA高级结构（助理不<br>考）<br>（5）DNA的功能　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、DNA理化性质及其应用", "alignment" : "left" }, { "text" : "（1）DNA变性和复性<br>（2）核酸杂交<br>（3）核酸的紫外线吸收　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、RNA结构与功能", "alignment" : "left" }, { "text" : "（1）mRNA<br>（2）tRNA<br>（3）rRNA<br>（4）其他RNA　", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "both", "text" : "核酸的基本组成单位——核苷酸", "content" : [{ "type" : "common", "alignment" : "left", "text" : "核酸分为脱氧核糖核酸（DNA）和核糖核酸（RNA）两类。核酸的基本组成单位是核苷酸。碱基包括：嘌呤碱（腺嘌呤A，鸟嘌呤G），嘧啶碱（胸腺嘧啶T，胞嘧啶C，尿嘧啶U）。", "picture" : "6673be09-ef71-45e2-901e-a17568817820.png" }] }] }, { "type" : "h1", "text" : "二、DNA的结构与功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "DNA一级结构", "alignment" : "left" }, { "text" : "DNA二级结构", "alignment" : "left" }, { "text" : "DNA高级结构", "alignment" : "left" }] }, { "content" : [{ "text" : "定义", "alignment" : "left" }, { "text" : "核苷酸排列顺序，即碱基排列顺序", "alignment" : "left" }, { "text" : "DNA双螺旋结构", "alignment" : "left" }, { "text" : "在双螺旋结构基础上进一步扭曲成超螺旋", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "DNA双螺旋结构是脱氧核糖核酸的二级结构，DNA是反平行、右手螺旋的双链结构，两条多聚核苷酸链在空间的走向呈反向平行，一条链的走向为5’ -3’，另一条为3’-5’。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "DNA双链中，配对互补的碱基与碱基之间形成氢键相连，位于双键内侧，维持双螺旋结构的稳定性。由脱氧核糖和磷酸基团组成的DNA骨架位于双键外侧。" }] }] }] }, { "type" : "h1", "text" : "三、DNA理化性质及其应用", "content" : [{ "type" : "common", "alignment" : "left", "text" : "DNA变性指的是在各种因素下，由双键解离成单链的过程。变性时，维系碱基配对的氢键断裂。最常使DNA变性的方法为加热，变性后，DNA在260nm处的吸光度随之增加、溶液粘度降低。" }] }, { "type" : "h1", "text" : "四、RNA结构与功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "mRNA", "alignment" : "left" }, { "text" : "tRNA", "alignment" : "left" }, { "text" : "rRNA", "alignment" : "left" }] }, { "content" : [{ "text" : "占总RNA比例", "alignment" : "left" }, { "text" : "2%～5%", "alignment" : "left" }, { "text" : "15%", "alignment" : "left" }, { "text" : "80%", "alignment" : "left" }] }, { "content" : [{ "text" : "主要功能", "alignment" : "left" }, { "text" : "蛋白质合成的模板", "alignment" : "left" }, { "text" : "蛋白质合成中作为运载氨基酸的载体", "alignment" : "left" }, { "text" : "核糖体的组成成分，核糖体为蛋白质的合成场所", "alignment" : "left" }] }, { "content" : [{ "text" : "二级结构", "alignment" : "left" }, { "text" : "无（为线形单链结构）", "alignment" : "left" }, { "text" : "三叶草形", "alignment" : "left" }, { "text" : "花状", "alignment" : "left" }] }, { "content" : [{ "text" : "结构特点", "alignment" : "left" }, { "text" : "5’末端有m<sup>7</sup>GpppN帽结构，3’末端有多聚A尾结构", "alignment" : "left" }, { "text" : "含稀有碱基", "alignment" : "left" }, { "text" : "核糖体分大、小亚基", "alignment" : "left" }] }, { "content" : [{ "text" : "主要分布", "alignment" : "left" }, { "text" : "胞核、胞质", "alignment" : "left" }, { "text" : "胞质", "alignment" : "left" }, { "text" : "胞质", "alignment" : "left" }] }] }] }] }, { "title" : "第三章", "text" : "酶", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、酶的催化作用", "alignment" : "left" }, { "text" : "（1）酶的分子结构与催化作用<br>（2）酶促反应的特点<br>（3）酶-底物复合物　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、辅酶与酶辅助因子", "alignment" : "left" }, { "text" : "（1）维生素与辅酶的关系<br>（2）辅酶作用<br>（3）金属离子作用　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、酶促反应动力学", "alignment" : "left" }, { "text" : "（1）Km和Vmax的概念<br>（2）最适pH、最适温度和酶浓度　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、抑制剂与激活剂", "alignment" : "left" }, { "text" : "（1）不可逆抑制<br>（2）可逆性抑制<br>（3）激活剂　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、酶活性的调节", "alignment" : "left" }, { "text" : "（1）别构调节<br>（2）共价修饰<br>（3）酶原激活<br>（4）同工酶　", "alignment" : "left" }] }, { "content" : [{ "text" : "六、核酶", "alignment" : "left" }, { "text" : "核酶的概念　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、酶的催化作用", "content" : [{ "type" : "common", "alignment" : "left", "text" : "酶活性中心内的必需基团有两类：结合基团，结合底物和辅酶，使之与酶形成复合物；催化基团，影响底物中某些化学键的稳定性，催化底物发生化学反应并将其转变为产物。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "酶具有以下特点：1.可在胞外、体外环境发挥作用；2.大多数酶的化学本质是蛋白质；3.不改变反应的平衡点；4.能大大降低反应的活化能；5.与底物结合都具有相对特异性，一种酶可有几种不同同工酶。" }] }] }, { "type" : "h1", "text" : "二、辅酶与酶辅助因子", "content" : [{ "type" : "common", "alignment" : "left", "text" : "全酶由酶蛋白和辅助因子结合形成复合物。其中酶蛋白决定反应的特异性。辅酶和辅基决定酶促反应的种类和性质。辅助因子按成分分为金属离子和小分子有机化合物；按其与酶蛋白结合的紧密程度及作用特点分为辅酶和辅基。" }] }, { "type" : "h1", "text" : "三、酶促反应动力学", "content" : [{ "type" : "common", "alignment" : "left", "text" : "Km值的含义：为酶促反应速度为最大速度一半时的底物浓度。Km 值是酶的特征性常数之一，只与酶的结构、底物和反应环境有关，与酶的浓度无关。Km 值可用来表示酶与底物的亲和力。Km值越小，酶与底物的亲和力越大，表示不需要很高的底物浓度就可容易达到最大反应速度，反之亦然。<br>Vmax是酶完全被底物饱和时的反应速度，与酶浓度呈正比。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "当底物浓度远大于酶浓度时，酶浓度对反应速率的影响呈直线关系。当其他因素不变时，底物浓度的变化对反应速度的影响的作图呈矩形双曲线。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "酶促反应有最适温度和pH，不是酶的特征性常数。" }] }] }] }, { "type" : "h1", "text" : "四、抑制剂与激活剂", "content" : [{ "type" : "common", "alignment" : "center", "text" : "抑制剂与酶结合作用的分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "不可逆性抑制作用", "alignment" : "left" }, { "text" : "竞争性抑制作用", "alignment" : "left" }, { "text" : "非竞争性抑制作用", "alignment" : "left" }, { "text" : "反竞争性抑制作用", "alignment" : "left" }] }, { "content" : [{ "text" : "作用机制", "alignment" : "left" }, { "text" : "抑制剂与酶活性中心上的必需基团以共价键结合，使酶失活", "alignment" : "left" }, { "text" : "抑制剂与酶的底物相似，可与底物竞争酶的活性中心，阻碍酶与底物结合成中间产物", "alignment" : "left" }, { "text" : "抑制剂与酶活性中心以外的必需基团结合，不影响酶与底物结合，底物和抑制剂无竞争关系", "alignment" : "left" }, { "text" : "抑制剂与酶和底物形成的中间产物结合，使中间产物的量下降", "alignment" : "left" }] }, { "content" : [{ "text" : "抑制剂去除方法", "alignment" : "left" }, { "text" : "不能去除", "alignment" : "left" }, { "text" : "可透析、超滤去除", "alignment" : "left" }, { "text" : "可透析、超滤去除", "alignment" : "left" }, { "text" : "可透析、超滤去除", "alignment" : "left" }] }, { "content" : [{ "text" : "表观Km", "alignment" : "left" }, { "text" : "—（反应终止）", "alignment" : "left" }, { "text" : "增大", "alignment" : "left" }, { "text" : "不变", "alignment" : "left" }, { "text" : "减小", "alignment" : "left" }] }, { "content" : [{ "text" : "最大速度Vmax", "alignment" : "left" }, { "text" : "—（反应终止）", "alignment" : "left" }, { "text" : "不变", "alignment" : "left" }, { "text" : "降低", "alignment" : "left" }, { "text" : "降低", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "五、酶活性的调节", "content" : [{ "type" : "common", "alignment" : "left", "text" : "酶的化学修饰，即共价修饰包括：磷酸化/去磷酸化、乙酰化/去乙酰化、甲基化/去甲基化、腺苷化/去腺苷化等，最多见的是磷酸化/去磷酸化调节。酶的化学修饰调节最多见的是磷酸化/去磷酸化调节。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "同工酶是指催化相同化学反应，但酶蛋白的分子结构、理化性质及免疫学性质均不相同的一组酶，乳酸脱氢酶有5种同工酶，其中LDH1在心肌含量最高，LDH3在骨骼肌含量最高，LDH5在肝脏含量最高。" }] }] }, { "type" : "h1", "text" : "六、核酶", "content" : [{ "type" : "common", "alignment" : "left", "text" : "核酶主要指一类具有催化功能的RNA，在RNA的剪接修饰中具有重要作用。" }] }] }, { "title" : "第四章", "text" : "糖代谢", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、糖的分解代谢", "alignment" : "left" }, { "text" : "（1）糖酵解的基本途径、关键酶和生理意义<br>（2）糖有氧氧化的基本途径、关键酶和生理意义<br>（3）三羧酸循环的生理意义", "alignment" : "left" }] }, { "content" : [{ "text" : "二、糖原的合成与分解", "alignment" : "left" }, { "text" : "（1）肝糖原的合成<br>（2）肝糖原的分解", "alignment" : "left" }] }, { "content" : [{ "text" : "三、糖异生", "alignment" : "left" }, { "text" : "（1）糖异生的基本途径和关键酶<br>（2）糖异生的生理意义<br>（3）乳酸循环", "alignment" : "left" }] }, { "content" : [{ "text" : "四、磷酸戊糖途径", "alignment" : "left" }, { "text" : "（1）磷酸戊糖途径的关键酶和重要的产物<br>（2）磷酸戊糖途径的生理意义", "alignment" : "left" }] }, { "content" : [{ "text" : "五、血糖及其调节", "alignment" : "left" }, { "text" : "（1）血糖浓度<br>（2）胰岛素的调节<br>（3）胰高血糖素的调节<br>（4）糖皮质激素的调节", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、糖的分解代谢", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 糖酵解的基本途径、关键酶和生理意义", "content" : [{ "type" : "common", "alignment" : "left", "text" : "糖的无氧氧化：又称糖酵解，葡萄糖在缺氧或供氧不足情况下，生成乳酸的过程。基本反应过程：分为两个反应阶段，全程在胞浆中进行。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "第一阶段", "alignment" : "left" }, { "text" : "糖酵解途径，由一分子葡萄糖分解分成两分子丙酮酸的过程；<br>记忆要点：反应的“一、二、三”，即“一次脱氢、二次底物水平磷酸化净生成二个ATP、三次不可逆性反应三个关键酶的参与”；<br>三个关键酶是己糖激酶、6-磷酸果糖激酶-1. 丙酮酸激酶。", "alignment" : "both" }] }, { "content" : [{ "text" : "第二阶段", "alignment" : "left" }, { "text" : "丙酮酸还原生成乳酸；<br>所需的氢原子由前述“一次脱氢”过程提供，反应由乳酸脱氢酶催化，辅酶是 NAD<sup>+</sup>。", "alignment" : "both" }] }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 糖酵解的生理意义：<br>（1）迅速提供能量，对肌收缩更为重要。<br>（2）成熟红细胞的供能。<br>（3）经组织、白细胞、骨髓等代谢活跃的组织，即使不缺氧也多由糖酵解提供能量。", "picture" : "0fe6fe79-d2cd-432e-ac21-ee58356f6fb9.png", "content" : [{ "type" : "common", "alignment" : "center", "text" : "糖酵解途径" }] }, { "type" : "h2", "alignment" : "left", "text" : "3. 糖有氧氧化的基本途径、关键酶和生理意义", "content" : [{ "type" : "common", "alignment" : "left", "text" : "糖有氧氧化的定义：葡萄糖在有氧条件下彻底氧化生成水和二氧化碳的过程。<br>基本反应过程：分为三个反应阶段", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "第一阶段", "alignment" : "left" }, { "text" : "糖酵解途径生成丙酮酸，同前述糖酵解过程。", "alignment" : "left" }] }, { "content" : [{ "text" : "第二阶段", "alignment" : "left" }, { "text" : "丙酮酸进入线粒体后，氧化脱羧生成乙酰 CoA。<br>总反应式为：丙酮酸 + NAD<sup>＋</sup> + 辅酶 A →乙酰 CoA +NADH+H<sup>＋</sup> + CO<sub>2</sub>，反应不可逆，由丙酮酸脱氢酶复合体催化。", "alignment" : "left" }] }, { "content" : [{ "text" : "第三阶段", "alignment" : "left" }, { "text" : "三羧酸循环及氧化磷酸化，生成大量的 ATP 和水。<br>记忆要点：三羧酸循环有“一、二、三、四”，即“一次底物水平磷酸化反应、二次脱羧基反应、三次关键酶的催化、四次脱氢反应”。", "alignment" : "both" }] }], "picture" : "1ffda577-44e4-4ee6-80dc-99b7b0a05727.jpeg", "content" : [{ "type" : "common", "alignment" : "left", "text" : "三羧酸循环常考点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "1次底物水平磷酸化", "alignment" : "left" }, { "text" : "生成GTP", "alignment" : "left" }] }, { "content" : [{ "text" : "消耗1分子乙酰CoA", "alignment" : "left" }, { "text" : "每次循环消耗1分子乙酰CoA", "alignment" : "left" }] }, { "content" : [{ "text" : "2次脱羧", "alignment" : "left" }, { "text" : "生成2分子CO<sub>2</sub>（体内CO<sub>2</sub>主要来源）", "alignment" : "left" }] }, { "content" : [{ "text" : "3个关键酶", "alignment" : "left" }, { "text" : "柠檬酸合酶、异柠檬酸脱氢酶、α-酮戊二酸脱氢酶复合体", "alignment" : "left" }] }, { "content" : [{ "text" : "4次脱氢", "alignment" : "left" }, { "text" : "3次由NAD<sup>+</sup>接受；1次由FAD接受", "alignment" : "left" }] }, { "content" : [{ "text" : "反应部位", "alignment" : "left" }, { "text" : "线粒体", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "糖酵解和有氧氧化的关键酶有己糖激酶、6-磷酸果糖激酶-1. 丙酮酸激酶、丙酮酸脱氢酶复合体、柠檬酸合酶、异柠檬酸脱氢酶、α-酮戊二酸脱氢酶复合体，其中柠檬酸合酶现不被认为是调节酶。" }] }] }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "4. 三羧酸循环的生理意义", "content" : [{ "type" : "h3", "alignment" : "left", "text" : "（1）氧化供能。<br>（2）三大营养素彻底氧化分解的最终代谢通路。<br>（3）是三大营养物质互变的枢纽。<br>（4）可为其他合成代谢提供小分子的前体 CoA。" }] }] }, { "type" : "h1", "text" : "二、糖原的合成与分解", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肝糖原的合成限速酶为糖原合酶；肝糖原的分解限速酶为糖原磷酸化酶。" }] }, { "type" : "h1", "text" : "三、糖异生", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 糖异生的基本途径和关键酶", "content" : [{ "type" : "common", "alignment" : "left", "text" : "糖异生概念：从非糖化合物（乳酸、甘油、生糖氨基酸）转变为葡萄糖或糖原的过程。进行糖异生的主要器官是肝脏，肾脏具有肝脏 1/10 的异生糖能力。<br>糖异生途径大部分反应是糖酵解途径的逆反应，由相同的酶催化。但酵解途径中有3步是不可逆反应，糖异生需通过不同酶绕过这3个不可逆反应，因此，糖异生关键酶为丙酮酸羧化酶、磷酸烯醇式丙酮酸羧激酶、果糖二磷酸酶、葡萄糖－6－磷酸酶。" }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 糖异生的生理意义：维持血糖浓度恒定；补充肝糖原；调节酸碱平衡。" }, { "type" : "h2", "alignment" : "left", "text" : "3. 乳酸循环(Cori循环)", "content" : [{ "type" : "common", "alignment" : "left", "text" : "概念：肌收缩（尤其氧供应不足时）通过糖酵解生成乳酸，乳酸通过细胞膜弥散进入血", "content" : [{ "type" : "common", "alignment" : "left", "text" : "液后入肝，在肝内异生为葡萄糖，葡萄糖释入血液后又被肌摄取，如此形成的循环。是一个耗能过程，2分子乳酸异生为1分子葡萄糖需6分子ATP。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "形成原因：肝内糖异生活跃，且有葡萄糖－6－磷酸酶水解6－磷酸葡萄糖释放葡萄糖；肌肉糖异生活性低，且无葡萄糖－6－磷酸酶。<br>生理意义：避免损失乳酸；防止乳酸堆积引起酸中毒。" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "4. 磷酸戊糖途径", "content" : [{ "type" : "h4", "alignment" : "left", "text" : "1）磷酸戊糖途径的反应过程：在胞浆中进行，分为两个阶段", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "第一阶段", "alignment" : "left" }, { "text" : "是氧化反应，生成磷酸戊糖、NADPH+H<sup>＋</sup>及CO<sub>2</sub>", "alignment" : "left" }] }, { "content" : [{ "text" : "第二阶段", "alignment" : "left" }, { "text" : "是基团转移反应，生成3-P-甘油醛和6-P-果糖", "alignment" : "left" }] }, { "content" : [{ "text" : "总反应式：3×6-P-葡萄糖 + 6NADP<sup>＋</sup>→2×6-P-果糖 + 3-P-甘油醛 + 6NADPH+H<sup>＋</sup>+ 3CO<sub>2</sub>", "alignment" : "left", "colSpan" : 2 }] }] }, { "type" : "h4", "alignment" : "left", "text" : "2）磷酸戊糖途径的生理意义<br>（1）为核酸的生物合成提供核糖。<br>（2）提供 NADPH 作为供氢体参与多种代谢反应。" }] }] }] }] }, { "title" : "第五章", "text" : "生物氧化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、ATP与其他高能化合物　", "alignment" : "left" }, { "text" : "（1）ATP循环与高能磷酸键<br>（2）ATP的利用<br>（3）其他高能磷酸化合物　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、氧化磷酸化　", "alignment" : "left" }, { "text" : "（1）氧化磷酸化的概念<br>（2）两条呼吸链的组成和排列顺序<br>（3）ATP合酶<br>（4）氧化磷酸化的调节　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、ATP与其他高能化合物", "content" : [{ "type" : "common", "alignment" : "left", "text" : "生物氧化过程中形成磷酸酯（磷酸酐），一般称为高能磷酸键，常用“~P”符号表示。ATP中含有两个高能磷酸键，呼吸链电子传递过程中释放的能量使ADP磷酸化是ATP生成的主要方式。其他的高能磷酸化合物有磷酸肌酸、磷酸烯醇式丙酮酸、乙酰磷酸、乙酰辅酶A等。" }] }, { "type" : "h1", "text" : "二、氧化磷酸化", "content" : [{ "type" : "common", "alignment" : "left", "text" : "氧化磷酸化：呼吸链电子传递的氧化过程与ADP磷酸化、生成ATP相偶联的过程。" }] }] }, { "title" : "第六章", "text" : "脂类代谢", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、脂类的生理功能", "alignment" : "left" }, { "text" : "（1）储能和功能<br>（2）生物膜的组成成分<br>（3）脂类衍生物的调节作用<br>（4）营养必需脂肪酸", "alignment" : "left" }] }, { "content" : [{ "text" : "二、脂肪的消化与吸收", "alignment" : "left" }, { "text" : "（1）脂肪乳化及消化所需酶<br>（2）甘油一酯合成途径及乳糜颗粒", "alignment" : "left" }] }, { "content" : [{ "text" : "三、脂肪的合成代谢", "alignment" : "left" }, { "text" : "（1）合成的部位<br>（2）合成的原料<br>（3）合成的基本途径", "alignment" : "left" }] }, { "content" : [{ "text" : "四、脂酸的合成代谢", "alignment" : "left" }, { "text" : "（1）合成的部位<br>（2）合成的原料", "alignment" : "left" }] }, { "content" : [{ "text" : "五、脂肪的分解代谢", "alignment" : "left" }, { "text" : "（1）脂肪动员<br>（2）脂肪酸β-氧化的基本过程<br>（3）酮体的生成、利用和生理意义", "alignment" : "left" }] }, { "content" : [{ "text" : "六、甘油磷脂代谢", "alignment" : "left" }, { "text" : "（1）甘油磷脂的基本结构与分类<br>（2）合成部位和合成原料", "alignment" : "left" }] }, { "content" : [{ "text" : "七、胆固醇代谢", "alignment" : "left" }, { "text" : "（1）胆固醇的合成部位、原料和关键酶<br>（2）胆固醇合成的调节<br>（3）胆固醇的转化及去路", "alignment" : "left" }] }, { "content" : [{ "text" : "八、血浆脂蛋白代谢", "alignment" : "left" }, { "text" : "（1）血脂及其组成<br>（2）血浆脂蛋白的分类及功能<br>（3）高脂蛋白血症", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、脂类的生理功能", "content" : [{ "type" : "common", "alignment" : "left", "text" : "人体内不饱和脂肪酸包括油酸、软油酸、亚油酸、亚麻酸和花生四烯酸，其中亚油酸、亚麻酸和花生四烯酸为必需脂肪酸，只能从食物获取。" }] }, { "type" : "h1", "text" : "二、脂类的消化与吸收", "content" : [{ "type" : "common", "alignment" : "left", "text" : "脂肪乳化：胆汁酸盐是脂肪消化的乳化剂，使脂类乳化，能降低脂肪和水相之间的界面张力。脂肪消化所需的酶类有：胰脂肪酶、磷脂酶A2. 胆固醇酯酶和辅酯酶。" }] }, { "type" : "h1", "text" : "三、脂肪的合成代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肝、脂肪组织和小肠是合成甘油三酯的主要场所。所需的原料甘油及脂肪酸主要由葡萄糖代谢提供。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "甘油三酯合成的两种途径：<br>甘油一酯途径：小肠黏膜细胞，以甘油一酯途径合成甘油三酯。<br>甘油二酯途径：肝细胞及脂肪细胞，以甘油二酯途径合成甘油三酯。" }] }] }, { "type" : "h1", "text" : "四、脂酸的合成代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "脂酸合成与分解比较", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "脂酸分解", "alignment" : "left" }, { "text" : "脂酸合成", "alignment" : "left" }] }, { "content" : [{ "text" : "大体部位", "alignment" : "left" }, { "text" : "除脑组织外的所有组织，肝、肌肉最活跃", "alignment" : "left" }, { "text" : "肝肾脑肺、乳腺、脂肪", "alignment" : "left" }] }, { "content" : [{ "text" : "亚细胞部位", "alignment" : "left" }, { "text" : "线粒体", "alignment" : "left" }, { "text" : "胞液内", "alignment" : "left" }] }, { "content" : [{ "text" : "关键酶", "alignment" : "left" }, { "text" : "肉碱脂酰转移酶I", "alignment" : "left" }, { "text" : "乙酰辅酶A羧化酶", "alignment" : "left" }] }, { "content" : [{ "text" : "重要中间代谢产物", "alignment" : "left" }, { "text" : "乙酰辅酶A", "alignment" : "left" }, { "text" : "丙二酰辅酶A", "alignment" : "left" }] }, { "content" : [{ "text" : "电子传递辅酶", "alignment" : "left" }, { "text" : "FAD、NAD+", "alignment" : "left" }, { "text" : "NADPH", "alignment" : "left" }] }, { "content" : [{ "text" : "需要HCO3-", "alignment" : "left" }, { "text" : "不需要", "alignment" : "left" }, { "text" : "需要", "alignment" : "left" }] }, { "content" : [{ "text" : "促进因素", "alignment" : "left" }, { "text" : "ADP含量高分解加强（饥饿、禁食）", "alignment" : "left" }, { "text" : "ATP含量高时合成加强（高糖饮食）", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "脂肪酸合成原料乙酰辅酶A可由所有代谢中产生，但主要由糖代谢产生，位于线粒体内的乙酰辅酶A必需经过柠檬酸-丙酮酸循环，在线粒体内与草酰乙酸结合成柠檬酸，经三羧酸载体转运进入胞液。" }] }] }] }, { "type" : "h1", "text" : "五、脂肪的分解代谢", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 脂肪动员：储存在脂肪细胞中的脂肪，被脂肪酶逐步水解为游离脂酸及甘油并释放入血供其它组织氧化利用的过程。" }, { "type" : "h2", "alignment" : "left", "text" : "2. 脂酸β-氧化的基本过程", "content" : [{ "type" : "common", "alignment" : "left", "text" : "脂肪酸β氧化的过程：三个步骤", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "第一步", "alignment" : "left" }, { "text" : "脂酸的活化，生成脂酰 CoA，胞液中进行，脂酰 CoA 合成酶催化；<br>脂肪酸+ ATP + 辅酶 A →脂酰 CoA + PPi", "alignment" : "both" }] }, { "content" : [{ "text" : "第二步", "alignment" : "left" }, { "text" : "脂酰 CoA 进入线粒体<br>依赖肉碱脂酰转移酶 I（外膜上）、肉碱-肉碱脂酰转位酶（内膜上）、肉碱脂酰转移酶 II（内膜上）三种酶作用转运。肉碱脂酰转移酶 I 是限速酶。", "alignment" : "both" }] }, { "content" : [{ "text" : "第三步", "alignment" : "left" }, { "text" : "脂酸的β氧化<br>每一次β氧化需要四个反应依次连续进行：<br>1．脱氢：生成 FADH2<br>2．加水<br>3．再脱氢：生成 NADH+H<sup>＋</sup><br>4．硫解：生成一分子乙酰 CoA 和脂酰(n-2)CoA，（n 为碳原子个数）", "alignment" : "both" }] }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "3. 酮体的生成、利用和生理意义", "content" : [{ "type" : "common", "alignment" : "left", "text" : "酮体包括：乙酰乙酸、β-羟丁酸及丙酮。酮体代谢的特点：肝内生酮肝外用，肝细胞内有生成酮体的酶，HMG CoA合成酶是合成的限速酶。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "酮体生成增加：饥饿时，胰高血糖素增多，脂肪动员加强。<br>酮体生成减少：饱食后，胰岛素分泌增多，脂肪动员减弱。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "酮体生成的意义：<br>1）为肝外组织（脑、肌组织）提供能源。<br>2）脑组织在糖供应不足时，利用酮体供能。<br>3）正常情况下，血中酮体为 0.03-0.5 mmol/L。" }] }] }] }] }, { "type" : "h1", "text" : "六、甘油磷脂代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "甘油磷脂由甘油、脂酸、磷脂及含氮化合物等组成。可分为磷脂酰胆碱（卵磷脂）、磷脂酰乙醇胺（脑磷脂）、磷脂酰丝氨酸、磷脂酸、二磷脂酰甘油（心磷脂）及磷脂酰肌醇等六类。" }] }, { "type" : "h1", "text" : "七、胆固醇代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "胆固醇的转化物质：1. 转化为胆汁酸；2. 转化为类固醇激素（醛固酮、皮质醇、雄激素、睾丸酮、雌二醇及孕酮）；3. 转化为7-脱氢胆固醇，后者在日光紫外线照射下转化为维生素D3。" }] }, { "type" : "h1", "text" : "八、血浆脂蛋白代谢", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "乳糜微粒", "alignment" : "left" }, { "text" : "VLDL", "alignment" : "left" }, { "text" : "LDL", "alignment" : "left" }, { "text" : "HDL", "alignment" : "left" }] }, { "content" : [{ "text" : "对应于", "alignment" : "left" }, { "text" : "CM", "alignment" : "left" }, { "text" : "前β-脂蛋白", "alignment" : "left" }, { "text" : "β-脂蛋白", "alignment" : "left" }, { "text" : "α-脂蛋白", "alignment" : "left" }] }, { "content" : [{ "text" : "合成部位、来源", "alignment" : "left" }, { "text" : "小肠黏膜细胞", "alignment" : "left" }, { "text" : "肝细胞", "alignment" : "left" }, { "text" : "血浆，由VLDL转化而来", "alignment" : "left" }, { "text" : "肝、肠、血浆", "alignment" : "left" }] }, { "content" : [{ "text" : "功能", "alignment" : "left" }, { "text" : "转运外源性甘油三酯及胆固醇", "alignment" : "left" }, { "text" : "转运内源性甘油三酯及胆固醇", "alignment" : "left" }, { "text" : "转运内源性胆固醇", "alignment" : "left" }, { "text" : "逆向转运胆固醇（肝外向肝转移）", "alignment" : "left" }] }] }] }] }, { "title" : "第七章", "text" : "氨基酸代谢", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、蛋白质的生理功能及营养作用", "alignment" : "left" }, { "text" : "（1）氨基酸和蛋白质的生理功能<br>（2）营养必需氨基酸的概念和种类<br>（3）氮平衡　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、蛋白质在肠道的消化、吸收及腐败作用", "alignment" : "left" }, { "text" : "（1）蛋白酶在消化中的作用<br>（2）氨基酸的吸收<br>（3）蛋白质的腐败作用　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、氨基酸的一般代谢", "alignment" : "left" }, { "text" : "（1）转氨酶作用<br>（2）脱氨基作用<br>（3）α-酮酸的代谢　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、氨的代谢", "alignment" : "left" }, { "text" : "（1）氨的来源<br>（2）氨的转运<br>（3）氨的去路　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、个别氨基酸的代谢", "alignment" : "left" }, { "text" : "（1）氨基酸的脱羧基作用<br>（2）一碳单位的概念、来源、载体和意义<br>（3）甲硫氨酸循环、SAM、PAPS<br>（4）苯丙氨酸和酪氨酸代谢　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、蛋白质的生理功能及营养作用", "content" : [{ "type" : "common", "alignment" : "left", "text" : "8种必需氨基酸：缬氨酸、异亮氨酸、亮氨酸、苯丙氨酸、蛋氨酸、色氨酸、苏氨酸、赖氨酸（写一两本单色书来）" }] }, { "type" : "h1", "text" : "二、蛋白质在肠道的消化、吸收及腐败作用", "content" : [{ "type" : "common", "alignment" : "left", "text" : "氨基酸的吸收部位是小肠，主要是耗能的主动转运吸收过程。" }] }, { "type" : "h1", "text" : "三、氨基酸的一般代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "丙氨酸-葡萄糖循环途径：", "content" : [{ "type" : "h4", "alignment" : "left", "text" : "1）肌肉中的氨基酸经转氨基作用将氨基转给丙酮酸生成丙氨酸，丙氨酸经血液运输到肝脏。", "content" : [{ "type" : "h4", "alignment" : "left", "text" : "2）肝脏中，丙氨酸通过联合脱氨基作用，释放出氨，用于尿素合成。" }, { "type" : "h4", "alignment" : "left", "text" : "3）脱氨基后生成丙酮酸可经糖异生生成葡萄糖。" }, { "type" : "h4", "alignment" : "left", "text" : "4）葡萄糖由血液运输到肌肉组织，沿糖分解途径转变为丙酮酸，后者接受氨基生成丙氨酸。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "心肌和骨骼肌中L-谷氨酸脱氢酶的活性很弱，氨基酸很难通过联合脱氨基作用脱去氨基。在这些组织中，氨基酸主要通过嘌呤核苷酸循环脱去氨基。" }] }] }] }] }, { "type" : "h1", "text" : "四、氨的代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "鸟氨酸循环为尿素合成的途径，故又名尿素循环、Krebs-Henseleit循环。鸟氨酸循环主要在肝内进行。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "其特点如下表：", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "2个合成部位", "alignment" : "left" }, { "text" : "肝脏线粒体、胞液", "alignment" : "left" }] }, { "content" : [{ "text" : "2个关键酶", "alignment" : "left" }, { "text" : "氨基甲酰磷酸合成酶I、精氨酸代琥珀酸合成酶", "alignment" : "left" }] }, { "content" : [{ "text" : "2个N来源", "alignment" : "left" }, { "text" : "NH3. 天冬氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "生成3个重要中间产物", "alignment" : "left" }, { "text" : "鸟氨酸、精氨酸、瓜氨酸", "alignment" : "left" }] }, { "content" : [{ "text" : "消耗3个ATP", "alignment" : "left" }, { "text" : "合成1分子尿素，消耗3分子ATP", "alignment" : "left" }] }, { "content" : [{ "text" : "消耗4个高能磷酸键", "alignment" : "left" }, { "text" : "合成1分子尿素，消耗4个高能磷酸键", "alignment" : "left" }] }] }] }] }] }, { "type" : "h1", "text" : "五、个别氨基酸的代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "一碳单位的定义：某些氨基酸在分解代谢中产生的含有一个碳原子的基团，包括甲基、甲烯基、甲炔基、甲酰基、亚氨甲基等。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "一碳单位的主要功能：是嘌呤和嘧啶的主要合成原料，是氨基酸和核苷酸联系的枢纽。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "一碳单位的转运：不能游离存在。常与四氢叶酸结合而转运和参与代谢；CO2不是一碳单位，因为它是无机物，可以游离存在。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "苯丙氨酸在苯丙氨酸羟化酶作用下生成酪氨酸。酪氨酸在酪氨酸羟化酶作用下生成多巴，继而生成儿茶酚胺（多巴胺、去甲肾上腺素、肾上腺素）。酪氨酸在酪氨酸转氨酶作用下生成对羟苯丙酮酸，继而生成尿黑酸，延胡索酸、乙酰乙酸。" }] }] }] }] }] }, { "title" : "第八章", "text" : "核苷酸代谢", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、核苷酸代谢", "alignment" : "left" }, { "text" : "（1）两条嘌呤核苷酸合成途径的原料<br>（2）嘌呤核苷酸的分解代谢产物<br>（3）两条嘧啶核苷酸合成途径的原料（助理不<br>考）<br>（4）嘧啶核苷酸的分解代谢产物", "alignment" : "left" }] }, { "content" : [{ "text" : "二、核苷酸代谢的调节", "alignment" : "left" }, { "text" : "（1）核苷酸合成途径的主要调节酶<br>（2）抗核苷酸代谢药物的生化机制　", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "核苷酸代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "嘌呤的从头合成原料：天冬氨酸、谷氨酰胺、甘氨酸、CO2. 一碳单位。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "嘧啶的从头合成原料：天冬氨酸、谷氨酰胺、CO2。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "嘌呤核苷酸最终分解代谢产物为尿酸；胞嘧啶、尿嘧啶最终代谢产物为β- 丙氨酸、二氧化碳和NH3；胸腺嘧啶最终代谢产物为β-氨基异丁酸、二氧化碳和NH3。" }] }] }] }] }] }, { "title" : "第九章", "text" : "遗传信息的传递", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、遗传信息传递概述", "alignment" : "left" }, { "text" : "中心法则", "alignment" : "left" }] }, { "content" : [{ "text" : "二、DNA的生物合成", "alignment" : "left" }, { "text" : "（1）DNA生物合成的概念<br>（2）DNA的复制过程<br>（3）逆转录<br>（4）DNA的损伤与修复　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、RNA的生物合成", "alignment" : "left" }, { "text" : "（1）RNA生物合成的概念<br>（2）转录体系的组成及转录过程<br>（3）转录后加工过程　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、遗传信息传递概述", "content" : [{ "type" : "common", "alignment" : "left", "text" : "中心法则：", "picture" : "4b72d7b3-1256-4e76-b7de-0080fe204a04.png" }] }, { "type" : "h1", "text" : "二、DNA的生物合成", "content" : [{ "type" : "common", "alignment" : "left", "text" : "DNA生物合成有DNA复制和逆转录合成DNA。DNA复制是指以DNA为模板的DNA合成，是基因组的复制过程。逆转录是以RNA为模板，合成DNA互补链再以此DNA链为模板合成第二条DNA链的过程。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "DNA复制为半保留复制方式，是自带细胞得到和亲代相一致的遗传物质，使复制具有高保真性。合成反应按照5’→3’延长规律。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "逆转录是指在宿主细胞中，逆转录病毒的逆转录酶以病毒RNA为模板，以宿主细胞的4种dNTP为原料催化合成DNA的过程。" }] }] }, { "type" : "h2", "alignment" : "left", "text" : "3.RNA的生物合成", "content" : [{ "type" : "common", "alignment" : "left", "text" : "DNA指导的RNA合成称为转录。RNA指导的RNA合成称为RNA复制。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "转录是在RNA聚合酶的作用下以DNA的一条链为模板，另一条为编码链的不对称转录。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "mRNA的转录后加工：转录生成的RNA是初级转录产物。真核生物mRNA转录后，需进行首尾修饰，以及对mRNA链进行剪接。首尾修饰包括为“戴帽”（5’-末端的有7-甲基鸟嘌呤的帽结构）和“加尾”（3’端添加多聚腺苷酸polyA结构）；剪接包括去除“内含子”和连接“外显子”。", "content" : [{ "type" : "common", "alignment" : "center", "text" : "复制与转录过程的异同点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "复制", "alignment" : "left" }, { "text" : "转录", "alignment" : "left" }] }, { "content" : [{ "text" : "特点", "alignment" : "left" }, { "text" : "半保留复制", "alignment" : "left" }, { "text" : "不对称转录", "alignment" : "left" }] }, { "content" : [{ "text" : "模板", "alignment" : "left" }, { "text" : "双链均复制", "alignment" : "left" }, { "text" : "仅模板链转录", "alignment" : "left" }] }, { "content" : [{ "text" : "原料", "alignment" : "left" }, { "text" : "dNTP(N=A、T、C、G)", "alignment" : "left" }, { "text" : "NTP(N =A、U、C、G)", "alignment" : "left" }] }, { "content" : [{ "text" : "酶", "alignment" : "left" }, { "text" : "依赖 DNA 的 DNA 聚合酶（DDDP）", "alignment" : "left" }, { "text" : "依赖 DNA 的 RNA 聚合酶（DDRP）", "alignment" : "left" }] }, { "content" : [{ "text" : "产物", "alignment" : "left" }, { "text" : "子代双链 DNA", "alignment" : "left" }, { "text" : "mRNA、tRNA、rRNA 等", "alignment" : "left" }] }, { "content" : [{ "text" : "碱基配对", "alignment" : "left" }, { "text" : "A＝T、G≡C", "alignment" : "left" }, { "text" : "A＝U、G≡C、T＝A", "alignment" : "left" }] }, { "content" : [{ "text" : "引物", "alignment" : "left" }, { "text" : "需要", "alignment" : "left" }, { "text" : "不需要", "alignment" : "left" }] }] }] }] }] }] }] }] }] }, { "title" : "第十章", "text" : "基因表达调控", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、基因表达调控的概述", "alignment" : "left" }, { "text" : "（1）基因表达及调控的概念和意义<br>（2）基因表达的时空性<br>（3）基因的组成性表达、诱导与阻遏<br>（4）基因表达的多级调控<br>（5）基因表达调控的基本要素　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、基因表达调控的基本原理", "alignment" : "left" }, { "text" : "（1）原核基因表达调控（乳糖操纵子）<br>（2）真核基因表达调控（顺式作用元件、反式作用<br>因子）　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、基因表达调控的概述", "content" : [{ "type" : "common", "alignment" : "left", "text" : "基因表达调控是指对基因转录和翻译的调控。基因的表达具有时间特异性和空间特异性。空间特异性即指多细胞生物个体在某一特定生长发育阶段，同一基因在不同的组织器官表达不同。空间特异性也称细胞特异性或组织特异性。基因表达的时间特异性即指某一特定基因的表达严格按照一定的时间顺序发生。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "基因表达的时间、空间特异性由特异的基因启动子和（或）增强子与调节蛋白相互作用决定。" }] }] }, { "type" : "h1", "text" : "二、基因表达调控的基本原理", "content" : [{ "type" : "common", "alignment" : "left", "text" : "理论上讲，改变遗传信息传递过程的任何环节均会导致基因表达的变化，因此基因表达调控可以发生在从DNA转录为RNA，再从RNA翻译为蛋白质的任何环节，但发生在转录水平，尤其是转录起始水平的调节，对基因表达起至关重要的作用。", "content" : [{ "type" : "common", "alignment" : "center", "text" : "转录激活调节的要素", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "原核生物", "alignment" : "left" }, { "text" : "真核生物", "alignment" : "left" }] }, { "content" : [{ "text" : "特异DNA序列", "alignment" : "left" }, { "text" : "操纵子", "alignment" : "left" }, { "text" : "顺式作用元件（启动子、增强子、沉默子）", "alignment" : "left" }] }, { "content" : [{ "text" : "<br><br>调节蛋白", "alignment" : "left" }, { "text" : "特异因子：决定 RNA 聚合酶的识别特异性<br>阻遏蛋白：介导负性调控<br>激活蛋白：增强 RNA 聚合<br>酶转录活性", "alignment" : "left" }, { "text" : "反式作用因子：与特异的顺式作用元件识别结合反式激活另一基因的转录<br>顺式作用蛋白：特异识别结合自身基因的调节序列，调节自身基因的开启或关闭", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "乳糖操纵子的记忆“一、二、三”：①一个 CAP（分解物基因激活蛋白）结合位点，产生正性调控机制；②两种机制（I基因编码阻遏蛋白的负性调控和 CAP 结合蛋白的正性调控）协调配合调节；③三个结构基因Z、Y、A ,分别编码β-半乳糖苷酶、透酶和乙酰基转移酶；三个调控基因：调节基因 I（编码一种阻遏蛋白）、启动基因 P（RNA聚合酶结合的位点）、操纵基因 O（阻遏蛋白结合部位）。" }] }] }] }] }] }, { "title" : "第十一章", "text" : "重组DNA技术", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、重组DNA技术的概述", "alignment" : "left" }, { "text" : "（1）重组DNA技术相关的概念<br>（2）基因工程的基本原理　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、基因工程与医学", "alignment" : "left" }, { "text" : "（1）疾病相关基因的发现<br>（2）生物制药<br>（3）基因诊断<br>（4）基因治疗　", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "重组DNA由载体DNA和目标DNA组成，载体DNA是携带目的基因实现外源基因的无性繁殖或表达有意义的蛋白质所采用的一类特殊 DNA 分子。DNA重组的克隆载体包括质粒、噬菌体和病毒等。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "质粒是存在于细菌染色体外的可自我复制的小型双链环状 DNA 分子。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "载体所具备的基本条件：1.自主稳定复制；2.多克隆位点；3.遗传标记；4.插入容量大；" }] }] }, { "type" : "h2", "alignment" : "left", "text" : "5.分子量小，拷贝多；" }, { "type" : "h2", "alignment" : "left", "text" : "6.安全。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "限制性核酸内切酶是重组DNA技术中常用的工具酶，其作用是识别特异序列，切割DNA。目标DNA与载体DNA连接在一起即为重组DNA。重组DNA分子经转化、转染或感染等方式可进入宿主细胞，可随受体细胞生长、增殖，使重组DNA分子得以复制、扩散。" }] }] }] }, { "title" : "第十二章", "text" : "血液生化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、血液的化学成分", "alignment" : "left" }, { "text" : "（1）水和无机盐<br>（2）血浆蛋白质<br>（3）非蛋白质含氮物质<br>（4）不合氮的有机化合物", "alignment" : "left" }] }, { "content" : [{ "text" : "二、血浆蛋白质", "alignment" : "left" }, { "text" : "（1）血浆蛋白质的分类<br>（2）血浆蛋白质的来源<br>（3）血浆蛋白质的功能", "alignment" : "left" }] }, { "content" : [{ "text" : "三、红细胞的代谢", "alignment" : "left" }, { "text" : "（1）血红素合成的原料、部位和关键酶<br>（2）成熟红细胞的代谢特点", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、血浆蛋白质", "content" : [{ "type" : "common", "alignment" : "left", "text" : "人血浆内蛋白质总浓度大约为 70～75g/L,是血浆中主要的固体成分。通常按来源、分离方法和生理功能将血清蛋白质分类。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "醋酸纤维素薄膜电泳分离方法分类——清蛋白、α1-球蛋白、α2-球蛋白、β-球蛋白、γ-球蛋白。清蛋白为最主要的血浆蛋白(约占 50％)，浓度 38～48g/L；球蛋白浓度 15～30g/L。正常清蛋白与球蛋白的比例（A/G）为 1.5～2.5:1。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "按生理功能分类：结合蛋白或载体、免疫防御系统蛋白、凝血和纤溶蛋白、酶、蛋白酶抑制剂、激素、参与炎症应答的蛋白等。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "血浆蛋白的功能：维持血浆胶体渗透压；维持血浆正常的 pH（7.40±0.05）；运输作用；免疫作用（抗体和补体）；催化作用（血清酶可分为三类：血浆功能酶、外分泌酶、细胞酶）；凝血、抗凝血和纤溶作用。" }] }] }] }] }, { "type" : "h1", "text" : "二、红细胞的代谢特点", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 成熟红细胞没有细胞器，只存在糖酵解与磷酸戊糖途径。糖酵解是红细胞获得能量的唯一途径，1分子葡萄糖生成 2分子ATP。磷酸戊糖途径是红细胞产生 NADPH 的唯一途径，1分子葡萄糖产生2分子NADPH + H+。2, 3-二磷酸甘油酸(2, 3-BPG)旁路：产生 2, 3-BPG，降低血红蛋白对氧的亲和力，从而调节血红蛋白的运氧能力。" }, { "type" : "h2", "alignment" : "left", "text" : "2. 血红蛋白的组成：珠蛋白和血红素。血红素的生物合成的主要部位是骨髓和肝脏，成熟红细胞不能合成。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "血红素的生物合成记忆要点：“一、二、三、四”", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一个关键酶", "alignment" : "left" }, { "text" : "ALA 合酶，催化琥珀酰辅酶 A 与甘氨酸缩合成ALA，辅酶是磷酸吡哆醛", "alignment" : "left" }] }, { "content" : [{ "text" : "二个不同部位", "alignment" : "left" }, { "text" : "起始与终末阶段在线粒体中，而中间阶段合成在胞浆内进行", "alignment" : "left" }] }, { "content" : [{ "text" : "三个合成原料", "alignment" : "left" }, { "text" : "甘氨酸、琥珀酰CoA、Fe2+", "alignment" : "left" }] }, { "content" : [{ "text" : "四个反应过程", "alignment" : "left" }, { "text" : "⑴ -氨基- -酮戊酸(ALA)的生成；⑵胆色素原的生成：进入胞液的两分子ALA脱水缩合成一分子胆色素原；⑶尿卟啉原与粪卟啉原的生成在胞液中进行；⑷血红素的生成：胞液中的粪卟啉原Ⅲ再进入线粒体", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "血红素合成的调节：⑴ALA合酶；⑵ALA脱水酶与亚铁螯合酶；⑶促红细胞生成素。" }] }] }] }] }] }, { "title" : "第十三章", "text" : "肝生化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、肝的生物转化作用", "alignment" : "left" }, { "text" : "（1）肝生物转化的概念和特点<br>（2）生物转化的反应类型及酶系<br>（3）影响肝脏生物转化作用的因素　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、胆汁酸代谢", "alignment" : "left" }, { "text" : "（1）胆汁酸的化学<br>（2）胆汁酸的代谢<br>（3）胆汁酸代谢的调节　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、胆色素代谢", "alignment" : "left" }, { "text" : "（1）游离胆红素和结合胆红素的性质<br>（2）胆色素代谢与黄疸　", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "both", "text" : "一、肝的生物转化作用", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肝脏生物转化分两相反应。第一相反应为氧化、还原、水解等，第二相反应为各种结合反应，主要为葡萄糖醛酸结合反应。肝脏生物转化的意义为解毒和排毒。" }] }] }, { "type" : "h1", "text" : "二、胆汁酸代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "胆汁酸是存在于胆汁中一大类胆烷酸的总称，以钠盐或钾盐的形式存在，即胆汁酸盐，简称胆盐。胆汁酸的功能：⑴促进脂类的消化与吸收；⑵抑制胆汁中胆固醇的析出。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "胆汁酸肠肝循环：胆汁酸（包括初级、次级、游离型、结合型）随胆汁排入肠腔后，通过重吸收经门静脉又回到肝，在肝内转变为结合型胆汁酸，与新合成的结合型胆汁酸一起经胆道再次排入肠腔的过程。由肝排入肠腔的胆汁酸 95%以上被重吸收利用，其中以回肠部的主动重吸收为主。" }] }, { "type" : "h2", "alignment" : "left", "text" : "1. 胆汁酸的分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "初级胆汁酸", "alignment" : "left" }, { "text" : "次级胆汁酸", "alignment" : "left" }] }, { "content" : [{ "text" : "游离胆汁酸", "alignment" : "left" }, { "text" : "胆酸<br>鹅脱氧胆酸", "alignment" : "left" }, { "text" : "脱氧胆酸<br>石胆酸", "alignment" : "left" }] }, { "content" : [{ "text" : "结合胆汁酸", "alignment" : "left" }, { "text" : "胆酸、鹅脱氧胆酸等与甘氨酸和牛磺酸的结合产物", "alignment" : "left" }, { "text" : "脱氧胆酸、石胆酸等与甘氨酸和牛磺酸的结合产物", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 初级胆汁酸与次级胆汁酸的生成比较", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "初级胆汁酸", "alignment" : "left" }, { "text" : "次级胆汁酸", "alignment" : "left" }] }, { "content" : [{ "text" : "部位", "alignment" : "left" }, { "text" : "肝细胞的胞液和微粒体中", "alignment" : "left" }, { "text" : "小肠下段和大肠", "alignment" : "left" }] }, { "content" : [{ "text" : "原料", "alignment" : "left" }, { "text" : "胆固醇", "alignment" : "left" }, { "text" : "初级胆汁酸", "alignment" : "left" }] }, { "content" : [{ "text" : "反应过程", "alignment" : "left" }, { "text" : "胆固醇→7-α羟胆固醇→初级胆汁酸", "alignment" : "left" }, { "text" : "7-位脱羟基", "alignment" : "left" }] }, { "content" : [{ "text" : "限速酶", "alignment" : "left" }, { "text" : "胆固醇7α-羟化酶（加单氧酶）", "alignment" : "left" }, { "text" : "", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "三、胆色素代谢", "content" : [{ "type" : "common", "alignment" : "left", "text" : "胆色素是体内铁卟啉化合物的主要分解代谢产物，包括胆红素、胆绿素、胆素原和胆素等。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "胆红素来源：体内的铁卟啉化合物——血红蛋白、肌红蛋白、细胞色素、过氧化氢酶及过氧化物酶。70％以上自衰老红细胞中血红蛋白的分解。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "结合胆红素肠道还原→胆素原（d-尿胆素原、中胆素原和粪胆素原）。<br>胆素原肠道下段氧化→胆素（d-尿胆素、i-尿胆素和粪胆素）。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "胆素原的肠肝循环：肠道中约有10％～20％的胆素原可被肠黏膜细胞重吸收，经门静脉入肝，其中大部分再随胆汁排入肠道，形成胆素原的肠肝循环。大部分（80％～90％）未被重吸收的胆素原在肠道氧化成胆素，随粪便排出，是粪便的主要色素。少量重吸收的胆素原经血液循环入肾并随尿排出，被氧化成胆素，是尿的主要色素。", "content" : [{ "type" : "common", "alignment" : "center", "text" : "未结合胆红素与结合胆红素的区别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "游离胆红素", "alignment" : "left" }, { "text" : "结合胆红素", "alignment" : "left" }] }, { "content" : [{ "text" : "别名", "alignment" : "left" }, { "text" : "间接胆红素", "alignment" : "left" }, { "text" : "直接胆红素", "alignment" : "left" }] }, { "content" : [{ "text" : "与葡萄糖醛酸结合", "alignment" : "left" }, { "text" : "未结合", "alignment" : "left" }, { "text" : "结合", "alignment" : "left" }] }, { "content" : [{ "text" : "与重氮试剂反应", "alignment" : "left" }, { "text" : "慢或间接反应", "alignment" : "left" }, { "text" : "快或直接反应", "alignment" : "left" }] }, { "content" : [{ "text" : "水中溶解度", "alignment" : "left" }, { "text" : "小", "alignment" : "left" }, { "text" : "大", "alignment" : "left" }] }, { "content" : [{ "text" : "经肾随尿排出", "alignment" : "left" }, { "text" : "不能", "alignment" : "left" }, { "text" : "能", "alignment" : "left" }] }, { "content" : [{ "text" : "通盘细胞膜对脑的毒性作用", "alignment" : "left" }, { "text" : "大", "alignment" : "left" }, { "text" : "无", "alignment" : "left" }] }] }] }] }] }] }] }] }] }, { "title" : "第十四章", "text" : "维生素", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、脂溶性维生素", "alignment" : "left" }, { "text" : "脂溶性维生素的生理功能及缺乏症　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、水溶性维生素", "alignment" : "left" }, { "text" : "水溶性维生素的生理功能及缺乏症　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、脂溶性维生素的生理功能及缺乏症", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "维生素", "alignment" : "left" }, { "text" : "主要功能", "alignment" : "left" }, { "text" : "活性形式", "alignment" : "left" }, { "text" : "缺乏症", "alignment" : "left" }] }, { "content" : [{ "text" : "VitA", "alignment" : "left" }, { "text" : "构成视紫红质；保持上皮组织结构的完整；促进生长发育；抗氧化作用", "alignment" : "left" }, { "text" : "视黄醇、视黄醛、视黄酸", "alignment" : "left" }, { "text" : "夜盲症、干眼病", "alignment" : "left" }] }, { "content" : [{ "text" : "VitD", "alignment" : "left" }, { "text" : "促进钙磷吸收，促进骨盐代谢及骨的正常生长", "alignment" : "left" }, { "text" : "1,25-（OH）<sub>2</sub>-D<sub>3</sub>", "alignment" : "left" }, { "text" : "佝偻病、软骨病", "alignment" : "left" }] }, { "content" : [{ "text" : "VitE", "alignment" : "left" }, { "text" : "抗氧化作用，保护生物膜，维持生殖功能；促进血红素生成", "alignment" : "left" }, { "text" : "生育酚", "alignment" : "left" }, { "text" : "人类尚未发现因缺乏维生素E所致的不孕症，新生儿缺乏维生素E可引起贫血", "alignment" : "left" }] }, { "content" : [{ "text" : "VitK", "alignment" : "left" }, { "text" : "促进肝合成凝血因子，维持骨盐含量，减少动脉钙化", "alignment" : "left" }, { "text" : "2-甲基1,4-萘醌", "alignment" : "left" }, { "text" : "易出血", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "二、水溶性维生素的生理功能及缺乏症", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "维生素", "alignment" : "left" }, { "text" : "主要功能", "alignment" : "left" }, { "text" : "活性形式", "alignment" : "left" }, { "text" : "缺乏症", "alignment" : "left" }] }, { "content" : [{ "text" : "VitB<sub>1</sub>", "alignment" : "left" }, { "text" : "α-酮酸氧化脱羧酶的辅酶、转酮基反应", "alignment" : "left" }, { "text" : "焦磷酸硫胺素", "alignment" : "left" }, { "text" : "脚气病、末梢神经炎", "alignment" : "left" }] }, { "content" : [{ "text" : "VitB<sub>2</sub>（核黄素）", "alignment" : "left" }, { "text" : "构成黄素酶的辅酶，参与生物氧化体系", "alignment" : "left" }, { "text" : "FMN、FAD", "alignment" : "left" }, { "text" : "口角炎、舌炎、唇炎、阴囊炎", "alignment" : "left" }] }, { "content" : [{ "text" : "VitB<sub>6</sub>", "alignment" : "left" }, { "text" : "氨基酸脱羧酶及转氨酶的辅酶；ALA合酶的辅酶、糖原磷酸化酶的组成成分", "alignment" : "left" }, { "text" : "磷酸吡哆醛、磷酸吡哆胺", "alignment" : "left" }, { "text" : "人类未发现缺乏症", "alignment" : "left" }] }, { "content" : [{ "text" : "VitB<sub>12</sub>", "alignment" : "left" }, { "text" : "促进甲基转移；促进DNA合成；促进红细胞合成；琥珀酰辅酶A的生成", "alignment" : "left" }, { "text" : "甲钴胺素、5′-脱氧腺苷钴胺素", "alignment" : "left" }, { "text" : "巨幼红细胞性贫血，神经脱髓鞘", "alignment" : "left" }] }, { "content" : [{ "text" : "VitPP", "alignment" : "left" }, { "text" : "构成脱氢酶的辅酶，参与生物氧化体系", "alignment" : "left" }, { "text" : "NAD<sup>+</sup>、NADP<sup>+</sup>", "alignment" : "left" }, { "text" : "癞皮病", "alignment" : "left" }] }, { "content" : [{ "text" : "VitC", "alignment" : "left" }, { "text" : "参与体内羟化反应；参与抗氧化作用；增强免疫力作用；促进铁吸收", "alignment" : "left" }, { "text" : "抗坏血酸", "alignment" : "left" }, { "text" : "坏血病", "alignment" : "left" }] }, { "content" : [{ "text" : "泛酸", "alignment" : "left" }, { "text" : "构成CoA的成分，参与体内酰基转移；参与脂酸合成", "alignment" : "left" }, { "text" : "CoA、ACP", "alignment" : "left" }, { "text" : "缺乏症少见", "alignment" : "left" }] }, { "content" : [{ "text" : "叶酸", "alignment" : "left" }, { "text" : "参与一碳单位的转移，与蛋白质、核酸合成以及红细胞、白细胞成熟有关", "alignment" : "left" }, { "text" : "FH<sub>4</sub>", "alignment" : "left" }, { "text" : "巨幼红细胞贫血", "alignment" : "left" }] }, { "content" : [{ "text" : "生物素", "alignment" : "left" }, { "text" : "构成羧化酶的辅酶，参与CO<sub>2</sub>固定；参与细胞信号传导", "alignment" : "left" }, { "text" : "生物素辅酶", "alignment" : "left" }, { "text" : "很少出现缺乏症", "alignment" : "left" }] }] }] }] }] }, { "text" : "第三篇  病理学", "guide" : [{ "text" : "执业医师考试——本篇约占临床执业医师考试的3%，出题量约为18题。其中细胞组织的损伤修复、局部血液循环障碍、炎症及肿瘤为复习重点，其余各个系统的病理学考点将穿插在临床内、外、妇、儿的知识点中，可在复习临床综合、生理学时结合在一起复习。" }], "content" : [{ "title" : "第一章", "text" : "细胞、组织的适应、损伤和修复", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、适应性改变", "alignment" : "left" }, { "text" : "（1）萎缩的概念及类型<br>（2）肥大、增生和化生的概念及类型", "alignment" : "left" }] }, { "content" : [{ "text" : "二、损伤", "alignment" : "left" }, { "text" : "（1）可逆性损伤的类型、概念及病理变化<br>（2）不可逆性损伤——细胞死亡的类型、概念及病理变化", "alignment" : "left" }] }, { "content" : [{ "text" : "三、修复", "alignment" : "left" }, { "text" : "（1）再生的概念<br>（2）各种细胞的再生潜能<br>（3）肉芽组织的结构和功能<br>（4）创伤愈合<br>（5）骨折愈合", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、适应性改变", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 细胞和由其构成的组织、器官对内、外环境中各种有害因子的刺激作用产生的非损伤性应答反应，称为适应。包括萎缩、肥大、增生和化生。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "概念", "alignment" : "left" }, { "text" : "定义", "alignment" : "left" }, { "text" : "好发部位", "alignment" : "left" }] }, { "content" : [{ "text" : "萎缩", "alignment" : "left" }, { "text" : "是指已发育正常的实质细胞、组织或器官的体积缩小，组织器官的未曾发育或发育不全不属于萎缩", "alignment" : "left" }, { "text" : "心肌、肝、肾上腺细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "肥大", "alignment" : "left" }, { "text" : "由于功能增加、合成代谢旺盛，使细胞、组织或器官体积增大，可分为生理性肥大和病理性肥大；代偿性肥大和内分泌性肥大", "alignment" : "left" }, { "text" : "妊娠期子宫、哺乳期乳腺，高血压时左心室肥大", "alignment" : "left" }] }, { "content" : [{ "text" : "增生", "alignment" : "left" }, { "text" : "是指组织或器官內实质细胞数量增多，常导致组织或器官体积增大，增生分生理性增生和病理性增生", "alignment" : "left" }, { "text" : "妊娠期子宫、青春期乳腺、肝叶切除后肝细胞的增生", "alignment" : "left" }] }, { "content" : [{ "text" : "化生", "alignment" : "left" }, { "text" : "一种分化成熟的细胞类型被另一种分化成熟的细胞类型所取代的过程", "alignment" : "left" }, { "text" : "上皮组织、间叶组织的化生", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 上皮的化生可以恶变，常见例子如下", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "上皮组织的化生", "alignment" : "left" }, { "text" : "常见例子", "alignment" : "left" }, { "text" : "化生癌变", "alignment" : "left" }] }, { "content" : [{ "text" : "柱状上皮→鳞状上皮", "alignment" : "left" }, { "text" : "慢性支气管炎假复层纤毛上皮化生", "alignment" : "left" }, { "text" : "支气管黏膜发生鳞癌", "alignment" : "left" }] }, { "content" : [{ "text" : "移行上皮→鳞状上皮", "alignment" : "left" }, { "text" : "肾盂上皮的化生、膀胱上皮的化生", "alignment" : "left" }, { "text" : "膀胱鳞癌", "alignment" : "left" }] }, { "content" : [{ "text" : "腺上皮→含杯状细胞或潘氏细胞的肠上皮组织", "alignment" : "left" }, { "text" : "慢性萎缩性胃炎的肠上皮化生", "alignment" : "left" }, { "text" : "胃黏膜发生肠型腺癌", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "二、损伤", "content" : [{ "type" : "common", "alignment" : "left", "text" : "损伤分为可逆性和不可逆性的损伤。可逆性损伤是指细胞或细胞间质受损伤后因代谢发生障碍，使细胞内或细胞间质出现异常物质或正常物质异常蓄积的现象，常伴功能下降。" }, { "type" : "h2", "alignment" : "left", "text" : "1. 常见细胞可逆性损伤类型", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "类型", "alignment" : "left" }, { "text" : "病理特点", "alignment" : "left" }, { "text" : "好发部位", "alignment" : "left" }] }, { "content" : [{ "text" : "细胞水肿", "alignment" : "left" }, { "text" : "细胞内水蓄积", "alignment" : "left" }, { "text" : "肝、心、肾", "alignment" : "left" }] }, { "content" : [{ "text" : "脂肪变", "alignment" : "left" }, { "text" : "非脂肪细胞胞质中的甘油三酯蓄积", "alignment" : "left" }, { "text" : "肝（最常见）、心、肾、骨骼肌细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "玻璃样变", "alignment" : "left" }, { "text" : "细胞内或细胞间质中蛋白质的异常蓄积", "alignment" : "left" }, { "text" : "肝细胞、肾小管上皮细胞等", "alignment" : "left" }] }, { "content" : [{ "text" : "淀粉样变", "alignment" : "left" }, { "text" : "细胞间质内淀粉样蛋白质-粘多糖复合物的沉积", "alignment" : "left" }, { "text" : "皮肤、结膜、霍奇金病、多发性骨髓瘤、甲状腺髓样癌", "alignment" : "left" }] }, { "content" : [{ "text" : "粘液样变", "alignment" : "left" }, { "text" : "细胞间质内粘多糖和蛋白质的蓄积", "alignment" : "left" }, { "text" : "间叶组织肿瘤、风湿病、动脉硬化", "alignment" : "left" }] }, { "content" : [{ "text" : "病理性色素沉着", "alignment" : "left" }, { "text" : "细胞内外有色物质的异常蓄积", "alignment" : "left" }, { "text" : "含铁血黄素、脂褐质等蓄积的疾病", "alignment" : "left" }] }, { "content" : [{ "text" : "病理性钙化", "alignment" : "left" }, { "text" : "骨和牙齿以外的组织中固态钙盐的沉积", "alignment" : "left" }, { "text" : "甲旁亢、骨肿瘤等", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 不可逆损伤——细胞死亡，包括坏死和凋亡两种类型。坏死是被动性坏死（他杀），凋亡是主动性坏死（自杀）。凋亡不会引起炎症反应。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "坏死的概念：以酶溶性变化为特点的活体内局部组织细胞的死亡称为坏死。细胞核的改变是细胞坏死的主要形态学标志，表现为核固缩、核碎裂、核溶解。", "content" : [{ "type" : "common", "alignment" : "center", "text" : "坏死的类型", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "类型", "alignment" : "left" }, { "text" : "病理特点", "alignment" : "left" }, { "text" : "常见部位", "alignment" : "left" }] }, { "content" : [{ "text" : "凝固性坏死", "alignment" : "left" }, { "text" : "蛋白质变性凝固且溶解酶水解作用较弱时，坏死区呈灰黄、干燥、质实状态", "alignment" : "left" }, { "text" : "最常见，多见于心、肾、脾等器官的缺血性坏死（梗死—缺血、缺水），干酪样坏死是一种特殊类型的凝固性坏死", "alignment" : "left" }] }, { "content" : [{ "text" : "液化性坏死", "alignment" : "left" }, { "text" : "坏死组织中可凝固的蛋白质少，或坏死细胞自身及浸润的中性粒细胞等释放大量水解酶，或组织富含水分和磷脂，组织易发生溶解液化", "alignment" : "left" }, { "text" : "脑、胰腺、化脓性感染、脂肪坏死", "alignment" : "left" }] }, { "content" : [{ "text" : "纤维素样坏死", "alignment" : "left" }, { "text" : "是结缔组织及小血管壁常见的坏死形式", "alignment" : "left" }, { "text" : "常见于某些变态反应性疾病，如风湿病、结节性多动脉炎，新月体性肾小球肾炎", "alignment" : "left" }] }, { "content" : [{ "text" : "坏疽", "alignment" : "left" }, { "text" : "指局部组织大块坏死并继发腐败菌感染，分为干性、湿性和气性坏疽", "alignment" : "left" }, { "text" : "干性坏疽：多见于四肢末端；<br>湿性坏疽：多见于肠、子宫、肺；<br>气性坏疽：多见于产气荚膜杆菌所致", "alignment" : "both" }] }] }] }] }] }] }, { "type" : "h1", "text" : "三、修复", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 再生的概念：组织和细胞损伤后，由周围健康的细胞进行增生，以实现修复的过程称为再生。再生能力最强的是上皮细胞（更新最快），再生能力最差的是神经细胞、心肌细胞。根据再生能力，将人体细胞分为稳定细胞、不稳定细胞、永久细胞。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "细胞分类", "alignment" : "left" }, { "text" : "定义", "alignment" : "left" }, { "text" : "常见细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "不稳定细胞", "alignment" : "left" }, { "text" : "这类细胞总在不断的增殖，以代替衰亡或破坏的细胞，其再生能力很强", "alignment" : "left" }, { "text" : "表皮细胞、呼吸道及消化道黏膜被覆细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "稳定细胞", "alignment" : "left" }, { "text" : "在生理情况下，这类细胞增殖现象不明显，但受到组织损伤刺激时，表现出较强的再生能力", "alignment" : "left" }, { "text" : "腺体实质细胞（肝、胰、汗腺、内分泌腺）、肾小管的上皮细胞、平滑肌细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "永久性细胞", "alignment" : "left" }, { "text" : "这类细胞不能再生", "alignment" : "left" }, { "text" : "神经细胞、骨骼肌细胞、心肌细胞", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 肉芽组织主要由成纤维细胞和新生薄壁的毛细血管组成，并伴炎症细胞浸润。炎症细胞主要是巨噬细胞、中性粒细胞。肉芽组织最后变为瘢痕组织。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肉芽组织的功能：（1）抗感染及保护创面；（2）填补伤口及其他组织缺损；（3）机化血凝块和坏死组织。" }] }] }] }, { "title" : "第二章", "text" : "局部血液循环障碍", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、充血和淤血", "alignment" : "left" }, { "text" : "（1）充血的概念和类型<br>（2）淤血的概念、原因、病理变化和对机体的影响", "alignment" : "left" }] }, { "content" : [{ "text" : "二、血栓形成", "alignment" : "left" }, { "text" : "（1）概念<br>（2）血栓形成的条件<br>（3）血栓的类型<br>（4）血栓的结局<br>（5）血栓对机体的影响　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、栓塞", "alignment" : "left" }, { "text" : "（1）栓子的概念<br>（2）栓子的运行途径<br>（3）栓塞的类型及概念<br>（4）栓塞对机体的影响　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、梗死", "alignment" : "left" }, { "text" : "（1）概念<br>（2）梗死的形成原因和条件<br>（3）梗死的类型和病理变化　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、充血和淤血", "content" : [{ "type" : "common", "alignment" : "left", "text" : "动脉性充血指器官或组织因动脉输入血量的增多而发生的充血，为一个主动的过程。静脉性充血（淤血）指器官或局部组织因静脉回流受阻，血液瘀滞于小静脉和毛细血管内，是一个被动过程。短期淤血后果轻微，长期淤血可至细胞萎缩、变性、坏死、硬化。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "充血与淤血的异同", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "动脉性充血", "alignment" : "left" }, { "text" : "静脉性充血（淤血）", "alignment" : "left" }] }, { "content" : [{ "text" : "定义", "alignment" : "left" }, { "text" : "器官或组织因动脉输入血量的增多而发生的充血。为主动过程", "alignment" : "left" }, { "text" : "指器官或局部组织因静脉回流受阻，血液淤积于小静脉和毛细血管内。为被动过程", "alignment" : "left" }] }, { "content" : [{ "text" : "病变", "alignment" : "left" }, { "text" : "器官或组织体积增大、红润、温度升高", "alignment" : "left" }, { "text" : "局部血液停滞、发绀、水肿、温度降低", "alignment" : "left" }] }, { "content" : [{ "text" : "后果", "alignment" : "left" }, { "text" : "短暂的血管反应；病因解除后恢复正常，对机体无不良影响", "alignment" : "left" }, { "text" : "短期淤血后果轻微，慢性淤血可至细胞萎缩、变性、坏死、硬化", "alignment" : "left" }] }, { "content" : [{ "text" : "分类", "alignment" : "left" }, { "text" : "生理性充血、炎症性充血、减压后充血", "alignment" : "left" }, { "text" : "肺淤血，多见于左心衰；肝淤血，多见于右心衰", "alignment" : "left" }] }] }] }] }] }, { "type" : "h1", "text" : "二、血栓形成", "content" : [{ "type" : "common", "alignment" : "left", "text" : "血栓的类型和形态", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "白色血栓", "alignment" : "left" }, { "text" : "混合血栓", "alignment" : "left" }, { "text" : "红色血栓", "alignment" : "left" }, { "text" : "透明血栓", "alignment" : "left" }] }, { "content" : [{ "text" : "别名", "alignment" : "left" }, { "text" : "血小板血栓<br>析出性血栓", "alignment" : "left" }, { "text" : "层状血栓", "alignment" : "left" }, { "text" : "—", "alignment" : "left" }, { "text" : "微血栓<br>纤维素性血栓", "alignment" : "left" }] }, { "content" : [{ "text" : "发生情况", "alignment" : "left" }, { "text" : "血流较快时", "alignment" : "left" }, { "text" : "血流缓慢的静脉", "alignment" : "left" }, { "text" : "血流缓慢的静脉", "alignment" : "left" }, { "text" : "DIC晚期病人", "alignment" : "left" }] }, { "content" : [{ "text" : "常见部位", "alignment" : "left" }, { "text" : "心瓣膜、动脉、静脉血栓的头部", "alignment" : "left" }, { "text" : "静脉延续性血栓的体部", "alignment" : "left" }, { "text" : "静脉延续性血栓的尾部", "alignment" : "left" }, { "text" : "毛细血管内、DIC", "alignment" : "left" }] }, { "content" : [{ "text" : "主要成分", "alignment" : "left" }, { "text" : "血小板+纤维蛋白", "alignment" : "left" }, { "text" : "血小板+纤维素+RBC", "alignment" : "left" }, { "text" : "纤维素+RBC+WBC", "alignment" : "left" }, { "text" : "纤维蛋白", "alignment" : "left" }] }, { "content" : [{ "text" : "外观特点", "alignment" : "left" }, { "text" : "灰白色赘生物，与血管壁粘连不易脱落", "alignment" : "left" }, { "text" : "灰白与褐色相间的条纹，粗糙干燥的圆柱状，与血管壁粘连不易脱落", "alignment" : "left" }, { "text" : "暗红色，新鲜时湿润，有弹性，与血管壁无粘连", "alignment" : "left" }, { "text" : "肉眼不可见", "alignment" : "left" }] }, { "content" : [{ "text" : "举例及特点", "alignment" : "left" }, { "text" : "急性风湿性心内膜炎、感染性心内膜炎心瓣膜上的赘生物", "alignment" : "left" }, { "text" : "二尖瓣狭窄、房颤时左房的球形血栓，动脉瘤内的附壁血栓", "alignment" : "left" }, { "text" : "容易脱落导致栓塞", "alignment" : "left" }, { "text" : "休克晚期、DIC微小血栓", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "血栓的结局通常有：软化、溶解、吸收；机化、再通；钙化。血栓一般不会主动排出。由肉芽组织逐渐取代血栓的过程称为血栓机化。如血栓未能软化又未能完全机化，可发生钙盐沉积，称为钙化。" }] }] }] }, { "type" : "h1", "text" : "三、栓塞", "content" : [{ "type" : "common", "alignment" : "left", "text" : "栓塞即指在循环血液中，出现不溶于血液的异常物质，随血液运行阻塞血管腔的现象。栓子常为脱落的血栓碎片或节段（最常见）、脂肪滴、空气、羊水和肿瘤细胞团。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "不同来源栓子及其栓塞部位", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "栓子来源", "alignment" : "left" }, { "text" : "栓塞部位", "alignment" : "left" }] }, { "content" : [{ "text" : "静脉系统及右心栓子", "alignment" : "left" }, { "text" : "肺栓塞", "alignment" : "left" }] }, { "content" : [{ "text" : "主动脉系统及左心栓子", "alignment" : "left" }, { "text" : "各器官的小动脉，常见于脑、脾、肾及四肢的指、趾部", "alignment" : "left" }] }, { "content" : [{ "text" : "门静脉系统栓子", "alignment" : "left" }, { "text" : "肝内门静脉的栓塞", "alignment" : "left" }] }, { "content" : [{ "text" : "交叉性栓塞（反常性栓塞）", "alignment" : "left" }, { "text" : "偶见来自右心或腔静脉系统的栓子，在右心压力突然升高的情况下，通过先天性房缺或室缺到达左心，进入体循环引起栓塞", "alignment" : "left" }] }, { "content" : [{ "text" : "逆行性栓塞", "alignment" : "left" }, { "text" : "罕见，下腔静脉内血栓在腹内压突然升高时，逆行进肝、肾静脉分支引起栓塞", "alignment" : "left" }] }] }] }] }] }, { "type" : "h1", "text" : "四、梗死", "content" : [{ "type" : "common", "alignment" : "left", "text" : "器官或局部组织由于血流阻断，又不能建立有效的侧枝循环而发生的坏死，称为梗死。梗死一般是由于动脉的阻塞而引起的局部组织缺血坏死。血栓形成是梗死的最常见原因。" }, { "type" : "h2", "alignment" : "left", "text" : "1. 贫血性梗死与出血性梗死鉴别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "梗死类型", "alignment" : "left" }, { "text" : "贫血性梗死", "alignment" : "left" }, { "text" : "出血性梗死", "alignment" : "left" }] }, { "content" : [{ "text" : "别名", "alignment" : "left" }, { "text" : "白色梗死", "alignment" : "left" }, { "text" : "红色梗死", "alignment" : "left" }] }, { "content" : [{ "text" : "梗死灶颜色", "alignment" : "left" }, { "text" : "灰白色", "alignment" : "left" }, { "text" : "暗红色", "alignment" : "left" }] }, { "content" : [{ "text" : "梗死灶出血量", "alignment" : "left" }, { "text" : "不多", "alignment" : "left" }, { "text" : "多", "alignment" : "left" }] }, { "content" : [{ "text" : "好发器官特点", "alignment" : "left" }, { "text" : "组织结构较致密、侧支循环不丰富的实质器官，支配该器官的动脉分支被堵塞后发生", "alignment" : "left" }, { "text" : "在严重淤血的基础上发生，组织疏松、双重血供或吻合支丰富的器官", "alignment" : "left" }] }, { "content" : [{ "text" : "好发器官", "alignment" : "left" }, { "text" : "心、肾、脾、脑", "alignment" : "left" }, { "text" : "肺、肠、卵巢肿瘤蒂扭转", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 梗死的形态变化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "心贫血性梗死", "alignment" : "center" }, { "text" : "地图状或不规则", "alignment" : "left" }, { "text" : "肺出血性梗死", "alignment" : "center" }, { "text" : "三角形", "alignment" : "left" }] }, { "content" : [{ "text" : "脾、肾贫血性梗死", "alignment" : "center" }, { "text" : "锥形或三角形", "alignment" : "left" }, { "text" : "肠出血性梗死", "alignment" : "center" }, { "text" : "节段性", "alignment" : "left" }] }] }] }] }] }, { "title" : "第三章", "text" : "炎症", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、概述", "alignment" : "left" }, { "text" : "（1）概念<br>（2）原因<br>（3）炎症的基本病理变化<br>（4）炎症的局部表现和全身反应<br>（5）炎症的结局", "alignment" : "left" }] }, { "content" : [{ "text" : "二、急性炎症", "alignment" : "left" }, { "text" : "（1）渗出<br>（2）炎症细胞的种类和主要功能<br>（3）炎症介质的概念和主要作用<br>（4）急性炎症的类型和病理变化", "alignment" : "left" }] }, { "content" : [{ "text" : "三、慢性炎症", "alignment" : "left" }, { "text" : "（1）一般慢性炎症的病理变化和特点<br>（2）慢性肉芽肿性炎的概念、病因和病变特点", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、炎症的概述", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "概念", "alignment" : "left" }, { "text" : "炎症是具有血管系统的活体组织对各种损伤因子的刺激所发生的以防御反应为主的基本病理过程", "alignment" : "left" }] }, { "content" : [{ "text" : "炎症的基本病理变化", "alignment" : "left" }, { "text" : "局部组织变质、渗出和增生；早期以变质和渗出变化为主，后期以增生为主", "alignment" : "left" }] }, { "content" : [{ "text" : "炎症的局部表现和全身反应", "alignment" : "left" }, { "text" : "局部表现为红肿、热、痛和功能障碍。全身反应如发热、头痛、白细胞增多等", "alignment" : "left" }] }, { "content" : [{ "text" : "炎症的结局", "alignment" : "left" }, { "text" : "1.痊愈；2.迁延不愈、转为慢性；3.蔓延传播（局部蔓延、淋巴道蔓延、血道蔓延）。有波动感提示脓肿形成", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "二、急性炎症", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 炎症细胞的种类及其意义", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "炎症细胞种类", "alignment" : "left" }, { "text" : "意义", "alignment" : "left" }] }, { "content" : [{ "text" : "中性粒细胞", "alignment" : "left" }, { "text" : "常见于炎症早期、急性炎症和化脓性炎症", "alignment" : "left" }] }, { "content" : [{ "text" : "巨噬细胞（来源于血液的单核细胞）", "alignment" : "left" }, { "text" : "常见于炎症后期、慢性炎症及非化脓性炎症和由病毒、原虫及真菌引起的炎症", "alignment" : "left" }] }, { "content" : [{ "text" : "淋巴细胞和浆细胞", "alignment" : "left" }, { "text" : "具有特异性免疫功能，常见于慢性炎症和病毒感染", "alignment" : "left" }] }, { "content" : [{ "text" : "嗜酸性粒细胞", "alignment" : "left" }, { "text" : "主要见于寄生虫感染和过敏性炎症", "alignment" : "left" }] }, { "content" : [{ "text" : "嗜碱性粒细胞和肥大细胞", "alignment" : "left" }, { "text" : "通过脱颗粒释放炎症介质而发挥作用", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 急性炎症的类型及其病理变化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "急性炎症的类型", "alignment" : "left" }, { "text" : "特点", "alignment" : "left" }] }, { "content" : [{ "text" : "浆液性炎", "alignment" : "left" }, { "text" : "以浆液性渗出为其特征，浆液渗出物以血浆成分为主，常发生于黏膜、浆膜和疏松结缔组织，如毒蛇咬伤", "alignment" : "left" }] }, { "content" : [{ "text" : "纤维素性炎", "alignment" : "left" }, { "text" : "以纤维蛋白原渗出为主，易发生于黏膜、浆膜和肺组织，如白喉的假膜性炎症、心脏浆膜的“绒毛心”、大叶性肺炎等", "alignment" : "left" }] }, { "content" : [{ "text" : "化脓性炎", "alignment" : "left" }, { "text" : "以中性粒细胞渗出为主，并有不同程度的组织坏死和脓液形成，包括表面化脓和积脓、蜂窝织炎、脓肿", "alignment" : "left" }] }, { "content" : [{ "text" : "出血性炎", "alignment" : "left" }, { "text" : "炎症灶血管损伤严重，渗出物含有大量红细胞，常见于流行性出血热、钩端螺旋体病和鼠疫等", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "3. 化脓性炎症的分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "表面化脓和积脓", "alignment" : "left" }, { "text" : "蜂窝织炎", "alignment" : "left" }, { "text" : "脓肿", "alignment" : "left" }] }, { "content" : [{ "text" : "定义", "alignment" : "left" }, { "text" : "发生于黏膜和浆膜的化脓性炎症", "alignment" : "left" }, { "text" : "疏松结缔组织的弥漫性化脓性炎症", "alignment" : "left" }, { "text" : "局限性化脓性炎", "alignment" : "left" }] }, { "content" : [{ "text" : "好发部位", "alignment" : "left" }, { "text" : "黏膜、浆膜", "alignment" : "left" }, { "text" : "皮肤、肌肉、阑尾", "alignment" : "left" }, { "text" : "皮下、内脏", "alignment" : "left" }] }, { "content" : [{ "text" : "致病菌", "alignment" : "left" }, { "text" : "化脓菌", "alignment" : "left" }, { "text" : "溶血性链球菌", "alignment" : "left" }, { "text" : "金黄色葡萄球菌", "alignment" : "left" }] }, { "content" : [{ "text" : "病理特点", "alignment" : "left" }, { "text" : "中性粒细胞向黏膜表面渗出，深部浸润不明显", "alignment" : "left" }, { "text" : "组织内大量中性粒细胞弥漫性浸润", "alignment" : "left" }, { "text" : "迁移性脓肿比较多见", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "三、慢性炎症", "content" : [{ "type" : "common", "alignment" : "left", "text" : "慢性肉芽肿性炎症是一种特殊的慢性炎症，是以肉芽肿形成为特征的炎症，肉芽肿是由巨噬细胞及其衍生的细胞（包括上皮样细胞和多核巨细胞）局部增生构成的境界清楚的结节状病灶。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "慢性肉芽肿性炎症常见病因：细菌感染（结核病、麻风病、猫抓病），螺旋体感染（梅毒），真菌和寄生虫感染（组织胞质菌病、血吸虫病），异物（手术缝线、石棉、滑石粉），原因不明（结节病）。结核性肉芽肿是最具有代表性的肉芽肿。" }] }] }] }, { "title" : "第四章", "text" : "肿瘤", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、概述", "alignment" : "left" }, { "text" : "（1）概念<br>（2）肿瘤的组织结构　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、肿瘤的生物学行为", "alignment" : "left" }, { "text" : "（1）肿瘤的异型性<br>（2）肿瘤的生长<br>（3）肿瘤的扩散和转移<br>（4）良、恶性肿瘤的区别<br>（5）交界性肿瘤的概念<br>（6）肿瘤对机体的影响　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、肿瘤的命名和分类", "alignment" : "left" }, { "text" : "（1）肿瘤的命名原则<br>（2）癌前病变、非典型增生、上皮内瘤变、原位<br>癌及早期滋润癌的概念<br>（3）癌与肉瘤的区别", "alignment" : "left" }] }, { "content" : [{ "text" : "四、常见的上皮性肿瘤", "alignment" : "left" }, { "text" : "（1）上皮组织良性肿瘤<br>（2）上皮组织恶性肿瘤　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、常见的非上皮性肿瘤", "alignment" : "left" }, { "text" : "（1）间叶组织良性肿瘤<br>（2）间叶组织恶性肿瘤<br>（3）其他类型肿瘤　", "alignment" : "left" }] }, { "content" : [{ "text" : "六、肿瘤的病因学和发病学", "alignment" : "left" }, { "text" : "（1）肿瘤发生的分子生物学基础<br>（2）常见的化学、物理和生物性致癌因素<br>（3）影响肿瘤发生、发展的内在因素　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、概述", "content" : [{ "type" : "common", "alignment" : "center", "text" : "常考肿瘤有关概念。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "恶性肿瘤", "alignment" : "left" }, { "text" : "精原细胞瘤、黑色素瘤、骨髓瘤、无性细胞瘤、尤文氏肉瘤、淋巴瘤、肾母细胞瘤、神经母细胞瘤、髓母细胞瘤、视网膜细胞瘤、肝母细胞瘤、未成熟畸胎瘤", "alignment" : "left" }] }, { "content" : [{ "text" : "良性肿瘤", "alignment" : "left" }, { "text" : "葡萄胎、间皮瘤、神经鞘瘤、骨母细胞瘤、软骨母细胞瘤、肌母细胞瘤", "alignment" : "left" }] }, { "content" : [{ "text" : "交界性肿瘤", "alignment" : "left" }, { "text" : "介于良性与恶性之间的肿瘤，如侵蚀性葡萄胎、骨巨细胞瘤", "alignment" : "left" }] }, { "content" : [{ "text" : "不属于肿瘤", "alignment" : "left" }, { "text" : "结核瘤、迷离瘤、动脉瘤、炎性假瘤、错构瘤", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "二、肿瘤的生物学行为", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肿瘤的分期即指恶性肿瘤的生长范围和播散程度。肿瘤的分期按TNM分期系统，T指肿瘤原发灶的情况，N指区域淋巴结受累情况，M指远处转移情况。" }, { "type" : "h2", "alignment" : "left", "text" : "1. 肿瘤的分级是指肿瘤细胞的分化程度。根据恶性肿瘤的分化程度、异型性及核分裂象将肿瘤分为3级：", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "Ⅰ级", "alignment" : "left" }, { "text" : "高分化、分化良好，恶性程度低", "alignment" : "left" }] }, { "content" : [{ "text" : "Ⅱ级", "alignment" : "left" }, { "text" : "中度分化，中度恶性", "alignment" : "left" }] }, { "content" : [{ "text" : "Ⅲ级", "alignment" : "left" }, { "text" : "低分化，恶性程度高", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 良性肿瘤与恶性肿瘤的区别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "良性肿瘤", "alignment" : "left" }, { "text" : "恶性肿瘤", "alignment" : "left" }] }, { "content" : [{ "text" : "分化程度", "alignment" : "left" }, { "text" : "分化好，异型性小", "alignment" : "left" }, { "text" : "分化不好，异型性大", "alignment" : "left" }] }, { "content" : [{ "text" : "核分裂象", "alignment" : "left" }, { "text" : "无或少，不见病理性核分裂象", "alignment" : "left" }, { "text" : "多，可见病理性核分裂象", "alignment" : "left" }] }, { "content" : [{ "text" : "生长速度", "alignment" : "left" }, { "text" : "缓慢", "alignment" : "left" }, { "text" : "较快", "alignment" : "left" }] }, { "content" : [{ "text" : "生长方式", "alignment" : "left" }, { "text" : "膨胀性或外生性生长", "alignment" : "left" }, { "text" : "浸润性或外生性生长", "alignment" : "left" }] }, { "content" : [{ "text" : "继发改变", "alignment" : "left" }, { "text" : "少见", "alignment" : "left" }, { "text" : "常见，如出血、坏死、溃疡形成", "alignment" : "left" }] }, { "content" : [{ "text" : "转移", "alignment" : "left" }, { "text" : "不转移", "alignment" : "left" }, { "text" : "可转移", "alignment" : "left" }] }, { "content" : [{ "text" : "复发", "alignment" : "left" }, { "text" : "不复发或很少复发", "alignment" : "left" }, { "text" : "易复发", "alignment" : "left" }] }, { "content" : [{ "text" : "对机体影响", "alignment" : "left" }, { "text" : "较小，主要为局部压迫或阻塞", "alignment" : "left" }, { "text" : "较大，破坏原发部位和转移部位的组织；坏死、出血，合并感染；恶病质", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "三、肿瘤的分类", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 原位癌、浸润癌、早期癌的区别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "原位癌", "alignment" : "left" }, { "text" : "指异型增生的细胞与癌细胞相同，并累及上皮全层，但未突破基底膜。", "alignment" : "left" }] }, { "content" : [{ "text" : "浸润癌", "alignment" : "left" }, { "text" : "指突破了基底膜的癌", "alignment" : "left" }] }, { "content" : [{ "text" : "早期癌", "alignment" : "left" }, { "text" : "癌浸润仅限于黏膜及黏膜下层者", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 癌前病变、非典型增生与上皮内瘤变的概念", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "癌前病变", "alignment" : "left" }, { "text" : "某些疾病或病变本身不是恶性肿瘤，但具有发展成为恶性肿瘤的潜能，称为癌前病变，如大肠腺瘤、乳腺纤维囊性病、慢性胃炎与肠化、溃疡性结肠炎、皮肤慢性溃疡、黏膜白斑。", "alignment" : "left" }] }, { "content" : [{ "text" : "非典型增生", "alignment" : "left" }, { "text" : "指细胞增生并出现异型性，但不足以诊断为肿瘤，增生未累及上皮全层，主要发生于被覆上皮和腺上皮", "alignment" : "left" }] }, { "content" : [{ "text" : "上皮内瘤变", "alignment" : "left" }, { "text" : "轻度、中度不典型增生分别称为上皮内瘤变Ⅰ、Ⅱ级，上皮内瘤变Ⅲ级即重度不典型增生和原位癌。", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "3. 癌与肉瘤在发生部位、质地、发生年龄都有很大区别，但最主要的区别在于组织来源不同。癌由上皮组织分化，肉瘤由间叶组织分化。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "癌与肉瘤的区别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "癌", "alignment" : "left" }, { "text" : "肉瘤", "alignment" : "left" }] }, { "content" : [{ "text" : "组织分化", "alignment" : "left" }, { "text" : "上皮组织", "alignment" : "left" }, { "text" : "间叶组织", "alignment" : "left" }] }, { "content" : [{ "text" : "发病率", "alignment" : "left" }, { "text" : "较高", "alignment" : "left" }, { "text" : "较低", "alignment" : "left" }] }, { "content" : [{ "text" : "好发部位", "alignment" : "left" }, { "text" : "皮肤、黏膜、内脏多见", "alignment" : "left" }, { "text" : "四肢、躯干多见", "alignment" : "left" }] }, { "content" : [{ "text" : "镜下特点", "alignment" : "left" }, { "text" : "多形成癌巢，实质与间质分化清楚，纤维组织常有增生", "alignment" : "left" }, { "text" : "肉瘤细胞多弥漫分布，实质与间质分界不清，间质血管丰富，纤维组织少", "alignment" : "left" }] }, { "content" : [{ "text" : "大体形态", "alignment" : "left" }, { "text" : "质较硬、色灰白、较干燥", "alignment" : "left" }, { "text" : "质软、色灰红、湿润、鱼肉状", "alignment" : "left" }] }, { "content" : [{ "text" : "转移方式", "alignment" : "left" }, { "text" : "多经淋巴道转移", "alignment" : "left" }, { "text" : "多经血道转移", "alignment" : "left" }] }] }] }] }] }, { "type" : "h1", "text" : "四、上皮组织恶性肿瘤的分型和病理特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "类型", "alignment" : "left" }, { "text" : "病理特点", "alignment" : "left" }, { "text" : "好发部位", "alignment" : "left" }] }, { "content" : [{ "text" : "鳞癌", "alignment" : "left" }, { "text" : "分化好的鳞癌，癌巢中央可见角化珠或癌珠，细胞间可见细胞间桥。<br>分化差的鳞癌，可无角化珠，细胞间桥少或无。", "alignment" : "both" }, { "text" : "鳞状上皮覆盖部位：皮肤、口腔、唇、食管、喉", "alignment" : "left" }] }, { "content" : [{ "text" : "腺癌", "alignment" : "left" }, { "text" : "癌细胞大小不等，排列成腺腔样结构，核分裂象多见，可表现为乳头状腺癌、囊腺癌、乳头状囊腺癌、黏液癌", "alignment" : "left" }, { "text" : "腺上皮的恶性肿瘤：胃肠道、肺、乳腺、子宫", "alignment" : "left" }] }, { "content" : [{ "text" : "粘液癌", "alignment" : "left" }, { "text" : "分泌大量黏液的腺癌称为粘液癌，腺腔扩张、含大量黏液，癌细胞似漂浮在黏液中", "alignment" : "left" }, { "text" : "胃、大肠", "alignment" : "left" }] }, { "content" : [{ "text" : "印戒细胞癌", "alignment" : "left" }, { "text" : "为特殊类型的粘液癌，黏液聚集在癌细胞内，将核推向一侧", "alignment" : "left" }, { "text" : "胃、大肠", "alignment" : "left" }] }, { "content" : [{ "text" : "基底细胞癌", "alignment" : "left" }, { "text" : "癌巢由深染的基底细胞样癌细胞构成。生长缓慢，表面常有溃疡，浸润破坏深层组织，很少发生转移，对放疗很敏感，低度恶性", "alignment" : "left" }, { "text" : "老年人面部", "alignment" : "left" }] }, { "content" : [{ "text" : "尿路上皮癌", "alignment" : "left" }, { "text" : "级别越高，越易复发", "alignment" : "left" }, { "text" : "膀胱、输尿管、肾盂", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "五、肿瘤病因学和发病学", "content" : [{ "type" : "common", "alignment" : "center", "text" : "与肿瘤发生关系密切的常见生物因素", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "肿瘤", "alignment" : "left" }, { "text" : "生物因素", "alignment" : "left" }] }, { "content" : [{ "text" : "肝癌、胆管癌", "alignment" : "left" }, { "text" : "华支睾吸虫", "alignment" : "left" }] }, { "content" : [{ "text" : "结肠癌", "alignment" : "left" }, { "text" : "慢性血吸虫", "alignment" : "left" }] }, { "content" : [{ "text" : "生殖道、喉等部位乳头状瘤", "alignment" : "left" }, { "text" : "人类乳头瘤病毒HVP6. HVP11", "alignment" : "left" }] }, { "content" : [{ "text" : "宫颈原位癌和浸润癌", "alignment" : "left" }, { "text" : "人类乳头瘤病毒HVP16. HVP18", "alignment" : "left" }] }, { "content" : [{ "text" : "伯基特淋巴瘤、鼻咽癌", "alignment" : "left" }, { "text" : "EB病毒", "alignment" : "left" }] }, { "content" : [{ "text" : "肝细胞癌", "alignment" : "left" }, { "text" : "HBV、HCV", "alignment" : "left" }] }, { "content" : [{ "text" : "胃癌、胃", "alignment" : "left" }, { "text" : "低度恶性B细胞性淋巴瘤", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "肿瘤的发生并非单个分子事件，而是一个多步骤过程。既有癌基因改变，又有肿瘤抑制基因改变。原癌基因存在于正常细胞中，只有在细胞发生某些异常时，才被激活，使细胞发生恶性转化。抑癌基因存在于正常细胞中，与癌基因的表达相关，肿瘤细胞不出现时也表达，其产物可限制细胞的生长。目前已知抑癌基因有10余种，如APC、RB、p53. NF-1. BRCA-1. BRCA-2等。" }] }] }] }] }, { "title" : "第五章", "text" : "心血管系统疾病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、动脉粥样硬化", "alignment" : "left" }, { "text" : "（1）血管的病理变化<br>（2）心脏、肾脏和脑的病理变化　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、原发性高血压", "alignment" : "left" }, { "text" : "（1）血管的病理变化<br>（2）心脏、肾脏和脑的病理变化　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、风湿性心脏病", "alignment" : "left" }, { "text" : "（1）基本病理变化<br>（2）心脏的病理变化　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、急性细菌性心内膜炎", "alignment" : "left" }, { "text" : "（1）病因<br>（2）心脏及血管的病理变化　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、心瓣膜病", "alignment" : "left" }, { "text" : "（1）病因<br>（2）心瓣膜病的类型和病理变化<br>（3）心瓣膜病对机体的影响", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、动脉粥样硬化", "content" : [{ "type" : "common", "alignment" : "left", "text" : "动脉粥样硬化血管病理变化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "分期", "alignment" : "left" }, { "text" : "病理特点", "alignment" : "left" }] }, { "content" : [{ "text" : "脂纹", "alignment" : "left" }, { "text" : "为最早肉眼病变，位于主动脉后壁及其分支开口处，镜下可见大量由巨噬细胞和平滑肌细胞发展而来的泡沫细胞聚集", "alignment" : "left" }] }, { "content" : [{ "text" : "纤维斑块", "alignment" : "left" }, { "text" : "由脂纹发展而来，镜下可见表层为大量胶原纤维玻璃样变性，平滑肌细胞增生并分泌大量细胞外基质组成纤维帽", "alignment" : "left" }] }, { "content" : [{ "text" : "粥样斑块", "alignment" : "left" }, { "text" : "由纤维斑块深层细胞的坏死发展而来，镜下见纤维帽下大量粥样物质等，是动脉粥样硬化的典型病变", "alignment" : "left" }] }, { "content" : [{ "text" : "继发性病变", "alignment" : "left" }, { "text" : "在纤维斑块和粥样斑块的基础上继发的病变，包括斑块内出血、斑块破裂伴溃疡形成、血栓形成、钙化和动脉瘤形成", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "冠脉粥样硬化最常发于左冠状动脉前降支。冠状动脉左前降支>右主干>左主干、左旋支、后降支。冠脉粥样硬化狭窄程度分级：Ⅰ级＜25%，Ⅱ级26%～50%、Ⅲ级51%～75%、Ⅳ级＞76%。" }] }] }] }, { "type" : "h1", "text" : "二、原发性高血压", "content" : [{ "type" : "common", "alignment" : "left", "text" : "原发性高血压（良性高血压）细小动脉硬化为主要病理特点，表现为细小动脉玻璃样变。细小动脉玻璃样变性，最易累及肾入球小动脉和视网膜动脉。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "高血压对脑的影响包括高血压脑病、脑软化和脑出血，其中脑出血为最严重并发症。高血压脑出血常发生于基底节、内囊，这是因为供应该区域的豆纹动脉从大脑中动脉呈直角分支，直接受到大脑中动脉压力较高的血流冲击和牵引，致豆纹动脉易破裂出血。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "高血压时由于入球小动脉玻璃样变及肌型小动脉硬化、肾小管萎缩、间质增生，病变相对较轻的肾小球代偿性肥大，肾小管代偿性扩张，肉眼观双肾对称性缩小，质地变硬，肾表面凹凸不平，呈细颗粒状，称原发性颗粒肾。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "高血压进程中，心脏左室代偿性肥大。早期向心性肥大，晚期离心性肥大，严重时发生心衰。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "动脉粥样硬化", "alignment" : "left" }, { "text" : "高血压", "alignment" : "left" }] }, { "content" : [{ "text" : "心", "alignment" : "left" }, { "text" : "心肌梗死", "alignment" : "left" }, { "text" : "左心室向心性肥大—离心性肥大", "alignment" : "left" }] }, { "content" : [{ "text" : "肾", "alignment" : "left" }, { "text" : "肾梗死；动脉粥样硬化性固缩肾", "alignment" : "left" }, { "text" : "原发性颗粒性固缩肾", "alignment" : "left" }] }, { "content" : [{ "text" : "脑", "alignment" : "left" }, { "text" : "脑梗死（软化）、脑萎缩、小动脉瘤、脑出血", "alignment" : "left" }, { "text" : "脑软化、微动脉瘤、脑出血", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "恶性高血压即急进型高血压，多见于青年人，临床表现为血压显著升高，常超过230/130mmHg，病变进展迅速，较早出现肾衰。特征病变为增生性小动脉硬化和坏死性细动脉炎。累及肾脏时，肾细小动脉管壁纤维素性坏死为其特征病变。" }] }] }] }] }] }] }, { "type" : "h1", "text" : "三、风湿性心脏病", "content" : [{ "type" : "common", "alignment" : "left", "text" : "风湿性心脏病是由A组乙型溶血性链球菌感染引起的。" }, { "type" : "h2", "alignment" : "left", "text" : "1. 基本病理变化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "病理特点", "alignment" : "center" }, { "text" : "病程", "alignment" : "center" }] }, { "content" : [{ "text" : "变质渗出期", "alignment" : "left" }, { "text" : "早期改变，结缔组织黏液样变性，纤维素样变性", "alignment" : "left" }, { "text" : "1个月", "alignment" : "center" }] }, { "content" : [{ "text" : "增生期或肉芽肿期", "alignment" : "left" }, { "text" : "特征性的风湿性肉芽肿（Aschoff小体）——中央为纤维素样坏死灶，周围为风湿细胞或Aschoff细胞和多核的Aschoff巨细胞", "alignment" : "left" }, { "text" : "2~3个月", "alignment" : "center" }] }, { "content" : [{ "text" : "纤维化期或愈合期", "alignment" : "left" }, { "text" : "出现纤维细胞，Aschoff小体变为梭形小瘢痕", "alignment" : "left" }, { "text" : "2~3个月", "alignment" : "center" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 风湿性心脏病的分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "风湿性心内膜炎", "alignment" : "left" }, { "text" : "风湿性心肌病", "alignment" : "left" }, { "text" : "风湿性心外膜炎（心包炎）", "alignment" : "left" }] }, { "content" : [{ "text" : "累及部位", "alignment" : "left" }, { "text" : "心瓣膜（二尖瓣最常见）", "alignment" : "left" }, { "text" : "心肌间质", "alignment" : "left" }, { "text" : "心外膜脏层", "alignment" : "left" }] }, { "content" : [{ "text" : "特征病理", "alignment" : "left" }, { "text" : "瓣膜闭锁缘疣状赘生物", "alignment" : "left" }, { "text" : "心肌间质出现风湿小体", "alignment" : "left" }, { "text" : "浆液性或纤维素性渗出", "alignment" : "left" }] }, { "content" : [{ "text" : "临床表现", "alignment" : "left" }, { "text" : "心尖区轻度收缩期/舒张期杂音，风湿停止杂音消失", "alignment" : "left" }, { "text" : "窦速、第一心音减弱、PR间期延长、室内阻滞", "alignment" : "left" }, { "text" : "心包摩擦音（干性心外膜炎）、心音弱而遥远（湿性心外膜炎）。可形成绒毛心和缩窄性心包炎", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "Aschoff小体又名风湿小体、风湿小结，为风湿病增生期的特征性病变。风湿小体多位于心肌间质的小血管旁，还可见于心内膜下、皮下结缔组织、心外膜、关节和血管等处。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "伤寒杆菌引起的炎症，是以巨噬细胞增生为特征的急性增生性炎。增生活跃时巨噬细胞内吞噬有伤寒杆菌、红细胞和细胞碎片。这种巨噬细胞称伤寒细胞。伤寒细胞常聚集成团，形成小结节称伤寒肉芽肿或伤寒小结，是伤寒的特征性病变。" }] }] }] }] }, { "type" : "h1", "text" : "四、亚急性细菌性心内膜炎", "content" : [{ "type" : "common", "alignment" : "left", "text" : "最常见的是草绿色链球菌、牛链球菌和表皮葡萄球菌，也可由某些真菌引起。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "心脏及血管的病理变化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "心脏", "alignment" : "left" }, { "text" : "最常见侵犯二尖瓣和主动脉瓣，病变特点是常在有病变的瓣膜上形成赘生物。瓣膜损害可致瓣膜口狭窄或关闭不全", "alignment" : "left" }] }, { "content" : [{ "text" : "血管", "alignment" : "left" }, { "text" : "栓塞最多见于脑，其次为肾、脾等", "alignment" : "left" }] }, { "content" : [{ "text" : "变态反应", "alignment" : "left" }, { "text" : "因微栓塞的发生引起局灶性或弥漫性肾小球肾炎。皮肤出现红色、微隆起、有压痛的小结节，称Osler小结", "alignment" : "left" }] }, { "content" : [{ "text" : "败血症", "alignment" : "left" }, { "text" : "脱落的赘生物内有细菌，侵入血流并繁殖，致患者长期发热、脾大、白细胞增多，皮肤、黏膜和眼底常有小出血点、贫血等表现", "alignment" : "left" }] }] }] }] }] }] }, { "title" : "第六章", "text" : "呼吸系统疾病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、慢性支气管炎", "alignment" : "left" }, { "text" : "（1）概念及病理变化<br>（2）临床病理联系", "alignment" : "left" }] }, { "content" : [{ "text" : "二、肺气肿", "alignment" : "left" }, { "text" : "（1）概念及病理变化<br>（2）类型和对机体的影响", "alignment" : "left" }] }, { "content" : [{ "text" : "三、大叶性肺炎", "alignment" : "left" }, { "text" : "（1）病因<br>（2）病理变化<br>（3）并发症", "alignment" : "left" }] }, { "content" : [{ "text" : "四、小叶性肺炎", "alignment" : "left" }, { "text" : "（1）病因<br>（2）病理变化<br>（3）并发症", "alignment" : "left" }] }, { "content" : [{ "text" : "五、肺硅沉着症（矽肺）", "alignment" : "left" }, { "text" : "（1）病因<br>（2）病理变化<br>（3）并发症", "alignment" : "left" }] }, { "content" : [{ "text" : "六、肺癌", "alignment" : "left" }, { "text" : "（1）病理类型和病理变化<br>（2）扩散和转移", "alignment" : "left" }] }, { "content" : [{ "text" : "七、急性呼吸窘迫综合征", "alignment" : "left" }, { "text" : "（1）病因及机制<br>（2）病理变化", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、慢性支气管炎", "content" : [{ "type" : "common", "alignment" : "left", "text" : "慢性支气管炎是指发生于支气管黏膜及其周围组织的慢性非特异性炎性疾病。以长期咳嗽、咳痰或伴喘息为主要症状。每年持续3个月，连续两年以上。" }] }, { "type" : "h1", "text" : "二、肺气肿", "content" : [{ "type" : "common", "alignment" : "center", "text" : "肺气肿分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "肺气肿分类", "alignment" : "left" }, { "text" : "常见病因", "alignment" : "left" }] }, { "content" : [{ "text" : "肺泡性肺气肿（阻塞性肺气肿）", "alignment" : "left" }, { "text" : "慢性支气管炎", "alignment" : "left" }] }, { "content" : [{ "text" : "间质性肺气肿", "alignment" : "left" }, { "text" : "外伤（肋骨骨折、胸壁穿透伤）、剧烈咳嗽引起肺内压急剧增高，可导致细支气管或肺泡间隔破裂，使空气进入肺间质形成间质性肺气肿", "alignment" : "left" }] }, { "content" : [{ "text" : "其他类型肺气肿", "alignment" : "left" }, { "text" : "1. 瘢痕旁肺气肿出现在肺组织瘢痕灶周围，由肺泡破裂融合形成<br>2. 代偿性肺气肿肺萎缩及肺叶切除后残余肺组织或肺炎实性变病灶周围肺泡代偿性过度充气<br>3. 老年性肺气肿老年人肺组织弹性回缩力减弱，使肺残气量增多引起肺膨胀", "alignment" : "both" }] }] }] }] }, { "type" : "h1", "text" : "三、肺炎", "content" : [{ "type" : "common", "alignment" : "left", "text" : "大叶性肺炎与小叶性肺炎的鉴别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "大叶性肺炎", "alignment" : "left" }, { "text" : "小叶性肺炎", "alignment" : "left" }] }, { "content" : [{ "text" : "病原菌", "alignment" : "left" }, { "text" : "主要为肺炎链球菌", "alignment" : "left" }, { "text" : "肺炎球菌、葡萄球菌、肺炎克雷伯杆菌、链球菌等", "alignment" : "left" }] }, { "content" : [{ "text" : "典型病变", "alignment" : "left" }, { "text" : "起始于肺泡，病变波及肺段或整个肺叶，支气管不受累", "alignment" : "left" }, { "text" : "起始于细支气管，以小叶为单位灶性散布，胸膜一般不受累", "alignment" : "left" }] }, { "content" : [{ "text" : "病变范围", "alignment" : "left" }, { "text" : "肺大叶", "alignment" : "left" }, { "text" : "肺小叶", "alignment" : "left" }] }, { "content" : [{ "text" : "好发人群", "alignment" : "left" }, { "text" : "青壮年", "alignment" : "left" }, { "text" : "小儿和年老体弱者", "alignment" : "left" }] }, { "content" : [{ "text" : "病理变化", "alignment" : "left" }, { "text" : "渗出性炎症，以肺泡纤维素渗出为主，典型的四期表现：充血水肿期、红色肝样变期、灰色肝样变期、溶解消散期", "alignment" : "left" }, { "text" : "化脓性炎症，以肺组织中性粒细胞浸润为主；<br>纤维素渗出少；<br>红细胞、脱落的肺上皮细胞少", "alignment" : "left" }] }, { "content" : [{ "text" : "并发症", "alignment" : "left" }, { "text" : "肺肉质变、胸膜肥厚和粘连、肺脓肿及脓胸、败血症、感染性休克等", "alignment" : "left" }, { "text" : "心衰、呼衰、肺脓肿、脓毒血症、脓胸", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "四、肺硅沉着病（矽肺）", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肺硅沉着病是因长期吸入大量含游离二氧化硅（SiO2）粉尘微粒引起的一种常见职业病。病程进展较慢，即使在脱离硅尘作业后，肺部病变仍继续发展。患者多在接触硅尘10~15年后才发病。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "基本病变是肺组织内硅结节形成和肺弥漫性间质纤维化。硅结节是硅沉着病的特征性病变。硅结节最早出现在肺门淋巴结。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肺硅沉着症最常见的并发症为肺结核。其余有慢性肺心病、肺部感染和阻塞性肺气肿。" }] }] }] }, { "type" : "h1", "text" : "五、肺癌", "content" : [{ "type" : "common", "alignment" : "left", "text" : "常考肺癌特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "恶性程度最低的肺癌", "alignment" : "left" }, { "text" : "类癌", "alignment" : "left" }] }, { "content" : [{ "text" : "恶性程度最高的肺癌", "alignment" : "left" }, { "text" : "小细胞癌", "alignment" : "left" }] }, { "content" : [{ "text" : "发病率最高", "alignment" : "left" }, { "text" : "鳞癌", "alignment" : "left" }] }, { "content" : [{ "text" : "男性发病率最高", "alignment" : "left" }, { "text" : "鳞癌", "alignment" : "left" }] }, { "content" : [{ "text" : "女性发病率最高", "alignment" : "left" }, { "text" : "腺癌", "alignment" : "left" }] }, { "content" : [{ "text" : "具有内分泌功能的肺癌", "alignment" : "left" }, { "text" : "小细胞癌", "alignment" : "left" }] }, { "content" : [{ "text" : "对化疗最敏感", "alignment" : "left" }, { "text" : "小细胞癌", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "六、急性呼吸窘迫综合征", "content" : [{ "type" : "common", "alignment" : "left", "text" : "急性呼吸窘迫综合征（ARDS）是指肺内、外严重疾病导致以肺毛细血管弥漫性损伤、通透性增强为基础，以肺水肿、透明膜形成和肺不张为主要病理变化，以进行性呼吸窘迫和难治性低氧血症为临床特征的急性呼吸衰竭综合征。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "组织学表现为肺间质毛细血管扩张、瘀滞，肺泡腔内及间质内大量粉染蛋白性液体。肺呼吸性细支气管、肺泡管及肺泡腔内见薄层红染丝状或膜状物衬覆，并有粉染透明膜形成。微血管内——透明血栓和白细胞栓塞。" }] }] }] }, { "title" : "第七章", "text" : "消化系统疾病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、消化性溃疡", "alignment" : "left" }, { "text" : "（1）病理变化<br>（2）并发症", "alignment" : "left" }] }, { "content" : [{ "text" : "二、病毒性肝炎", "alignment" : "left" }, { "text" : "（1）基本病理变化<br>（2）临床病理类型和病变特点", "alignment" : "left" }] }, { "content" : [{ "text" : "三、门脉性肝硬化", "alignment" : "left" }, { "text" : "（1）病因<br>（2）病理变化<br>（3）病理临床联系", "alignment" : "left" }] }, { "content" : [{ "text" : "四、食管癌、胃癌和大肠癌", "alignment" : "left" }, { "text" : "病理类型和病理变化", "alignment" : "left" }] }, { "content" : [{ "text" : "五、原发性肝癌", "alignment" : "left" }, { "text" : "病理类型和病理变化", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、消化性溃疡", "content" : [{ "type" : "common", "alignment" : "left", "text" : "溃疡底部由内向外分四层：最表层有少量炎性渗出物覆盖；其下为一层坏死组织；再下则见较新鲜的肉芽组织层；最下层由肉芽组织移行为陈旧瘢痕组织。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "消化性溃疡的并发症", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "发生率", "alignment" : "left" }, { "text" : "原因", "alignment" : "left" }, { "text" : "临床表现", "alignment" : "left" }] }, { "content" : [{ "text" : "出血", "alignment" : "left" }, { "text" : "10%-35%", "alignment" : "left" }, { "text" : "溃疡底部毛细血管或大血管破裂", "alignment" : "left" }, { "text" : "大便潜血试验阳性，呕血、便血；十二指肠出血多在后壁，胃溃疡出血和穿孔多在胃小弯", "alignment" : "left" }] }, { "content" : [{ "text" : "穿孔", "alignment" : "left" }, { "text" : "5%", "alignment" : "left" }, { "text" : "十二指肠溃疡因肠壁较薄更易穿孔", "alignment" : "left" }, { "text" : "十二指肠溃疡穿孔多见于前壁溃疡。大肠内容物进入腹腔引起腹膜炎", "alignment" : "left" }] }, { "content" : [{ "text" : "幽门狭窄", "alignment" : "left" }, { "text" : "3%", "alignment" : "left" }, { "text" : "由于瘢痕收缩，可引起幽门狭窄", "alignment" : "left" }, { "text" : "幽门梗阻，胃扩张，反复呕吐，碱中毒", "alignment" : "left" }] }, { "content" : [{ "text" : "恶变", "alignment" : "left" }, { "text" : "1%以下", "alignment" : "left" }, { "text" : "长期胃溃疡恶变率＜1%", "alignment" : "left" }, { "text" : "十二指肠溃疡几乎不发生癌变", "alignment" : "left" }] }] }] }] }] }, { "type" : "h1", "text" : "二、病毒性肝炎", "content" : [{ "type" : "common", "alignment" : "left", "text" : "基本病理变化：以肝细胞的弥漫性变质性炎（变质、坏死）为主，伴有不同程度的炎细胞浸润、肝细胞再生和纤维组织增生等变化。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肝炎分型及特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "急性普通型肝炎", "alignment" : "left" }, { "text" : "慢性普通型肝炎", "alignment" : "left" }, { "text" : "急性重型肝炎", "alignment" : "left" }, { "text" : "亚急性重型肝炎", "alignment" : "left" }] }, { "content" : [{ "text" : "坏死类型", "alignment" : "left" }, { "text" : "点状坏死", "alignment" : "left" }, { "text" : "点状坏死、灶状坏死、碎片状坏死、桥接坏死", "alignment" : "left" }, { "text" : "大片坏死", "alignment" : "left" }, { "text" : "大片坏死", "alignment" : "left" }] }, { "content" : [{ "text" : "再生", "alignment" : "left" }, { "text" : "完全再生", "alignment" : "left" }, { "text" : "少量再生", "alignment" : "left" }, { "text" : "再生不明显", "alignment" : "left" }, { "text" : "结节状再生", "alignment" : "left" }] }, { "content" : [{ "text" : "炎性细胞浸润", "alignment" : "left" }, { "text" : "轻度", "alignment" : "left" }, { "text" : "慢性", "alignment" : "left" }, { "text" : "大量", "alignment" : "left" }, { "text" : "明显", "alignment" : "left" }] }, { "content" : [{ "text" : "肝脏大小", "alignment" : "left" }, { "text" : "肿胀变大、质较软", "alignment" : "left" }, { "text" : "无变化或略增大", "alignment" : "left" }, { "text" : "明显缩小（左叶为甚）", "alignment" : "left" }, { "text" : "缩小", "alignment" : "left" }] }, { "content" : [{ "text" : "肝脏被膜", "alignment" : "left" }, { "text" : "紧张", "alignment" : "left" }, { "text" : "稍紧张", "alignment" : "left" }, { "text" : "皱缩", "alignment" : "left" }, { "text" : "皱缩", "alignment" : "left" }] }, { "content" : [{ "text" : "临床表现", "alignment" : "left" }, { "text" : "肝脏肿大、肝区疼痛、肝功能异常、黄疸", "alignment" : "left" }, { "text" : "可无症状", "alignment" : "left" }, { "text" : "黄疸、出血倾向、肝衰、肝性脑病", "alignment" : "left" }, { "text" : "可治愈，常转化为坏死后性肝硬化", "alignment" : "left" }] }] }] }] }] }, { "type" : "h1", "text" : "三、门脉性肝硬化", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肝硬化常见病因：病毒性肝炎、慢性酒精中毒、营养不良、有毒物质的损伤。在我国，引起肝硬化的主要病因为病毒性肝炎，多由乙肝及丙肝引起，其中以乙肝最常见。慢性酒精中毒为欧美肝硬化发生的最主要病因。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "假小叶是指广泛增生的纤维组织分割原来的肝小叶并包绕成大小不等的圆形或类圆形的肝细胞团。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "假小叶是肝硬化的特征性病理变化，其病理特点：（1）正常肝小叶结构破坏，被假小叶所取代。（2）假小叶内肝细胞排列紊乱，可有变性、坏死、再生的肝细胞。（3）中央静脉缺如、偏位或有两个以上。（4）包绕假小叶的纤维间隔内可有少量慢性炎细胞浸润。（5）假小叶内可见小胆管增生。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "临床病理联系：门脉高压表现和肝功能不全表现。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "门脉高压征", "alignment" : "left" }, { "text" : "胃肠道淤血、水肿；脾大；腹水；食管胃底静脉曲张、直肠静脉丛曲张，脐周浅静脉扩张等", "alignment" : "left" }] }, { "content" : [{ "text" : "肝功能不全", "alignment" : "left" }, { "text" : "肝掌、蜘蛛痣、出血倾向、黄疸、肝性脑病", "alignment" : "left" }] }] }] }] }] }] }] }, { "type" : "h1", "text" : "四、食管癌、胃癌、大肠癌及肝癌的特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "食管癌", "alignment" : "center" }, { "text" : "胃癌", "alignment" : "center" }, { "text" : "大肠癌", "alignment" : "center" }, { "text" : "肝癌", "alignment" : "center" }] }, { "content" : [{ "text" : "好发部位", "alignment" : "left" }, { "text" : "食管中段最多见，下段次之，上段最少。", "alignment" : "left" }, { "text" : "胃窦小弯侧", "alignment" : "left" }, { "text" : "直肠最多见，乙状结肠次之", "alignment" : "left" }, { "text" : "—", "alignment" : "left" }] }, { "content" : [{ "text" : "癌前病变", "alignment" : "left" }, { "text" : "—", "alignment" : "left" }, { "text" : "慢性萎缩性胃炎、胃息肉、胃溃疡伴异型增生、胃黏膜大肠型肠上皮化生", "alignment" : "left" }, { "text" : "大肠腺瘤和溃疡性结肠炎", "alignment" : "left" }, { "text" : "—", "alignment" : "left" }] }, { "content" : [{ "text" : "肉眼分型", "alignment" : "left" }, { "text" : "溃疡型<br>蕈伞型<br>髓质型<br>缩窄型", "alignment" : "left" }, { "text" : "早期胃癌：微小癌＜0.5cm，0.6~1.0cm为小胃癌；<br>进展期胃癌：息肉型、溃疡型、浸润型", "alignment" : "left" }, { "text" : "息肉型<br>溃疡型<br>胶样型<br>浸润型", "alignment" : "left" }, { "text" : "早期肝癌：<br>＜3.0cm<br>晚期肝癌：<br>巨块型<br>多结节型<br>弥漫型", "alignment" : "left" }] }, { "content" : [{ "text" : "组织学分型", "alignment" : "left" }, { "text" : "鳞状细胞癌<br>腺癌<br>小细胞癌", "alignment" : "left" }, { "text" : "管状腺癌<br>黏液腺癌<br>印戒细胞癌<br>乳头状腺癌<br>未分化癌", "alignment" : "left" }, { "text" : "乳头状癌<br>管状腺癌<br>粘液腺癌<br>未分化癌<br>腺鳞癌<br>鳞状细胞癌", "alignment" : "left" }, { "text" : "肝细胞性肝癌<br>胆管上皮癌<br>混合型肝癌", "alignment" : "left" }] }] }] }] }, { "title" : "第八章", "text" : "泌尿系统疾病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、肾小球肾炎", "alignment" : "left" }, { "text" : "（1）各型病理变化<br>（2）病理临床联系", "alignment" : "left" }] }, { "content" : [{ "text" : "二、慢性肾盂肾炎", "alignment" : "left" }, { "text" : "（1）病理变化<br>（2）病理临床联系", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、肾小球肾炎", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肾小球肾炎是以肾小球损害为主的变态反应性疾病。临床主要表现为：", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肾炎综合征：血尿、蛋白尿、水肿、高血压。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肾病综合征：高蛋白尿、低蛋白血症、高度水肿和高脂血症。", "content" : [{ "type" : "common", "alignment" : "center", "text" : "肾小球肾炎各型病理变化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "类型", "alignment" : "center", "colSpan" : 2, "rowSpan" : 2 }, { "text" : "病理特点", "alignment" : "center", "colSpan" : 3 }, { "text" : "临床病理联系", "alignment" : "center", "rowSpan" : 2 }, { "text" : "常考点", "alignment" : "center", "rowSpan" : 2 }] }, { "content" : [{ "text" : "光镜", "alignment" : "left" }, { "text" : "免疫荧光", "alignment" : "left" }, { "text" : "电镜", "alignment" : "left" }] }, { "content" : [{ "text" : "急性肾小球肾炎", "alignment" : "left", "colSpan" : 2 }, { "text" : "弥漫性系膜细胞和内皮细胞增生", "alignment" : "left" }, { "text" : "GBM和系膜区颗粒状IgG和C3沉积", "alignment" : "left" }, { "text" : "上皮下驼峰状沉积物", "alignment" : "left" }, { "text" : "急性肾炎综合征", "alignment" : "left" }, { "text" : "大红肾<br>蚤咬肾<br>多见于儿童", "alignment" : "both" }] }, { "content" : [{ "text" : "急进性肾小球肾炎", "alignment" : "left", "rowSpan" : 3 }, { "text" : "Ⅰ型，抗GBM型", "alignment" : "left" }, { "text" : "新月体（壁层上皮细胞增生形成）", "alignment" : "left", "rowSpan" : 3 }, { "text" : "线性", "alignment" : "left" }, { "text" : "无沉积物", "alignment" : "left" }, { "text" : "急进性肾炎综合征", "alignment" : "left", "rowSpan" : 3 }, { "text" : "新月体形成", "alignment" : "left", "rowSpan" : 3 }] }, { "content" : [{ "text" : "Ⅱ型，免疫复合物型", "alignment" : "left" }, { "text" : "颗粒状沉积物", "alignment" : "left" }, { "text" : "沉积物", "alignment" : "left" }] }, { "content" : [{ "text" : "Ⅲ型，ANCA（+）型", "alignment" : "left" }, { "text" : "阴性", "alignment" : "left" }, { "text" : "无沉积物", "alignment" : "left" }] }, { "content" : [{ "text" : "膜性肾小球肾炎（膜性肾病）", "alignment" : "left", "colSpan" : 2 }, { "text" : "弥漫性GBM增厚，钉状突起形成", "alignment" : "left" }, { "text" : "基膜颗粒状IgG和C3", "alignment" : "left" }, { "text" : "上皮下沉积物，GBM增厚；钉状突起-梳齿-虫蚀状空隙", "alignment" : "left" }, { "text" : "肾病综合征", "alignment" : "left" }, { "text" : "大白肾；<br>引起成人肾病综合征最常见原因", "alignment" : "both" }] }, { "content" : [{ "text" : "系膜增生性肾小球肾炎", "alignment" : "left", "colSpan" : 2 }, { "text" : "系膜细胞增生，系膜基质增多", "alignment" : "left" }, { "text" : "系膜区IgG、IgM和C3沉积", "alignment" : "left" }, { "text" : "系膜区沉积物", "alignment" : "left" }, { "text" : "血尿、蛋白尿、肾病综合征", "alignment" : "left" }, { "text" : "慢性肾小球肾炎", "alignment" : "left" }] }, { "content" : [{ "text" : "膜增生性肾小球肾炎", "alignment" : "left", "rowSpan" : 2 }, { "text" : "Ⅰ型", "alignment" : "left" }, { "text" : "系膜增生，插入，基膜增厚，双轨状", "alignment" : "left", "rowSpan" : 2 }, { "text" : "IgG+C3；C1+C4", "alignment" : "left" }, { "text" : "内皮下沉积物", "alignment" : "left" }, { "text" : "肾病综合征", "alignment" : "left" }, { "text" : "双轨征", "alignment" : "left" }] }, { "content" : [{ "text" : "Ⅱ型", "alignment" : "left" }, { "text" : "只有C3", "alignment" : "left" }, { "text" : "致密沉积物", "alignment" : "left" }, { "text" : "血尿、蛋白尿、慢性肾衰", "alignment" : "left" }, { "text" : "—", "alignment" : "left" }] }, { "content" : [{ "text" : "微小病变性肾小球肾炎", "alignment" : "left", "colSpan" : 2 }, { "text" : "肾小球正常，肾小管脂质沉积", "alignment" : "left" }, { "text" : "（—）", "alignment" : "left" }, { "text" : "上皮细胞足突消失，无沉积物", "alignment" : "left" }, { "text" : "肾病综合征", "alignment" : "left" }, { "text" : "脂性肾病，多见于幼儿", "alignment" : "left" }] }, { "content" : [{ "text" : "慢性肾小球肾炎", "alignment" : "left", "colSpan" : 2 }, { "text" : "肾小球玻璃样变性、纤维化、硬化", "alignment" : "left" }, { "text" : "因肾炎起始类型而异", "alignment" : "left" }, { "text" : "因肾炎起始类型而异", "alignment" : "left" }, { "text" : "慢性肾炎综合征；<br>慢性肾衰", "alignment" : "both" }, { "text" : "继发性颗粒性固缩肾", "alignment" : "left" }] }, { "content" : [{ "text" : "IgA肾病", "alignment" : "left", "colSpan" : 2 }, { "text" : "局灶性节段性增生或弥漫系膜增宽", "alignment" : "left" }, { "text" : "系膜区IgA和C3沉积", "alignment" : "left" }, { "text" : "系膜区沉积物", "alignment" : "left" }, { "text" : "反复发作的血尿、蛋白尿", "alignment" : "left" }, { "text" : "", "alignment" : "left" }] }, { "content" : [{ "text" : "局灶性阶段性肾小球硬化", "alignment" : "left", "colSpan" : 2 }, { "text" : "局灶性节段性玻璃样变和硬化", "alignment" : "left" }, { "text" : "局灶性，IgM和C3", "alignment" : "left" }, { "text" : "上皮细胞足突消失，上皮细胞剥脱", "alignment" : "left" }, { "text" : "肾病综合征，蛋白尿", "alignment" : "left" }, { "text" : "", "alignment" : "left" }] }] }] }] }] }] }] }, { "type" : "h1", "text" : "二、慢性肾盂肾炎", "content" : [{ "type" : "common", "alignment" : "left", "text" : "慢性肾盂肾炎是肾小管、肾间质的化脓性炎症，其病理特点为慢性间质性炎、纤维化和疤痕形成，常伴有肾盂、肾盏的纤维化和变形。" }] }] }, { "title" : "第九章", "text" : "内分泌系统疾病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、甲状腺疾病", "alignment" : "left" }, { "text" : "（1）弥漫性非毒性甲状腺肿病因及病理变化<br>（2）甲状腺肿瘤的类型及病理变化", "alignment" : "left" }] }, { "content" : [{ "text" : "二、胰腺疾病", "alignment" : "left" }, { "text" : "（1）糖尿病的类型、病因及病理变化<br>（2）胰腺肿瘤的类型及病理变化", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "甲状腺疾病", "content" : [{ "type" : "common", "alignment" : "left", "text" : "弥漫性非毒性甲状腺肿亦称单纯性甲状腺肿，是由于缺碘使甲状腺素分泌不足，使促甲状腺素分泌增多，甲状腺滤泡上皮增生，滤泡内胶质堆积而使甲状腺肿大，一般不伴甲亢。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "甲状腺癌的分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "乳头状癌", "alignment" : "left" }, { "text" : "滤泡癌", "alignment" : "left" }, { "text" : "未分化癌", "alignment" : "left" }, { "text" : "髓样癌", "alignment" : "left" }] }, { "content" : [{ "text" : "发病率", "alignment" : "left" }, { "text" : "60%，最常见", "alignment" : "left" }, { "text" : "20%", "alignment" : "left" }, { "text" : "15%", "alignment" : "left" }, { "text" : "约7%", "alignment" : "left" }] }, { "content" : [{ "text" : "好发年龄", "alignment" : "left" }, { "text" : "青少年女性", "alignment" : "left" }, { "text" : "40岁以上女性", "alignment" : "left" }, { "text" : "50岁以上女性", "alignment" : "left" }, { "text" : "40~60岁", "alignment" : "left" }] }, { "content" : [{ "text" : "恶性程度", "alignment" : "left" }, { "text" : "低", "alignment" : "left" }, { "text" : "中", "alignment" : "left" }, { "text" : "高", "alignment" : "left" }, { "text" : "中", "alignment" : "left" }] }, { "content" : [{ "text" : "远处转移", "alignment" : "left" }, { "text" : "少", "alignment" : "left" }, { "text" : "1/3有转移", "alignment" : "left" }, { "text" : "迅速", "alignment" : "left" }, { "text" : "可有", "alignment" : "left" }] }, { "content" : [{ "text" : "肉眼观", "alignment" : "left" }, { "text" : "肿快2~3cm，圆形无包膜，可出血坏死", "alignment" : "left" }, { "text" : "结节状，质软，包膜不完整", "alignment" : "left" }, { "text" : "形状不规则，无包膜，常出血坏死", "alignment" : "left" }, { "text" : "单发或多发，假包膜，质实而软", "alignment" : "left" }] }, { "content" : [{ "text" : "预后", "alignment" : "left" }, { "text" : "好", "alignment" : "left" }, { "text" : "较好", "alignment" : "left" }, { "text" : "最差", "alignment" : "left" }, { "text" : "较差", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "甲状腺髓样癌又称C细胞癌，是由滤泡旁细胞（C细胞）发生的恶性肿瘤，滤泡旁细胞可产生降钙素，导致严重腹泻和低钙血症，故属于神经内分泌肿瘤。" }] }] }] }] }] }] }, { "title" : "第十章", "text" : "乳腺及女性生殖系统疾病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、乳腺癌", "alignment" : "left" }, { "text" : "常见组织学类型、常见扩散及转移途径　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、子宫颈癌", "alignment" : "left" }, { "text" : "（1）组织学类型<br>（2）扩散与转移", "alignment" : "left" }] }, { "content" : [{ "text" : "三、葡萄胎、侵袭性葡萄胎及绒毛膜癌", "alignment" : "left" }, { "text" : "病理变化　", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "both", "text" : "一、乳腺癌", "content" : [{ "type" : "common", "alignment" : "left", "text" : "乳腺癌是来自乳腺终末导管小叶单位上皮及滤泡上皮的肿瘤。乳腺癌的好发部位为乳腺外上象限（50%以上），其次为乳腺中央区，其他部位少见。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "乳腺癌分浸润性癌和非浸润性癌，浸润性癌最常见，约占70%～85%，浸润性癌中以浸润性导管癌最常见（约70%～85%）。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "淋巴转移是乳腺癌最常见的转移途径，最早转移到同侧腋窝淋巴结。" }] }] }] }] }, { "type" : "h1", "text" : "二、子宫颈癌", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 子宫颈上皮内瘤变", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "CINI级", "alignment" : "left" }, { "text" : "异型细胞局限在上皮层的下1/3", "alignment" : "left" }] }, { "content" : [{ "text" : "CINII级", "alignment" : "left" }, { "text" : "异型细胞局限在上皮层的下1/3～2/3", "alignment" : "left" }] }, { "content" : [{ "text" : "CINIII级", "alignment" : "left" }, { "text" : "异型细胞几乎累及或全部累及上皮层．即宫颈重度不典型增生及宫颈原位癌", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 子宫颈浸润癌", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "子宫颈鳞癌（占95%）", "alignment" : "left", "rowSpan" : 2 }, { "text" : "早期子宫颈癌", "alignment" : "left" }, { "text" : "起源于宫颈外口和柱状上皮交界处的鳞状上皮，浸润深度不超过基底膜下5mm", "alignment" : "left" }] }, { "content" : [{ "text" : "浸润癌", "alignment" : "left" }, { "text" : "癌组织浸润深度超过基底膜下5mm", "alignment" : "left" }] }, { "content" : [{ "text" : "子宫颈腺癌（占5%）", "alignment" : "left", "colSpan" : 2 }, { "text" : "主要来源于子宫颈管黏膜的柱状上皮和腺上皮，预后较差", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "三、葡萄胎、侵袭性葡萄胎及绒毛膜癌病理变化", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "葡萄胎", "alignment" : "left" }, { "text" : "侵袭性葡萄胎", "alignment" : "left" }, { "text" : "绒毛膜癌", "alignment" : "left" }] }, { "content" : [{ "text" : "侵袭性", "alignment" : "left" }, { "text" : "无", "alignment" : "left" }, { "text" : "有", "alignment" : "left" }, { "text" : "有", "alignment" : "left" }] }, { "content" : [{ "text" : "绒毛结构", "alignment" : "left" }, { "text" : "有", "alignment" : "left" }, { "text" : "有", "alignment" : "left" }, { "text" : "无", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "绒毛膜癌中无绒毛，瘤组织中只有实质细胞，而无间质，这是与侵袭性葡萄胎主要鉴别点。化疗治疗侵袭性葡萄胎及绒毛膜癌有很多好的疗效。" }] }] }] }, { "title" : "第十一章", "text" : "常见传染病及寄生虫病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、结核病", "alignment" : "left" }, { "text" : "（1）基本病理变化<br>（2）原发性肺结核病的病理变化和结局<br>（3）继发性肺结核病的病理变化和结局<br>（4）肺外结核的病理变化　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、细菌性痢疾", "alignment" : "left" }, { "text" : "（1）病理变化<br>（2）病理临床联系　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、伤寒", "alignment" : "left" }, { "text" : "（1）肠道病理变化<br>（2）病理临床联系　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、流行性脑脊髓膜炎", "alignment" : "left" }, { "text" : "（1）病理变化<br>（2）病理临床联系　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、流行性乙型脑炎", "alignment" : "left" }, { "text" : "（1）病理变化<br>（2）病理临床联系　", "alignment" : "left" }] }, { "content" : [{ "text" : "六、血吸虫病", "alignment" : "left" }, { "text" : "（1）基本病理变化<br>（2）肝、肠的病理变化及后果　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、结核病", "content" : [{ "type" : "common", "alignment" : "left", "text" : "结核结节由上皮样细胞、朗格汉斯细胞、淋巴细胞、少量反应性增生的纤维母细胞构成，典型结核结节中央有干酪样坏死，为结核病的特征性病理变化。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "原发性肺结核好发于儿童，开始时无免疫力，病程中产生，好发于肺门部淋巴结，起病隐匿，病程短，多数可以自愈，少数血行播散为全身粟粒性结核病。肺门部常有明显结核病变为原发性肺结核特点。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "继发性肺结核好发于肺尖部，一般不易自然痊愈。继发性肺结核病变进展为慢性纤维空洞型肺结核时，可有空洞形成，如空洞壁的干酪样坏死侵蚀较大血管，可引起大咯血，患者可因吸入大量血液而窒息死亡。" }] }] }] }, { "type" : "h1", "text" : "二、细菌性痢疾", "content" : [{ "type" : "common", "alignment" : "left", "text" : "伤寒与急性菌痢的鉴别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "伤寒", "alignment" : "left" }, { "text" : "急性细菌性痢疾", "alignment" : "left" }] }, { "content" : [{ "text" : "致病菌", "alignment" : "left" }, { "text" : "伤寒杆菌", "alignment" : "left" }, { "text" : "痢疾杆菌", "alignment" : "left" }] }, { "content" : [{ "text" : "易感人群", "alignment" : "left" }, { "text" : "儿童、青壮年", "alignment" : "left" }, { "text" : "儿童多见、其次青壮年，老年少见", "alignment" : "left" }] }, { "content" : [{ "text" : "传染源", "alignment" : "left" }, { "text" : "病人、带菌者", "alignment" : "left" }, { "text" : "病人、带菌者", "alignment" : "left" }] }, { "content" : [{ "text" : "传播途径", "alignment" : "left" }, { "text" : "经口传播", "alignment" : "left" }, { "text" : "经口传播", "alignment" : "left" }] }, { "content" : [{ "text" : "病程", "alignment" : "left" }, { "text" : "4周（10天潜伏期）", "alignment" : "left" }, { "text" : "1～2周", "alignment" : "left" }] }, { "content" : [{ "text" : "侵犯部位", "alignment" : "left" }, { "text" : "回肠末端", "alignment" : "left" }, { "text" : "乙状结肠、直肠", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "三、伤寒", "content" : [{ "type" : "common", "alignment" : "left", "text" : "伤寒小结的主要组成细胞是伤寒细胞，而伤寒细胞的本质为巨噬细胞，当巨噬细胞吞噬伤寒杆菌、红细胞及细胞碎片后，称为伤寒细胞。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "伤寒的临床表现为持续高热、相对缓脉、脾大、皮肤玫瑰疹及中性粒细胞、嗜酸性粒细胞减少。伤寒最严重的并发症为肠穿孔。" }] }] }, { "type" : "h1", "text" : "四、流脑和乙脑的鉴别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "流行性脑脊髓膜炎（流脑）", "alignment" : "left" }, { "text" : "流行性乙型脑炎（乙脑）", "alignment" : "left" }] }, { "content" : [{ "text" : "病原体", "alignment" : "left" }, { "text" : "细菌（脑膜炎双球菌）", "alignment" : "left" }, { "text" : "病毒（乙型脑炎病毒）", "alignment" : "left" }] }, { "content" : [{ "text" : "寄生部位", "alignment" : "left" }, { "text" : "病人和带菌者的鼻咽部", "alignment" : "left" }, { "text" : "中枢神经系统", "alignment" : "left" }] }, { "content" : [{ "text" : "传染源", "alignment" : "left" }, { "text" : "病人、带菌者", "alignment" : "left" }, { "text" : "病人、中间宿主家畜、家禽", "alignment" : "left" }] }, { "content" : [{ "text" : "传播途径", "alignment" : "left" }, { "text" : "呼吸道直接传播（飞沫传播）", "alignment" : "left" }, { "text" : "通过媒介（蚊）", "alignment" : "left" }] }, { "content" : [{ "text" : "发病季节", "alignment" : "left" }, { "text" : "冬春季", "alignment" : "left" }, { "text" : "夏秋季", "alignment" : "left" }] }, { "content" : [{ "text" : "病变特点", "alignment" : "left" }, { "text" : "化脓性炎症", "alignment" : "left" }, { "text" : "变质性炎症", "alignment" : "left" }] }, { "content" : [{ "text" : "发病人群", "alignment" : "left" }, { "text" : "多见于儿童、青少年", "alignment" : "left" }, { "text" : "多见于10岁以下儿童", "alignment" : "left" }] }, { "content" : [{ "text" : "主要病变部位", "alignment" : "left" }, { "text" : "脑脊髓膜（软脑膜、蛛网膜），脑实质一般不受累", "alignment" : "left" }, { "text" : "主要为脑实质（神经元），脑膜病变轻微", "alignment" : "left" }] }, { "content" : [{ "text" : "病理改变", "alignment" : "left" }, { "text" : "脑脊髓膜血管高度扩张充血，蛛网膜下腔灰黄色脓性渗出物，以额顶叶最明显", "alignment" : "left" }, { "text" : "脑实质血管高度扩张充血，脑回变宽、沟变浅，以顶叶及丘脑最明显，可见筛状软化灶", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "五、血吸虫病", "content" : [{ "type" : "common", "alignment" : "left", "text" : "基本病理变化——关键词：嗜酸性脓肿+虫卵肉芽肿性结节", "content" : [{ "type" : "h3", "alignment" : "both", "text" : "（1）尾蚴——尾蚴性皮炎" }, { "type" : "h3", "alignment" : "both", "text" : "（2）童虫——血管炎、血管周围炎" }, { "type" : "h3", "alignment" : "both", "text" : "（3）成虫——嗜酸性脓肿。死亡虫体周围组织坏死，大量嗜酸性粒细胞浸润形成。" }, { "type" : "h3", "alignment" : "left", "text" : "（4）虫卵——是血吸虫病最主要的病变，对人体危害最大。主要发生在大肠壁和肝脏，其病变表现为急、慢性虫卵结节。" }] }] }] }, { "title" : "第十二章", "text" : "艾滋病、性传播疾病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、艾滋病", "alignment" : "left" }, { "text" : "病因、发病机制及病理变化　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、梅毒", "alignment" : "left" }, { "text" : "病因、传染途径、类型及病理变化　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、淋病", "alignment" : "left" }, { "text" : "病因及病理变化　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、尖锐湿疣", "alignment" : "left" }, { "text" : "病因及病理变化　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、艾滋病", "content" : [{ "type" : "common", "alignment" : "left", "text" : "本病由HIV感染引起。发病机制包括：①HIV感染CD4+T细胞；②HIV感染组织中单核巨噬细胞。艾滋病机会性感染最常见病原体为肺孢子菌。约70%~80%的患者可经历一次或多次肺孢子虫感染，约50%病人死于肺孢子菌感染。" }] }, { "type" : "h1", "text" : "二、梅毒", "content" : [{ "type" : "common", "alignment" : "left", "text" : "第一期——下疳——无痛性丘疹", "content" : [{ "type" : "common", "alignment" : "left", "text" : "第二期——梅毒疹", "content" : [{ "type" : "common", "alignment" : "left", "text" : "第三期——累及内脏，树胶样肿和瘢痕", "content" : [{ "type" : "common", "alignment" : "center", "text" : "树胶样肿与结核肉芽肿的鉴别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "树胶样肿", "alignment" : "left" }, { "text" : "结核肉芽肿", "alignment" : "left" }] }, { "content" : [{ "text" : "病原菌", "alignment" : "left" }, { "text" : "梅毒螺旋体", "alignment" : "left" }, { "text" : "结核分枝杆菌", "alignment" : "left" }] }, { "content" : [{ "text" : "代表疾病", "alignment" : "left" }, { "text" : "梅毒", "alignment" : "left" }, { "text" : "结核病", "alignment" : "left" }] }, { "content" : [{ "text" : "病理特点", "alignment" : "left" }, { "text" : "类似干酪坏死，绝少钙化，坏死灶周围含大量淋巴细胞、浆细胞，类上皮细胞和朗格汉斯巨细胞很少，必有闭塞性小动脉内膜炎和动脉周围炎", "alignment" : "left" }, { "text" : "干酪样坏死，可有钙化，含大量淋巴、上皮样细胞和朗汉斯巨细胞", "alignment" : "left" }] }] }] }] }] }] }] }, { "type" : "h1", "text" : "三、淋病——淋球菌、急性化脓性炎，是最常见的性传播疾病。" }, { "type" : "h1", "text" : "四、尖锐湿疣——HPV引起、乳头瘤样+凹空细胞。" }] }, { "title" : "第十三章", "text" : "自身免疫病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一.自身免疫性疾病", "alignment" : "left" }, { "text" : "（1）发生机制 <br>（2）类型及特点", "alignment" : "both" }] }, { "content" : [{ "text" : "二.免疫缺陷病", "alignment" : "left" }, { "text" : "（1）概念<br>（2）原发性免疫缺陷病<br>（3）继发性免疫缺陷病", "alignment" : "both" }] }, { "content" : [{ "text" : "三.器官和骨髓移植", "alignment" : "left" }, { "text" : "（1）移植排斥反应及发生机制<br>（2）移植排斥的病理变化", "alignment" : "both" }] }], "content" : [{ "type" : "common", "alignment" : "both", "text" : "一、发病机制：（1）免疫耐受的丢失及隐蔽抗原的暴露：包括①回避TH细胞的耐受 ②交叉免疫反应 ③TS细胞和TH细胞功能失衡 ④隐蔽抗原释放。", "content" : [{ "type" : "common", "alignment" : "both", "text" : "二、类型及特点：（1）器官或细胞特异性自身免疫性疾病：病理损害仅限于抗体或致敏淋巴细胞所针对的某一器官或某一类细胞（2）系统型自身免疫性疾病。", "content" : [{ "type" : "common", "alignment" : "both", "text" : "三、系统性红斑狼疮：（1）狼疮小体，又名苏木素小体，是诊断该病的特征性依据。抗核抗体为其自身抗体，本身并不细胞毒性，但能攻击变性的细胞膜受损的细胞，与之接触后可以使细胞核肿胀呈均质一片，并被挤出胞体，形成狼疮小体。吞噬了狼疮小体的中性粒细胞或巨噬细胞称为狼疮细胞。（2）皮肤损害最常见，以面部蝶形红斑为特征（3）肾脏损害占60%，是该病主要死因。", "content" : [{ "type" : "common", "alignment" : "both", "text" : "四、类风湿关节炎：以多发性对称性滑膜炎为主要表现。血清类风湿因子阳性。病变常见于手足小关节，受累关节表现为慢性滑膜炎。" }] }] }] }] }] }, { "title" : "第十四章", "text" : "淋巴造血系统疾病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一.霍奇金淋巴瘤", "alignment" : "left" }, { "text" : "类型及特点", "alignment" : "left" }] }, { "content" : [{ "text" : "二.非霍奇金淋巴瘤", "alignment" : "left" }, { "text" : "（1）分型<br>（2）类型及特点", "alignment" : "both" }] }] }, { "type" : "h1", "text" : "一、霍奇金淋巴结", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "结节性淋巴C为主型", "alignment" : "center" }, { "text" : "结节硬化型", "alignment" : "center" }, { "text" : "混合细胞型", "alignment" : "center" }, { "text" : "富于淋巴细胞型", "alignment" : "center" }, { "text" : "淋巴细胞减少型", "alignment" : "center" }] }, { "content" : [{ "text" : "占比", "alignment" : "center" }, { "text" : "5%", "alignment" : "center" }, { "text" : "多见", "alignment" : "center" }, { "text" : "20%", "alignment" : "center" }, { "text" : "少见", "alignment" : "center" }, { "text" : "最少见", "alignment" : "center" }] }, { "content" : [{ "text" : "好发人群", "alignment" : "center" }, { "text" : "＜35岁男", "alignment" : "center" }, { "text" : "年轻女", "alignment" : "center" }, { "text" : "老年男性", "alignment" : "center" }, { "text" : "", "alignment" : "left" }, { "text" : "老年人", "alignment" : "center" }] }, { "content" : [{ "text" : "预后", "alignment" : "center" }, { "text" : "极好", "alignment" : "center" }, { "text" : "较好", "alignment" : "center" }, { "text" : "较好", "alignment" : "center" }, { "text" : "好", "alignment" : "center" }, { "text" : "差", "alignment" : "center" }] }, { "content" : [{ "text" : "合并", "alignment" : "center" }, { "text" : "不伴有EBV感染", "alignment" : "center" }, { "text" : "", "alignment" : "left" }, { "text" : "常合并EBV感染", "alignment" : "center" }, { "text" : "40%伴EBV感染", "alignment" : "center" }, { "text" : "常伴EBV感染", "alignment" : "center" }] }, { "content" : [{ "text" : "肿瘤细胞", "alignment" : "center" }, { "text" : "爆米花细胞", "alignment" : "center" }, { "text" : "陷窝细胞", "alignment" : "center" }, { "text" : "镜影细胞和RS细胞", "alignment" : "center" }, { "text" : "单核或镜影细胞", "alignment" : "center" }, { "text" : "多形性变异型瘤细胞", "alignment" : "center" }] }, { "content" : [{ "text" : "免疫表型", "alignment" : "center" }, { "text" : "B细胞表型", "alignment" : "center" }, { "text" : "不表达B或T", "alignment" : "center" }, { "text" : "不表达B或T", "alignment" : "center" }, { "text" : "CD15. 30、20、45", "alignment" : "center" }, { "text" : "不表达B或T", "alignment" : "center" }] }, { "content" : [{ "text" : "病理", "alignment" : "center" }, { "text" : "缺乏镜影细胞", "alignment" : "center" }, { "text" : "结节状", "alignment" : "center" }, { "text" : "合并炎症细胞", "alignment" : "center" }, { "text" : "大量淋巴细胞", "alignment" : "center" }, { "text" : "大量RS细胞", "alignment" : "center" }] }] }] }, { "type" : "h1", "text" : "二、非霍奇金淋巴瘤", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1.弥漫大B淋巴瘤：最常见，B细胞来源，高度恶性，Bcl6基因突变，表现为淋巴结迅速增大。" }, { "type" : "h2", "alignment" : "left", "text" : "2.滤泡性淋巴瘤：B细胞来源，惰性，Bcl6和t（14，18），表现为腹股沟和脾脏受累。" }, { "type" : "h2", "alignment" : "left", "text" : "3.浆细胞骨髓瘤：B细胞来源，恶性，尿中本周蛋白阳性。" }, { "type" : "h2", "alignment" : "left", "text" : "4.前体T/B细胞淋巴瘤：B、T细胞来源，可见星空现象。" }, { "type" : "h2", "alignment" : "left", "text" : "5.外周T细胞淋巴瘤：T细胞来源，高度侵袭性，容易侵犯血管。" }, { "type" : "h2", "alignment" : "left", "text" : "6.NK/T细胞淋巴瘤：NK/T细胞来源，侵袭性强，鼻腔容易受累。" }, { "type" : "h2", "alignment" : "left", "text" : "7.蕈样霉菌病：T细胞来源，低度恶性，表现为皮肤湿疹样改变。" }] }] }] }, { "text" : "第四篇   药理学", "guide" : [{ "text" : "执业医师考试——本篇约占临床执业医师考试的2%，出题量约为12题。药理学章节较多，但是考试内容不多，很多章节往年均未考到，其中心血管系统、血液系统用药及抗生素为考试重点，其余各章节只需掌握往年考过的考点。" }], "content" : [{ "title" : "第一章", "text" : "药物效应动力学及代谢动力学", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、不良反应", "alignment" : "left" }, { "text" : "（1）副反应<br>（2）毒性反应<br>（3）后遗效应<br>（4）停药反应<br>（5）变态反应<br>（6）特异质反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、药物剂量与效应关系", "alignment" : "left" }, { "text" : "（1）半数有效量<br>（2）治疗指数　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、药物与受体", "alignment" : "left" }, { "text" : "（1）激动药<br>（2）拮抗药　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、吸收", "alignment" : "left" }, { "text" : "首过消除", "alignment" : "left" }] }, { "content" : [{ "text" : "五、分布", "alignment" : "left" }, { "text" : "（1）血脑屏障<br>（2）胎盘屏障　", "alignment" : "left" }] }, { "content" : [{ "text" : "六、体内药量变化的时间过程", "alignment" : "left" }, { "text" : "生物利用度　", "alignment" : "left" }] }, { "content" : [{ "text" : "七、药物消除动力学", "alignment" : "left" }, { "text" : "（1）一级消除动力学<br>（2）零级消除动力学　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、药物效应动力学", "content" : [{ "type" : "common", "alignment" : "left", "text" : "不良反应：凡是与用药目的无关，并为病人带来不适或造成痛苦的反应，统称为不良反应。多数不良反应为药物固有的效应，在一般情况下是可以预知的，但不一定是能够避免的。少数较严重的不良反应较难恢复，称为药源性疾病，如庆大霉素引起的神经性耳聋。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "副反应：由于药物选择性低，药理效应涉及多个器官，当某一效应用作治疗目的时，其余效应就成为副反应。副反应是在治疗剂量下发生的，是药物本身固有的作用，多数较轻微并可以预知。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "毒性反应：指在剂量过大或药物在体内蓄积过多时发生的危害性反应，一般比较严重。毒性反应一般是可以预知的，应该避免发生。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "治疗指数：通常将药物的LD50/ED50的比值称为治疗指数（TI），用以表示药物的安全性。LD50指半数致死量，ED50指半数有效量。治疗指数大的药物相对治疗指数小的药物安全。但以治疗指数衡量药物的安全性并不可靠。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "激动药：指既有亲和力又有内在活性，能与受体结合，并使之激活而产生效应的药物。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "拮抗药：与受体有较强的亲和力，而无内在活性的药物。虽然本身不产生效应，但可拮抗激动药的效应。" }] }] }] }] }] }] }, { "type" : "h1", "text" : "二、药物代谢动力学", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 首过消除：口服给药时，从胃肠道吸收入门静脉系统的药物在到达全身各处之前要先通过肝脏，若肝脏对药物的代谢能力很强，或胆汁排泄量很大，则使进入全身血循环的有效药量明显减少，这种作用称为首过效应。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "首过消除最主要器官是肝脏，肺和肠壁亦是首过消除器官。口服给药为最常见首过消除给药途径。" }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 药物消除动力学", "content" : [{ "type" : "common", "alignment" : "left", "text" : "零级消除动力学（恒量消除）：消除速度恒定，半衰期与浓度成正比。单位时间内药物以恒定速率进行消除。消除速率与血药浓度无关（单位时间消除药量不变）。当机体消除功能低下或用药过量超过机体最大消除能力的时候，药物按恒量消除，如饮酒过量时。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "一级消除动力学（恒比消除）：体内药物以恒定的百分比消除，单位时间实际消除的药量随时间递减。药物消除半衰期恒定，与药物浓度无关。绝大多数药物都按一级动力学消除。" }] }] }] }] }, { "title" : "第二章", "text" : "传出神经系统药", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、胆碱受体激动药", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.乙酰胆碱", "alignment" : "left" }, { "text" : "药理作用", "alignment" : "left" }] }, { "content" : [{ "text" : "2.毛果芸香碱", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、抗胆碱酯酶药和胆碱酯酶复活药", "alignment" : "left", "rowSpan" : 3 }, { "text" : "1.易逆性抗胆碱酯酶药", "alignment" : "left" }, { "text" : "（1）作用机制<br>（2）药理作用<br>（3）新斯的明的临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.难逆性抗胆碱酯酶药", "alignment" : "left" }, { "text" : "（1）毒理作用机制<br>（2）急性中毒　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.胆碱酯酶复活药", "alignment" : "left" }, { "text" : "碘解磷定的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、M胆碱受体阻断药", "alignment" : "left" }, { "text" : "阿托品", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用<br>（3）不良反应及中毒　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、肾上腺素受体激动药", "alignment" : "left", "rowSpan" : 4 }, { "text" : "1.去甲肾上腺素", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用<br>（3）不良反应及禁忌症　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.肾上腺素", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.多巴胺", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "4.异丙肾上腺素", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、肾上腺素受体阻断药", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.α肾上腺素受体阻断药", "alignment" : "left" }, { "text" : "酚妥拉明的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.β肾上腺素受体阻断药", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用<br>（3）不良反应及禁忌症<br>（4）代表药物　", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "乙酰胆碱Ach的作用：", "picture" : "fe881460-a136-4a67-8349-331ee4a5e00f.png" }, { "type" : "h2", "alignment" : "left", "text" : "1. 各传出神经药物的药理及临床作用", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "药物名称", "alignment" : "left" }, { "text" : "药理作用", "alignment" : "left" }, { "text" : "临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "毛果芸香碱", "alignment" : "left" }, { "text" : "作用于M胆碱受体；<br>可缩瞳、降低眼内压、调节痉挛、使腺体分泌增加", "alignment" : "both" }, { "text" : "青光眼降低眼压、虹膜睫状体炎、用于阿托品中毒的解毒", "alignment" : "left" }] }, { "content" : [{ "text" : "阿托品", "alignment" : "left" }, { "text" : "M胆碱受体阻断药；<br>瞳孔扩张，升高眼内压，调节麻痹，使腺体分泌减少；<br>阿托品可解除平滑肌痉挛，适用于各种内脏绞痛，对膀胱刺激症状、胃肠绞痛疗效较好，对胆绞痛、肾绞痛疗效差", "alignment" : "both" }, { "text" : "阿托品的临床应用：1. 解除平滑肌痉挛；2. 全麻前给药，抑制腺体分泌；3. 眼科用于虹膜睫状体炎及验光、眼底检查；4. 用于缓慢型心律失常；5. 抗休克；6. 解救有机磷酸酯类中毒；<br>青光眼及前列腺肥大患者禁用阿托品，可增高眼压及加重排尿困难；<br>阿托品的常见不良反应有：口干、视力模糊、心率加快、瞳孔扩大、皮肤潮红等。大剂量阿托品可导致中枢中毒症状，如运动失调、不安、激动、幻觉、谵妄、昏迷等<br><br>", "alignment" : "left" }] }, { "content" : [{ "text" : "新斯的明", "alignment" : "left" }, { "text" : "抗胆碱酯酶药，可逆的与胆碱酯酶结合，抑制胆碱酯酶活性，造成乙酰胆碱堆积，表现出乙酰胆碱的M样作用和N样作用，新斯的明对骨骼肌兴奋作用较强，对胃肠平滑肌作用次之，对腺体、眼、心血管及支气管平滑肌作用弱", "alignment" : "left" }, { "text" : "新斯的明主要治疗重症肌无力，也常用于减轻由手术或其他原因引起的腹胀气及尿潴留，禁用于机械性肠梗阻或泌尿道梗阻患者", "alignment" : "left" }] }, { "content" : [{ "text" : "碘解磷定", "alignment" : "left" }, { "text" : "胆碱酯酶复活剂主要解除烟碱样症状（N样），可恢复胆碱酯酶活性", "alignment" : "left" }, { "text" : "对有机磷中毒24-48小时后已老化的胆碱酯酶无复活作用。因其对M样作用的影响较小，故常与阿托品联合应用，以控制症状", "alignment" : "left" }] }, { "content" : [{ "text" : "去甲肾上腺素", "alignment" : "left" }, { "text" : "对α受体具有强大激动作用，对心脏β<sub>1</sub>受体作用较弱，对β<sub>2</sub>受体几乎无作用", "alignment" : "left" }, { "text" : "早期神经源性休克以及嗜铬细胞瘤切除后或药物中毒时的低血压；<br>稀释后口服可使食管和胃黏膜血管收缩产生局部止血作用；<br>引起肾衰很常见，用药期间看尿量", "alignment" : "both" }] }, { "content" : [{ "text" : "肾上腺素", "alignment" : "left" }, { "text" : "激动心脏β<sub>1</sub>受体，起正性作用（心缩力加强、心率加快、传导加强、自律性增加）；<br>激动平滑肌β<sub>2</sub>受体，显著舒张支气管；<br>激动黏膜及肥大细胞β<sub>2</sub>受体，抑制其释放组胺及其他过敏性物质；<br>激动黏膜血管的α受体，使其收缩，消除支气管黏膜水肿", "alignment" : "both" }, { "text" : "肾上腺素常用于心脏骤停、过敏性疾病、与局麻药配伍使用、治疗青光眼<br><br><br><br><br><br><br><br><br>", "alignment" : "left" }] }, { "content" : [{ "text" : "多巴胺", "alignment" : "left" }, { "text" : "激动α、β和外周的多巴胺受体", "alignment" : "left" }, { "text" : "低浓度时可激动D<sub>1</sub>受体，舒张肾血管，使肾血流量增大，增加尿量；<br>大剂量时使肾血管明显收缩；<br>多巴胺对心脏起正性作用", "alignment" : "both" }] }, { "content" : [{ "text" : "异丙肾上腺素", "alignment" : "left" }, { "text" : "主要激动β受体", "alignment" : "left" }, { "text" : "控制支气管哮喘急性发作；<br>治疗Ⅱ、Ⅲ度房室传导阻滞；<br>心脏骤停的抢救；<br>适用于中心静脉压高、心排量低的感染性休克", "alignment" : "both" }] }, { "content" : [{ "text" : "酚妥拉明", "alignment" : "left" }, { "text" : "竞争性阻断α受体", "alignment" : "left" }, { "text" : "治疗外周血管痉挛性疾病；<br>抗休克；<br>肾上腺嗜铬细胞瘤的诊断与治疗；<br>急性心肌梗死和顽固性充血性心力衰竭；<br>治疗去甲肾上腺素外漏；<br>治疗肾上腺素所致的高血压", "alignment" : "both" }] }, { "content" : [{ "text" : "普萘洛尔", "alignment" : "left" }, { "text" : "β受体阻断药，负性肌力、负性传导，引起肝、肾、骨骼肌血管收缩，降低血流量，起降压作用，但对正常人血压无影响。亦可通过阻断肾小球旁器细胞的β<sub>1</sub>受体而抑制肾素释放，降低血压", "alignment" : "left" }, { "text" : "治疗快速型心律失常；心绞痛和心肌梗死；高血压；充血性心力衰竭等<br>一般认为人类脂肪的分解主要与激动β<sub>1. </sub>β<sub>2</sub>受体有关，故β受体阻滞剂可抑制脂肪的分解", "alignment" : "both" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 肾上腺素受体阻断药分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "非选择性α受体阻断药", "alignment" : "left", "rowSpan" : 2 }, { "text" : "短效类", "alignment" : "left" }, { "text" : "酚妥拉明、妥拉唑林", "alignment" : "left" }] }, { "content" : [{ "text" : "长效类", "alignment" : "left" }, { "text" : "酚苄明", "alignment" : "left" }] }, { "content" : [{ "text" : "选择性α<sub>1</sub>受体阻断药", "alignment" : "left", "colSpan" : 2 }, { "text" : "哌唑嗪", "alignment" : "left" }] }, { "content" : [{ "text" : "选择性α<sub>2</sub>受体阻断药", "alignment" : "left", "colSpan" : 2 }, { "text" : "育亨宾", "alignment" : "left" }] }, { "content" : [{ "text" : "非选择性β受体阻断剂", "alignment" : "left", "colSpan" : 2 }, { "text" : "普萘洛尔、纳多洛尔、吲哚洛尔", "alignment" : "left" }] }, { "content" : [{ "text" : "选择性β受体阻断剂", "alignment" : "left", "colSpan" : 2 }, { "text" : "美托洛尔、阿替洛尔", "alignment" : "left" }] }, { "content" : [{ "text" : "α、β受体阻断剂", "alignment" : "left", "colSpan" : 2 }, { "text" : "醋丁洛尔、拉贝洛尔", "alignment" : "left" }] }] }] }] }] }, { "title" : "第三章", "text" : "中枢神经系统药", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、局部麻醉药", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.局麻作用及作用机制", "alignment" : "left" }, { "text" : "（1）局麻作用<br>（2）作用机制　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.常用局麻药", "alignment" : "left" }, { "text" : "（1）普鲁卡因的临床应用<br>（2）利多卡因的临床应用<br>（3）丁卡因的临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、镇静催眠药", "alignment" : "left" }, { "text" : "苯二氮卓类", "alignment" : "left" }, { "text" : "（1）药理作用及临床应用<br>（2）作用机制　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、抗癫痫药和抗惊厥药", "alignment" : "left", "rowSpan" : 6 }, { "text" : "1.苯妥英钠", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.卡马西平", "alignment" : "left" }, { "text" : "药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.苯巴比妥、扑米酮", "alignment" : "left" }, { "text" : "临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "4.乙琥胺", "alignment" : "left" }, { "text" : "临床应用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "5.丙戊酸钠", "alignment" : "left" }, { "text" : "临床应用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "6.硫酸镁", "alignment" : "left" }, { "text" : "药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、抗帕金森病药", "alignment" : "left", "rowSpan" : 3 }, { "text" : "1.左旋多巴", "alignment" : "left" }, { "text" : "（1）体内过程<br>（2）药理作用及临床应用<br>（3）不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.卡比多巴", "alignment" : "left" }, { "text" : "药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.苯海索", "alignment" : "left" }, { "text" : "药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、抗精神失常药", "alignment" : "left", "rowSpan" : 4 }, { "text" : "1.氯丙嗪", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用<br>（3）不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.丙米嗪", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.碳酸锂", "alignment" : "left" }, { "text" : "药理作用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "4.氯氮平", "alignment" : "left" }, { "text" : "药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "六、镇痛药", "alignment" : "left", "rowSpan" : 3 }, { "text" : "1.吗啡", "alignment" : "left" }, { "text" : "（1）药理作用及作用机制<br>（2）临床应用<br>（3）不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.哌替啶", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用<br>（3）不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.纳洛酮", "alignment" : "left" }, { "text" : "药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "七、解热镇痛抗炎药", "alignment" : "left", "rowSpan" : 3 }, { "text" : "1.阿司匹林", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用<br>（3）不良反应", "alignment" : "left" }] }, { "content" : [{ "text" : "2.对乙酰氨基酚", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用<br>（3）不良反应", "alignment" : "left" }] }, { "content" : [{ "text" : "3.布洛芬", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用", "alignment" : "left" }] }], "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "药物名称", "alignment" : "left" }, { "text" : "药理作用", "alignment" : "left" }, { "text" : "临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "苯二氮卓类（安定）", "alignment" : "left" }, { "text" : "与加强中枢抑制性神经递质GABA功能有关", "alignment" : "left" }, { "text" : "（1）抗焦虑作用，苯二氮卓类对各种原因引起的焦虑均有显著疗效，主要用于焦虑症。（2）镇静催眠作用，主要延长非快动眼睡眠的第二期，对快动眼睡眠影响较小。（3）抗惊厥作用，临床可用于治疗破伤风、小儿高热惊厥、子痫、药物中毒性惊厥等。（4）抗癫痫作用，地西泮静脉注射是目前治疗癫痫持续状态的首选药。（5）中枢性肌肉松弛作用，可缓解大脑损伤所致肌肉僵直", "alignment" : "left" }] }, { "content" : [{ "text" : "苯妥英钠", "alignment" : "left" }, { "text" : "抗癫痫药，对细胞膜有稳定作用，降低细胞膜兴奋性，使动作电位不易产生", "alignment" : "left" }, { "text" : "是治疗癫痫大发作的首选用药，但对小发作无效，甚至可加重病情，小发作选乙琥胺。大+小首选丙戊酸钠；苯妥英钠可用于治疗中枢疼痛综合征，对三叉神经痛、舌咽神经痛效果较好，可减轻疼痛，减少发作次数，甚至完全消失", "alignment" : "left" }] }, { "content" : [{ "text" : "卡马西平", "alignment" : "left" }, { "text" : "抗癫痫药，作用机理与苯妥英钠相似", "alignment" : "left" }, { "text" : "为治疗三叉神经痛的首选用药", "alignment" : "left" }] }, { "content" : [{ "text" : "氯丙嗪", "alignment" : "left" }, { "text" : "阻断中枢多巴胺受体", "alignment" : "left" }, { "text" : "1. 对中枢神经系统作用：抗精神病作用、镇吐作用、治疗顽固性呃逆、抑制体温调节中枢；对晕动症引起的呕吐无效。<br>2. 对自主神经系统作用：阻断肾上腺α受体及M胆碱受体；<br>3. 对内分泌系统的影响：阻断结节-漏斗系统中的D<sub>2</sub>受体，增加催乳素的分泌，抑制促性腺激素和糖皮质激素的分泌", "alignment" : "both" }] }, { "content" : [{ "text" : "左旋多巴", "alignment" : "left" }, { "text" : "左旋多巴口服后经小肠芳香族氨基酸转运体迅速吸收，不在胃内、肾内吸收。左旋多巴为多巴胺的前体物质，口服后，约99%在外周被L-芳香族氨基酸脱羧酶转变为多巴胺，约1%可进入脑内，在中枢脱羧酶作用下，转变为多巴胺发挥治疗作用。", "alignment" : "left" }, { "text" : "是治疗帕金森病的首选用药，帕金森病是由于黑质受损，脑内多巴胺含量下降，对乙酰胆碱能系统的抑制作用减弱，机体出现的Ach递质亢进症状。临床给予左旋多巴或M受体阻断剂，可明显缓解这一症状。帕金森病还可出现静止性震颤，此症状与中缝核5-羟色胺能系统受损有关，与黑质受损无关，因此不能被左旋多巴或M受体阻断剂缓解，而给予5-羟色胺酸治疗，可明显改变静止性震颤症状", "alignment" : "left" }] }, { "content" : [{ "text" : "吗啡", "alignment" : "left" }, { "text" : "镇痛药，阿片类受体激动药，主要作用于中枢神经系统及胃肠平滑肌", "alignment" : "left" }, { "text" : "1. 镇痛；2. 心源性哮喘；3. 止泻。吗啡的禁忌证：1. 禁用于分娩止痛及哺乳期止痛；2. 禁用于支气管哮喘及肺心病患者；3. 颅脑损伤所致颅内高压患者、肝功能严重减退及新生儿、婴幼儿；<br>中毒解救首选纳洛酮", "alignment" : "both" }] }, { "content" : [{ "text" : "哌替啶", "alignment" : "left" }, { "text" : "激动μ型阿片受体，药理作用与吗啡相同，镇痛作用弱于吗啡，镇静、呼吸抑制、致欣性和扩血管作用与吗啡相当", "alignment" : "left" }, { "text" : "1. 镇痛，新生儿对哌替啶抑制呼吸作用极为敏感，产妇临产前2-4h内不宜使用；<br>2. 麻醉前给药及人工冬眠，与氯丙嗪、异丙嗪合用组成冬眠合剂用于人工冬眠疗法", "alignment" : "both" }] }] }] }] }, { "title" : "第四章", "text" : "心血管系统药", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、钙拮抗药", "alignment" : "left", "rowSpan" : 4 }, { "text" : "1.钙拮抗药的分类及药名", "alignment" : "left" }, { "text" : "（1）选择性钙拮抗药<br>（2）非选择性钙拮抗药", "alignment" : "left" }] }, { "content" : [{ "text" : "2.硝苯地平", "alignment" : "left" }, { "text" : "药理作用及临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "3.维拉帕米", "alignment" : "left" }, { "text" : "药理作用及临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "4.尼莫地平", "alignment" : "left" }, { "text" : "临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "二、抗心律失常药", "alignment" : "left", "rowSpan" : 5 }, { "text" : "1.抗心律失常药的分类", "alignment" : "left" }, { "text" : "（1）Ⅰ类钠通道阻滞药<br>（2）Ⅱ类β肾上腺素受体阻断药<br>（3）Ⅲ类选择性延长复极的药物<br>（4）Ⅳ类钙拮抗药", "alignment" : "left" }] }, { "content" : [{ "text" : "2.利多卡因", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "3.普萘洛尔", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "4.胺碘酮", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "5.维拉帕米", "alignment" : "left" }, { "text" : "临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "三、治疗充血性心力衰竭的药物", "alignment" : "left", "rowSpan" : 4 }, { "text" : "1.β肾上腺索受体阻断药", "alignment" : "left" }, { "text" : "卡维地洛/美托洛尔的药理作用和作用机制　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.血管紧张素转化酶抑制药", "alignment" : "left" }, { "text" : "抗心衰的作用机制　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.利尿药", "alignment" : "left" }, { "text" : "呋塞米的药理作用和临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "4.强心苷", "alignment" : "left" }, { "text" : "（1）地高辛的药理作用和作用机制<br>（2）地高辛的临床应用和不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、抗心绞痛药", "alignment" : "left", "rowSpan" : 3 }, { "text" : "1.硝酸甘油", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）作用机制　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.β肾上腺素受体阻断药", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.钙拮抗药", "alignment" : "left" }, { "text" : "抗心绞痛作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、抗动脉粥样硬化药", "alignment" : "left", "rowSpan" : 3 }, { "text" : "1.HMG-CoA还原酶抑制药", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用<br>（3）不良反应<br>（4）代表药物　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.贝特类药物", "alignment" : "left" }, { "text" : "药理作用及调血脂机制　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.胆汁酸结合树脂", "alignment" : "left" }, { "text" : "考来烯胺的药理作用", "alignment" : "left" }] }, { "content" : [{ "text" : "六、抗高血压药", "alignment" : "left", "rowSpan" : 5 }, { "text" : "1.利尿药", "alignment" : "left" }, { "text" : "药理作用、作用机制及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.钙拮抗药", "alignment" : "left" }, { "text" : "药理作用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.β肾上腺素受体阻断药", "alignment" : "left" }, { "text" : "抗高血压的作用及作用机制　", "alignment" : "left" }] }, { "content" : [{ "text" : "4.血管紧张素转化酶抑制药", "alignment" : "left" }, { "text" : "（1）药理作用及作用机制<br>（2）临床应用<br>（3）不良反应<br>（4）代表药物　", "alignment" : "left" }] }, { "content" : [{ "text" : "5.血管紧张素Ⅱ受体阻断药", "alignment" : "left" }, { "text" : "氯沙坦药理作用及作用机制", "alignment" : "left" }] }, { "content" : [{ "text" : "七、利尿药", "alignment" : "left", "rowSpan" : 5 }, { "text" : "1.袢利尿药", "alignment" : "left" }, { "text" : "药理作用、临床应用及不良反应", "alignment" : "left" }] }, { "content" : [{ "text" : "2.噻嗪类", "alignment" : "left" }, { "text" : "药理作用、临床应用及不良反应", "alignment" : "left" }] }, { "content" : [{ "text" : "3.保钾利尿药", "alignment" : "left" }, { "text" : "螺内酯的药理作用、临床应用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "4.碳酸酐酶抑制药", "alignment" : "left" }, { "text" : "乙酰唑胺的药理作用、临床应用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "5.渗透性利尿药", "alignment" : "left" }, { "text" : "甘露醇的药理作用及临床应用", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、钙拮抗剂", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "维拉帕米", "alignment" : "left" }, { "text" : "非二氢吡啶类，陈发性室上性心动过速首选药，心率过快的患者（高血压、心绞痛、脑血管病）可降低心率，严重传导阻滞的禁用", "alignment" : "left" }] }, { "content" : [{ "text" : "硝苯地平", "alignment" : "left" }, { "text" : "对变异型心绞痛最佳", "alignment" : "left" }] }, { "content" : [{ "text" : "尼莫地平", "alignment" : "left" }, { "text" : "对高血压合并脑出血效果好（保护脑血管作用）", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "二、抗心律失常药物的分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "分类", "alignment" : "left" }, { "text" : "作用机制", "alignment" : "left" }, { "text" : "代表药物", "alignment" : "left" }] }, { "content" : [{ "text" : "钠通道阻断剂（Ia类、Ib类、Ic类）", "alignment" : "left", "rowSpan" : 3 }, { "text" : "Ia类适度阻滞钠通道，减慢传导，延长复极", "alignment" : "left" }, { "text" : "奎尼丁、普鲁卡因胺", "alignment" : "left" }] }, { "content" : [{ "text" : "Ib类轻度阻滞钠通道，传导略减慢或不变，加速复极", "alignment" : "left" }, { "text" : "利多卡因、苯妥英钠", "alignment" : "left" }] }, { "content" : [{ "text" : "Ic类明显阻滞钠通道，减慢传导，对复极影响小", "alignment" : "left" }, { "text" : "普罗帕酮、氟卡尼", "alignment" : "left" }] }, { "content" : [{ "text" : "β肾上腺素受体拮抗剂（II类）", "alignment" : "left" }, { "text" : "阻断心脏β受体，降低自律性、传导性", "alignment" : "left" }, { "text" : "普萘洛尔", "alignment" : "left" }] }, { "content" : [{ "text" : "延长动作电位时程药（III类）", "alignment" : "left" }, { "text" : "抑制多种钾电流，延长复极和ERP", "alignment" : "left" }, { "text" : "胺碘酮", "alignment" : "left" }] }, { "content" : [{ "text" : "钙通道阻滞药（IV类）", "alignment" : "left" }, { "text" : "降低窦性心律，减慢房室结传导性", "alignment" : "left" }, { "text" : "维拉帕米、地尔硫䓬", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "三、降压药物的种类及其临床适应证和禁忌证", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "药物类型", "alignment" : "left" }, { "text" : "适应证", "alignment" : "left" }, { "text" : "禁忌证", "alignment" : "left" }, { "text" : "代表药物", "alignment" : "left" }] }, { "content" : [{ "text" : "血管紧张素转换酶抑制剂（ACEI）", "alignment" : "left" }, { "text" : "心衰、左心室肥厚、心梗后、合并糖尿病", "alignment" : "left" }, { "text" : "双肾动脉狭窄、高血钾、妊娠", "alignment" : "left" }, { "text" : "卡托普利、依那普利", "alignment" : "left" }] }, { "content" : [{ "text" : "血管紧张素II受体阻滞剂（ARB）", "alignment" : "left" }, { "text" : "心脏衰竭、心肌梗死后、糖尿病肾病、左心室肥厚、对ACEI不耐受的患者", "alignment" : "left" }, { "text" : "体位性低血压", "alignment" : "left" }, { "text" : "氯沙坦、缬沙坦", "alignment" : "left" }] }, { "content" : [{ "text" : "β受体阻滞剂（β-B）", "alignment" : "left" }, { "text" : "劳力性心绞痛、心梗后、快速性心律失常", "alignment" : "left" }, { "text" : "哮喘、COPD、II度或III度房室传导阻滞、周围血管病、高脂血症", "alignment" : "left" }, { "text" : "美托洛尔、阿替洛尔", "alignment" : "left" }] }, { "content" : [{ "text" : "钙通道阻滞剂（CCB）", "alignment" : "left" }, { "text" : "心绞痛、收缩期高血压", "alignment" : "left" }, { "text" : "心衰、房室传导阻滞", "alignment" : "left" }, { "text" : "硝苯地平、维拉帕米", "alignment" : "left" }] }, { "content" : [{ "text" : "利尿剂（Diuretics）", "alignment" : "left" }, { "text" : "心衰、收缩期高血压、老年性高血压", "alignment" : "left" }, { "text" : "痛风、高血脂、妊娠", "alignment" : "left" }, { "text" : "氢氯噻嗪", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "四、常见降压药物的不良反应", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "药物类型", "alignment" : "left" }, { "text" : "不良反应", "alignment" : "left" }] }, { "content" : [{ "text" : "血管紧张素转换酶抑制剂（ACEI）", "alignment" : "left" }, { "text" : "刺激性干咳、血管性水肿", "alignment" : "left" }] }, { "content" : [{ "text" : "血管紧张素受体阻滞剂（ARB）", "alignment" : "left" }, { "text" : "无干咳，副作用很少", "alignment" : "left" }] }, { "content" : [{ "text" : "β-受体阻滞剂", "alignment" : "left" }, { "text" : "房室传导阻滞、支气管痉挛、抑制心肌收缩力", "alignment" : "left" }] }, { "content" : [{ "text" : "钙通道阻滞剂", "alignment" : "left" }, { "text" : "心率增快、面部潮红、头痛、下肢水肿", "alignment" : "left" }] }, { "content" : [{ "text" : "利尿剂", "alignment" : "left" }, { "text" : "低钾血症，影响血脂、血糖、血尿酸", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "五、利尿药", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "作用机制", "alignment" : "left" }, { "text" : "主要应用", "alignment" : "left" }] }, { "content" : [{ "text" : "呋塞米", "alignment" : "left" }, { "text" : "抑制髓襻升支粗段的Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>-</sup>共转运子", "alignment" : "left" }, { "text" : "严重水肿，尤其肺水肿、脑水肿；<br>高钙血症；<br>急性肾衰；<br>排泄毒物", "alignment" : "left" }] }, { "content" : [{ "text" : "氢氯噻嗪", "alignment" : "left" }, { "text" : "抑制远曲小管Na<sup>+</sup>-Cl<sup>-</sup>共转运子", "alignment" : "left" }, { "text" : "轻中度水肿；<br>高血压；", "alignment" : "left" }] }, { "content" : [{ "text" : "螺内酯", "alignment" : "left" }, { "text" : "拮抗醛固酮受体", "alignment" : "left" }, { "text" : "治疗与醛固酮升高有关的顽固性水肿；<br>充血性心力衰竭", "alignment" : "left" }] }, { "content" : [{ "text" : "乙酰唑胺", "alignment" : "left" }, { "text" : "抑制碳酸酐酶的活性——抑制HCO<sub>3</sub><sup>-</sup>重吸收", "alignment" : "left" }, { "text" : "急性青光眼首选；<br>碱化尿液；<br>纠正代谢性碱中毒", "alignment" : "left" }] }, { "content" : [{ "text" : "甘露醇", "alignment" : "left" }, { "text" : "渗透性利尿", "alignment" : "left" }, { "text" : "急性脑水肿首选<br>降低青光眼眼压", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "六、其他常考心血管药物的药理作用", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "普萘洛尔", "alignment" : "left" }, { "text" : "普萘洛尔阻断β受体，可降低自律性、延长不应期、减慢传导，用于室上性心律失常的治疗；<br>可通过收缩肝、肾、骨骼肌血管，减少血流量，起降压作用；<br>亦可使心绞痛患者发作次数减少、改善心肌血供、增加患者运动耐量，减少心肌耗氧量，缩小心肌梗死范围。", "alignment" : "both" }] }, { "content" : [{ "text" : "异丙肾上腺素", "alignment" : "left" }, { "text" : "异丙肾上腺素为β受体激动剂，对β<sub>1. </sub>β<sub>2</sub>受体选择性低，对α受体无作用；<br>异丙肾上腺素为人工合成品，主要用于心搏停跳、房室传导阻滞（II度、III度房室传导阻滞）、支气管哮喘、休克（现少用）。", "alignment" : "both" }] }, { "content" : [{ "text" : "硝酸甘油", "alignment" : "left" }, { "text" : "松弛平滑肌，以血管平滑肌松弛作用最显著；<br>1. 降低心肌耗氧量（前后负荷都将降）；2. 扩张冠状动脉，增加缺血区血液灌注；3. 降低左室充盈压，增加心内膜供血，改善左室顺应性；4. 保护缺血心肌细胞，减轻缺血损伤", "alignment" : "both" }] }, { "content" : [{ "text" : "强心苷", "alignment" : "left" }, { "text" : "正性肌力作用和减慢心率作用。视觉异常是中毒先兆，作为停药指征。中毒反应：最早的反应时胃肠道反应，最严重、最危急的不良反应时心脏毒性，最常见的不良反应是心律失常，最常见的心律失常是室早。", "alignment" : "left" }] }] }] }] }, { "title" : "第五章", "text" : "作用于呼吸、消化、血液系统的药物", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、作用于血液及造血器官的药物", "alignment" : "left", "rowSpan" : 7 }, { "text" : "1.肝素", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.香豆素类抗凝血药", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）药物相互作用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.抗血小板药", "alignment" : "left" }, { "text" : "（1）阿司匹林的作用、作用机制及临床应用<br>（2）双嘧达莫的作用机制和临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "4.纤维蛋白溶解药", "alignment" : "left" }, { "text" : "链激酶的作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "S.促凝血药", "alignment" : "left" }, { "text" : "维生素K的临床应用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "6.抗贫血药", "alignment" : "left" }, { "text" : "（1）铁剂的临床应用<br>（2）叶酸的药理作用和临床应用<br>（3）维生素B<sub>12</sub>的药理作用和临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "7.血容量扩充剂", "alignment" : "left" }, { "text" : "右旋糖酐的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、组胺受体阻断药", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.H<sub>1</sub>受体阻断药", "alignment" : "left" }, { "text" : "（1）氯苯那敏的药理作用、临床应用及不良反应<br>（2）氯雷他定的药理作用、临床应用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.H<sub>2</sub>受体阻断药", "alignment" : "left" }, { "text" : "雷尼替丁的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、作用于呼吸系统的药物", "alignment" : "left", "rowSpan" : 3 }, { "text" : "1.抗炎平喘药", "alignment" : "left" }, { "text" : "糖皮质激素的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.支气管扩张药", "alignment" : "left" }, { "text" : "（1）沙丁胺醇、特布他林的药理作用和临床应用<br>（2）氨茶碱的药理作用、作用机制及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.抗过敏平喘药", "alignment" : "left" }, { "text" : "色甘酸钠的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、作用于消化系统的药物", "alignment" : "left" }, { "text" : "抗消化性溃疡药", "alignment" : "left" }, { "text" : "（1）奥美拉唑的药理作用、临床应用及不良反应<br>（2）雷尼替丁的药理作用及临床应用　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、作用于血液及造血器官的药物", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "药物名称", "alignment" : "left" }, { "text" : "药理作用", "alignment" : "left" }, { "text" : "临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "阿司匹林", "alignment" : "left" }, { "text" : "非甾体类抗炎药阿司匹林为环氧酶抑制药，可抑制血小板聚集", "alignment" : "left" }, { "text" : "阿司匹林的临床应用：1. 预防应用：小剂量可预防慢性稳定性心绞痛，心肌梗死的一级和二级预防，脑梗死、脑卒中、或短暂性脑缺血发作后脑梗死的二级预防，预防瓣膜修复术或冠脉搭桥术后的血栓形成。2. 治疗：冠脉硬化性心脏病如心绞痛、心肌梗死和缺血性脑血管病", "alignment" : "left" }] }, { "content" : [{ "text" : "维生素K", "alignment" : "left" }, { "text" : "促凝血药，维生素K是γ-羧化酶的辅酶，主要作用是参与肝合成凝血因子II、VII、IX、X、抗凝血蛋白C和抗凝血蛋白S等的活化过程", "alignment" : "left" }, { "text" : "维生素K的临床运用：主要用于梗阻性黄疸、胆瘘、慢性腹泻、早产儿、新生儿出血等患者及香豆素类、水杨酸类药物或其他原因导致凝血酶原过低引起的出血者；亦可用于预防长期应用广谱抗菌素继发的维生素K缺乏症", "alignment" : "left" }] }, { "content" : [{ "text" : "华法林（香豆素类）", "alignment" : "left" }, { "text" : "拮抗维生素K", "alignment" : "left" }, { "text" : "血栓栓塞疾病（房颤、心瓣膜病所致），体外抗凝无效", "alignment" : "left" }] }, { "content" : [{ "text" : "肝素", "alignment" : "left" }, { "text" : "抗凝（促进抗凝血酶Ⅲ活化），降血脂，抗炎", "alignment" : "left" }, { "text" : "抗血栓<br>体内外抗凝都有效", "alignment" : "both" }] }] }] }, { "type" : "h1", "text" : "二、作用于呼吸系统的药物", "content" : [{ "type" : "common", "alignment" : "left", "text" : "呼吸系统常见药物分类：1. 抗炎平喘药（糖皮质激素）；2. 支气管扩张药（β受体激动剂、氨茶碱）；3. 抗过敏平喘药（色甘酸二钠）。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "常用β受体激动剂分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "非选择性激动剂", "alignment" : "left", "colSpan" : 2 }, { "text" : "异丙肾上腺素", "alignment" : "left" }] }, { "content" : [{ "text" : "选择性激动剂（β<sub>2</sub>受体）", "alignment" : "left", "rowSpan" : 5 }, { "text" : "短效激动剂", "alignment" : "left", "rowSpan" : 2 }, { "text" : "沙丁胺醇", "alignment" : "left" }] }, { "content" : [{ "text" : "特布他林", "alignment" : "left" }] }, { "content" : [{ "text" : "长效激动剂", "alignment" : "left", "rowSpan" : 3 }, { "text" : "克仑特罗", "alignment" : "left" }] }, { "content" : [{ "text" : "福莫特罗", "alignment" : "left" }] }, { "content" : [{ "text" : "班布特罗", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "哮喘急性发作首选β2受体激动剂（吸入）；治疗哮喘最有效的药物是激素（吸入，静脉使用—严重哮喘发作或持续状态）；预防哮喘发作首选色甘酸钠。" }] }] }] }] }, { "type" : "h1", "text" : "三、作用于消化系统的药物", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 抑制胃酸分泌用药：", "content" : [{ "type" : "common", "alignment" : "left", "text" : "常见H2受体阻断药：西咪替丁、雷尼替丁、法莫替丁、尼扎替丁。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "常见质子泵抑制药：奥美拉唑（抑酸作用最强）、兰索拉唑、泮多拉唑、雷贝拉唑。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "M胆碱受体阻断药：阿托品、溴化丙胺太林、哌仑西平等。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "胃泌素受体阻断药：丙谷胺。" }] }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 胃黏膜保护药：增强胃黏膜屏障功能的药物称为胃黏膜保护药，胃黏膜屏障包括细胞屏障和黏液-碳酸氢盐屏障。常见胃黏膜保护药：米索前列醇、恩前列素、硫糖铝、胶体次枸橼酸铋、替普瑞酮、麦滋林等。" }] }] }, { "title" : "第六章", "text" : "激素及降糖药", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、肾上腺皮质激素类药物", "alignment" : "left" }, { "text" : "糖皮质激素类药", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用<br>（3）不良反应<br>（4）代表药物　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、甲状腺激素及抗甲状腺药物", "alignment" : "left" }, { "text" : "抗甲状腺药", "alignment" : "left" }, { "text" : "（1）硫脲类的药理作用、临床应用及不良反应<br>（2）碘及碘化物药理作用、临床应用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、胰岛素及口服降血糖药", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.胰岛素", "alignment" : "left" }, { "text" : "胰岛素的药理作用、作用机制及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.口服降血糖药", "alignment" : "left" }, { "text" : "（1）胰岛素增敏剂罗格列酮的药理作用及临床应用<br>（2）磺酰脲类的药理作用及临床应用<br>（3）双胍类的药理作用及临床应用<br>（4）α葡萄糖苷酶抑制剂阿卡波糖的药理作用及临床应用　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、糖皮质激素", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "“五抗”", "alignment" : "left" }, { "text" : "抗炎、抗毒、抗免疫、抗休克、抗血液系统疾病", "alignment" : "left" }] }, { "content" : [{ "text" : "四大代谢", "alignment" : "left" }, { "text" : "升高血糖；负氮平衡；向心性肥胖；潴钠排钾", "alignment" : "left" }] }, { "content" : [{ "text" : "三大系统", "alignment" : "left" }, { "text" : "提高中枢神经系统兴奋性；应激性溃疡；增强血管对其他活性物质反应", "alignment" : "left" }] }, { "content" : [{ "text" : "两类组织", "alignment" : "left" }, { "text" : "骨质疏松；肌肉萎缩", "alignment" : "left" }] }, { "content" : [{ "text" : "五诱发", "alignment" : "left" }, { "text" : "诱发加重感染，诱发溃疡、糖尿病、精神病、高血压", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "二、降糖药", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 胰岛素药理作用：1）促进脂肪合成，抑制脂肪分解，减少游离脂肪酸及酮体生成，增加葡萄糖及脂肪酸的转运，使其利用率增加；2）促进糖原合成和储存，加速葡萄糖氧化和酵解，抑制糖原分解和异生；3）增加氨基酸的转运和核酸、蛋白质的合成，抑制蛋白质的分解；4）加快心率，加强心肌收缩力和减少肾血流量；5）促进钾离子进入细胞内。" }, { "type" : "h2", "alignment" : "left", "text" : "2. 各降糖药降糖机理比较", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "降糖药", "alignment" : "left" }, { "text" : "降糖机理", "alignment" : "left" }, { "text" : "临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "胰岛素", "alignment" : "left" }, { "text" : "增加葡萄糖去路，减少其来源；<br>胰岛素可通过激活Na<sup>+</sup> -K<sup>+</sup> -ATP 酶，使钾离子及葡萄糖进入细胞内，从而降低血糖", "alignment" : "both" }, { "text" : "1型糖尿病等", "alignment" : "left" }] }, { "content" : [{ "text" : "罗格列酮", "alignment" : "left" }, { "text" : "胰岛素增敏剂，改善靶器官胰岛素抵抗", "alignment" : "left" }, { "text" : "2型糖尿病伴胰岛素抵抗首选", "alignment" : "left" }] }, { "content" : [{ "text" : "磺酰脲类", "alignment" : "left" }, { "text" : "促进残存胰岛B细胞分泌胰岛素", "alignment" : "left" }, { "text" : "2型糖尿病非肥胖者首选", "alignment" : "left" }] }, { "content" : [{ "text" : "双胍类", "alignment" : "left" }, { "text" : "促进脂肪组织摄取葡萄糖，降低葡萄糖在肠的吸收及糖异生，抑制胰高血糖素释放，对正常人血糖无明显影响", "alignment" : "left" }, { "text" : "2型糖尿病肥胖者首选", "alignment" : "left" }] }, { "content" : [{ "text" : "阿卡波糖", "alignment" : "left" }, { "text" : "α葡萄糖苷酶抑制剂可在小肠上皮刷状缘与碳水化合物竞争水解碳水化合物的糖苷水解酶，从而减慢碳水化合物水解及产生葡萄糖的速度并延缓葡萄糖的吸收", "alignment" : "left" }, { "text" : "2型糖尿病餐后血糖高的首选", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "三、抗甲状腺药", "content" : [{ "type" : "common", "alignment" : "left", "text" : "硫脲类药理作用：抑制外周组织的T4转化为T3——重症甲亢、甲状腺危象首选。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "临床应用：（1）甲亢；（2）甲状腺术前准备；（3）甲状腺危象——大剂量碘剂（抑制甲状腺激素释放），并立即应用硫脲类（阻止甲状腺素合成）。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "不良反应：（1）过敏反应——最常见。（2）粒细胞缺乏症——最严重。" }] }] }] }] }, { "title" : "第七章", "text" : "抗微生物药", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、β-内酰胺类抗生素", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.青霉素类", "alignment" : "left" }, { "text" : "（1）青霉素G的抗菌作用、临床应用及不良反应<br>（2）氨苄西林、阿莫西林的抗菌作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.头孢菌素类", "alignment" : "left" }, { "text" : "（1）各代产品的特点及常用药物<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、大环内酯类及林可霉素类抗生素", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.红霉素", "alignment" : "left" }, { "text" : "（1）抗菌作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.林可霉素类", "alignment" : "left" }, { "text" : "林可霉素、克林霉素的抗菌作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、氨基苷类抗生素", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.氨基苷类抗生素的共性", "alignment" : "left" }, { "text" : "（1）抗菌作用及作用机制<br>（2）不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.常用氨基苷类", "alignment" : "left" }, { "text" : "庆大霉素、妥布霉素、阿米卡星的临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、四环素类及氯霉素", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.四环素类", "alignment" : "left" }, { "text" : "（1）四环素、多西环素、米诺环素的抗菌作用及临床应用<br>（2）不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.氯霉素", "alignment" : "left" }, { "text" : "（1）抗菌作用及临床应用<br>（2）不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、人工合成的抗菌药", "alignment" : "left", "rowSpan" : 3 }, { "text" : "1.喹诺酮类", "alignment" : "left" }, { "text" : "第三代喹诺酮类药物的抗菌作用、作用机制、临床应用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.磺胺类", "alignment" : "left" }, { "text" : "抗菌作用、作用机制及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.其他类", "alignment" : "left" }, { "text" : "（1）甲氧苄啶的抗菌作用、作用机制及临床应用<br>（2）甲硝唑的抗菌作用、作用机制及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "六、抗真菌药和抗病毒药", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.抗真菌药", "alignment" : "left" }, { "text" : "氟康唑的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.抗病毒药", "alignment" : "left" }, { "text" : "利巴韦林的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "七、抗结核病药", "alignment" : "left", "rowSpan" : 5 }, { "text" : "1.异烟肼", "alignment" : "left" }, { "text" : "（1）临床应用<br>（2）不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.利福平", "alignment" : "left" }, { "text" : "（1）临床应用<br>（2）不良反应及药物相互作用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.乙胺丁醇", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "4.吡嗪酰胺", "alignment" : "left" }, { "text" : "（1）药理作用<br>（2）临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.主要用于病因性预防的抗疟药", "alignment" : "left" }, { "text" : "乙胺嘧啶的药理作用及临床应用　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、头孢菌素类抗生素的特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "第一代头孢", "alignment" : "left" }, { "text" : "第二代头孢", "alignment" : "left" }, { "text" : "第三代头孢", "alignment" : "left" }, { "text" : "第四代头孢", "alignment" : "left" }] }, { "content" : [{ "text" : "杀菌特点", "alignment" : "left" }, { "text" : "对G<sup>+</sup>菌作用较2. 3代强，对G<sup>-</sup>作用弱", "alignment" : "left" }, { "text" : "对G<sup>+</sup>作用弱于第1代，对G<sup>-</sup>菌敏感，对厌氧菌有效，对铜绿假单胞菌无效", "alignment" : "left" }, { "text" : "对G<sup>+</sup>作用不及第1. 2代，对G-有较强作用，对铜绿假单胞菌、厌氧菌作用较强", "alignment" : "left" }, { "text" : "对G<sup>+</sup>、G<sup>-</sup>均有高效", "alignment" : "left" }] }, { "content" : [{ "text" : "β内酰胺酶对其作用", "alignment" : "left" }, { "text" : "易被酶破坏", "alignment" : "left" }, { "text" : "比较稳定", "alignment" : "left" }, { "text" : "较稳定，不易被酶破坏", "alignment" : "left" }, { "text" : "高度稳定", "alignment" : "left" }] }, { "content" : [{ "text" : "主要临床应用", "alignment" : "left" }, { "text" : "敏感菌所致呼吸道、尿路感染，皮肤和软组织感染", "alignment" : "left" }, { "text" : "敏感菌所致肺炎、胆道感染、菌血症、尿路感染", "alignment" : "left" }, { "text" : "危及生命的败血症、脑膜炎、肺炎、骨髓炎、尿路感染、铜绿假单胞菌感染", "alignment" : "left" }, { "text" : "对第三代头孢耐药的菌株", "alignment" : "left" }] }, { "content" : [{ "text" : "肾毒性", "alignment" : "left" }, { "text" : "部分品种大剂量使用有肾毒性", "alignment" : "left" }, { "text" : "较第一代头孢轻", "alignment" : "left" }, { "text" : "基本无肾毒性", "alignment" : "left" }, { "text" : "几无肾毒性", "alignment" : "left" }] }, { "content" : [{ "text" : "代表药物", "alignment" : "left" }, { "text" : "头孢噻吩、头孢唑林钠", "alignment" : "left" }, { "text" : "头孢呋辛、头孢孟多", "alignment" : "left" }, { "text" : "头孢噻肟、头孢哌酮", "alignment" : "left" }, { "text" : "头孢匹罗、头孢吡肟", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "二、各类抗微生物药", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "抗生素", "alignment" : "left" }, { "text" : "抗菌作用", "alignment" : "left" }, { "text" : "临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "青霉素", "alignment" : "left" }, { "text" : "主要作用于G<sup>+</sup>菌、G<sup>-</sup>球菌、嗜血杆菌属以及各种致病螺旋体等", "alignment" : "left" }, { "text" : "为治疗A组和B组溶血性链球菌感染、敏感葡萄球菌感染、气性坏疽、梅毒、鼠咬热等的首选药；<br>青霉素也是治疗草绿色链球菌心内膜炎的首选药；<br>作为预防放线菌病、钩端螺旋体病、梅毒、回归热等及感染性心内膜炎发生的首选药", "alignment" : "both" }] }, { "content" : [{ "text" : "红霉素", "alignment" : "left" }, { "text" : "对G<sup>+</sup>菌有强大抗菌作用<br>对G<sup>-</sup>菌中脑膜炎、淋病、流感杆菌、百日咳、布鲁斯菌、军团菌也敏感", "alignment" : "both" }, { "text" : "耐青霉素的金葡菌和对青霉素过敏者；<br>厌氧菌引起的口腔感染和肺炎支原体、肺炎衣原体、溶脲脲原体感染等", "alignment" : "both" }] }, { "content" : [{ "text" : "氨基糖苷类", "alignment" : "left" }, { "text" : "需氧G<sup>-</sup>如大肠杆菌、克雷伯菌属、肠杆菌属、变形杆菌属等；<br>作用机制为抑制细菌蛋白质合成，破坏细菌胞浆膜完整性", "alignment" : "both" }, { "text" : "耳毒性和肾毒性；<br>庆大霉素：氨基糖类首选药<br>妥布霉素：对铜绿假单胞菌作用最强<br>阿米卡星：抗菌谱为本类药物中最宽的，对钝化酶稳定，故对氨基糖苷类耐药菌首选", "alignment" : "both" }] }, { "content" : [{ "text" : "四环素类", "alignment" : "left" }, { "text" : "对G<sup>+</sup>菌抑制作用强于G<sup>-</sup>，但对G<sup>+</sup>作用不如青霉素和头孢菌素，对G<sup>-</sup>菌作用不如氨基糖苷类", "alignment" : "left" }, { "text" : "首选——立克次体、支原体、衣原体以及某些螺旋体，多西环素是四环素类中的首选药物；<br>不良反应主要有二重感染和“四环素牙", "alignment" : "both" }] }, { "content" : [{ "text" : "喹诺酮类", "alignment" : "left" }, { "text" : "通过抑制DNA螺旋酶作用，阻碍DNA合成而导致细菌死亡<br>", "alignment" : "left" }, { "text" : "抗菌谱广，尤其对G<sup>-</sup>杆菌包括绿脓杆菌在内有强大杀菌作用；<br>18岁以下孩子慎用此类药物", "alignment" : "both" }] }, { "content" : [{ "text" : "磺胺类", "alignment" : "left" }, { "text" : "抑制细菌二氢叶酸合成酶，阻碍细菌二氢叶酸的合成，从而影响核酸的生成，抑制细菌生长繁殖", "alignment" : "left" }, { "text" : "对大多数G<sup>+</sup>菌和G<sup>-</sup>菌均有抗菌活性，最敏感的是A群链球菌、肺炎链球菌、脑膜炎奈瑟菌、淋病奈瑟菌等", "alignment" : "left" }] }, { "content" : [{ "text" : "甲硝唑", "alignment" : "left" }, { "text" : "为一种人工合成抗菌药，其分子中的硝基在细胞内无氧环境中被还原成氨基，从而抑制病原体DNA的合成", "alignment" : "left" }, { "text" : "抗厌氧菌作用，对脆弱类杆菌尤为敏感；<br>对滴虫、阿米巴滋养体以及破伤风梭菌具有很强的杀灭作用；<br>对需氧菌或兼性厌氧菌无效", "alignment" : "both" }] }, { "content" : [{ "text" : "抗真菌药——氟康唑", "alignment" : "left" }, { "text" : "具有广谱抗真菌包括隐球菌、念珠菌和球孢子菌", "alignment" : "left" }, { "text" : "是治疗艾滋病患者隐球菌性脑膜炎的首选药", "alignment" : "left" }] }, { "content" : [{ "text" : "抗病毒药——利巴韦林", "alignment" : "left" }, { "text" : "具有广谱抗病毒活性，抑制多种RNA、DNA病毒的复制", "alignment" : "left" }, { "text" : "抗RNA病毒作用较强，治疗呼吸道合胞病毒肺炎和支气管肺炎效果最佳", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "三、抗结核药", "content" : [{ "type" : "common", "alignment" : "left", "text" : "一线抗结核病药有：异烟肼、利福平、乙胺丁醇、链霉素、吡嗪酰胺等。二线抗结核病药：对氨基水杨酸、氨硫脲、卡那霉素、阿米卡星、乙硫异烟胺、卷曲霉素、环丝氨酸等。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "三种抗结核药的比较", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "异烟肼", "alignment" : "left" }, { "text" : "利福平", "alignment" : "left" }, { "text" : "乙胺丁醇", "alignment" : "left" }] }, { "content" : [{ "text" : "对结核杆菌作用", "alignment" : "left" }, { "text" : "静止期菌抑制；繁殖期菌杀灭；<br>抑制DNA合成", "alignment" : "both" }, { "text" : "低浓度抑菌；高浓度杀菌抑制mRNA的合成", "alignment" : "left" }, { "text" : "细胞内外结核杆菌抑制作用抑制菌体蛋白质的合成", "alignment" : "left" }] }, { "content" : [{ "text" : "对其他细菌作用", "alignment" : "left" }, { "text" : "无作用", "alignment" : "left" }, { "text" : "广谱抗菌，对多种G<sup>-</sup>和G<sup>+</sup>球菌有强大抗菌作用", "alignment" : "left" }, { "text" : "无作用", "alignment" : "left" }] }, { "content" : [{ "text" : "不良反应", "alignment" : "left" }, { "text" : "神经系统（周围神经炎）；肝损害", "alignment" : "left" }, { "text" : "胃肠道反应；肝损害", "alignment" : "left" }, { "text" : "球后视神经炎", "alignment" : "left" }] }] }] }] }] }] }, { "title" : "第八章", "text" : "抗疟药与抗恶性肿瘤药", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、抗疟药", "alignment" : "left", "rowSpan" : 3 }, { "text" : "1.主要用于控制症状的抗疟药", "alignment" : "left" }, { "text" : "氯喹、青蒿素的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.主要用于控制远期复发和传播的抗疟药", "alignment" : "left" }, { "text" : "伯氨喹的药理作用、临床应用及不良反应　", "alignment" : "left" }] }, { "content" : [{ "text" : "3.主要用于病因性预防的抗疟药", "alignment" : "left" }, { "text" : "乙胺嘧啶的药理作用及临床应用　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、抗恶性肿瘤药", "alignment" : "left", "rowSpan" : 2 }, { "text" : "1.抗肿瘤药的分类", "alignment" : "left" }, { "text" : "（1）干扰核酸合成<br>（2）破坏DNA结构与功能<br>（3）嵌入DNA及干扰转录RNA<br>（4）干扰蛋白质合成　", "alignment" : "left" }] }, { "content" : [{ "text" : "2.常用药物", "alignment" : "left" }, { "text" : "甲氨蝶呤、巯嘌呤、羟基脲、环磷酰胺、氟尿嘧啶、阿霉素的临床应用　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、抗疟原虫药物及其作用特点：氯喹、青蒿素为控制疟疾症状的药物，可迅速有效的控制疟疾的临床发作。伯氨喹可控制疟疾的复发和传播，是防治疟疾远期复发的主要药物。乙胺嘧啶为病因性预防的药物，可阻断传播。" }, { "type" : "h1", "text" : "二、抗肿瘤药物分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "细胞毒类抗肿瘤药", "alignment" : "left", "rowSpan" : 13 }, { "text" : "影响核酸生物合成的药物（抗代谢药）", "alignment" : "left", "rowSpan" : 5 }, { "text" : "二氢叶酸还原酶抑制剂如甲氨蝶呤", "alignment" : "left" }] }, { "content" : [{ "text" : "胸苷酸合成酶抑制剂如氟尿嘧啶", "alignment" : "left" }] }, { "content" : [{ "text" : "嘌呤核苷酸互变抑制剂如巯嘌呤", "alignment" : "left" }] }, { "content" : [{ "text" : "核苷酸还原酶抑制剂如羟基脲", "alignment" : "left" }] }, { "content" : [{ "text" : "DNA多聚酶抑制剂如阿糖胞苷等", "alignment" : "left" }] }, { "content" : [{ "text" : "影响DNA结构与功能的药物", "alignment" : "left", "rowSpan" : 4 }, { "text" : "DNA交联剂如氮芥、环磷酰胺、噻替派等", "alignment" : "left" }] }, { "content" : [{ "text" : "破坏DNA的铂类配合物如顺铂", "alignment" : "left" }] }, { "content" : [{ "text" : "破坏DNA的抗生素如丝裂霉素和博来霉素", "alignment" : "left" }] }, { "content" : [{ "text" : "拓扑异构酶抑制剂如喜树碱类", "alignment" : "left" }] }, { "content" : [{ "text" : "干扰转录过程和阻止RNA合成的药物", "alignment" : "left" }, { "text" : "多柔比星等蒽环抗生素和放线菌素D", "alignment" : "left" }] }, { "content" : [{ "text" : "抑制蛋白质合成与功能的药物", "alignment" : "left", "rowSpan" : 3 }, { "text" : "微管蛋白活性抑制剂如长春碱类和紫杉醇类；", "alignment" : "left" }] }, { "content" : [{ "text" : "干扰核蛋白体功能的药物如三尖杉生物碱类；", "alignment" : "left" }] }, { "content" : [{ "text" : "影响氨基酸供应的药物如L-门冬酰胺酶", "alignment" : "left" }] }, { "content" : [{ "text" : "非细胞毒类抗肿瘤药", "alignment" : "left", "rowSpan" : 3 }, { "text" : "调节体内激素平衡药物", "alignment" : "left" }, { "text" : "雌激素、雄激素、甲羟孕酮酯等", "alignment" : "left" }] }, { "content" : [{ "text" : "分子靶向药物", "alignment" : "left", "rowSpan" : 2 }, { "text" : "单克隆抗体类如利妥昔单抗", "alignment" : "left" }] }, { "content" : [{ "text" : "小分子化合物类如伊马替尼", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "三、常用抗肿瘤药物的临床应用", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "常用药物", "alignment" : "left" }, { "text" : "临床应用", "alignment" : "left" }] }, { "content" : [{ "text" : "甲氨蝶呤", "alignment" : "left" }, { "text" : "儿童急性白血病、绒毛膜上皮癌、鞘内注射治疗中枢神经系统白血病", "alignment" : "left" }] }, { "content" : [{ "text" : "氟尿嘧啶", "alignment" : "left" }, { "text" : "消化系统癌、乳腺癌疗效好", "alignment" : "left" }] }, { "content" : [{ "text" : "巯嘌呤", "alignment" : "left" }, { "text" : "急性淋巴细胞白血病的维持治疗、绒癌", "alignment" : "left" }] }, { "content" : [{ "text" : "羟基脲", "alignment" : "left" }, { "text" : "慢性粒细胞性白血病有显著疗效", "alignment" : "left" }] }, { "content" : [{ "text" : "环磷酰胺", "alignment" : "left" }, { "text" : "对恶性淋巴瘤疗效显著", "alignment" : "left" }] }, { "content" : [{ "text" : "阿霉素", "alignment" : "left" }, { "text" : "急性白血病、淋巴瘤、乳腺癌、肺癌等", "alignment" : "left" }] }] }] }] }] }, { "text" : "第五篇  医学免疫学", "guide" : [{ "text" : "执业医师考试——本篇约占临床执业医师考试的1.3%，出题量约为8题。其中超敏反应、免疫球蛋白、免疫缺陷病为考试重点，往年的出题量较多，复习时只需掌握往年考过的知识点，理解透真题，无需花过多时间。" }], "content" : [{ "title" : "第一章", "text" : "抗原", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、基本概念", "alignment" : "left" }, { "text" : "（1）抗原及其特性<br>（2）抗原表位<br>（3）T细胞抗原表位和B细胞抗原表位<br>（4）共同抗原<br>（5）交叉反应<br>（6）耐受原与变应原　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、抗原的分类", "alignment" : "left" }, { "text" : "（1）完全抗原和半抗原<br>（2）胸腺依赖性抗原（TD-Ag）和胸腺非依赖性抗原（TI-Ag）<br>（3）异嗜性抗原、异种抗原、同种异型抗原、自身抗原和独特<br>型抗原　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、超抗原", "alignment" : "left" }, { "text" : "（1）概念<br>（2）种类<br>（3）与普通抗原的区别<br>（4）与临床疾病的关系", "alignment" : "left" }] }, { "content" : [{ "text" : "四、佐剂", "alignment" : "left" }, { "text" : "（1）概念<br>（2）种类<br>（3）作用机制", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、基本概念", "content" : [{ "type" : "common", "alignment" : "left", "text" : "抗原（Ag）是指能与T细胞、B淋巴细胞的TCR或BCR结合，促使其增值、分化，产生抗体或致敏淋巴细胞，并与之结合，进而发挥免疫效应的物质。抗原有两个重要特性：免疫原性，即抗原刺激机体产生免疫应答，诱导产生抗体或致敏淋巴细胞的能力；免疫反应性（抗原性），即抗原与其所诱导产生的抗体或致敏淋巴细胞特异性结合的能力。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "抗原分子中决定抗原特异性的特殊化学基团，称为抗原表位又称抗原决定基（簇），抗原特异性取决于抗原表位。" }] }] }, { "type" : "h1", "text" : "二、抗原的分类", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "完全抗原", "alignment" : "left" }, { "text" : "指既有免疫原性又有抗原性的抗原", "alignment" : "left" }] }, { "content" : [{ "text" : "半抗原", "alignment" : "left" }, { "text" : "指只有抗原性，无免疫原性的简单小分子抗原，与蛋白质载体偶联后形成半抗原-载体复合物，可获得免疫原性", "alignment" : "left" }] }, { "content" : [{ "text" : "TD-Ag（胸腺依赖性抗原）", "alignment" : "left" }, { "text" : "指需要T细胞辅助才能激活B细胞产生抗体的抗原", "alignment" : "left" }] }, { "content" : [{ "text" : "TI-Ag（胸腺非依赖性抗原）", "alignment" : "left" }, { "text" : "指无需T细胞辅助，就能直接激活B细胞产生抗体的抗原", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "三、佐剂", "content" : [{ "type" : "common", "alignment" : "left", "text" : "佐剂为预先或与抗原同时注入体内，可增强机体对该抗原的免疫应答或改变免疫应答类型的非特异性免疫增强型物质。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "佐剂的作用机制及功能：1. 改变抗原物理性状，延缓抗原降解和排除，延长抗原在体内滞留时间；2. 刺激单核-巨噬细胞系统，增强其对抗原的处理和提呈能力；3. 刺激淋巴细胞的增殖和分化，从而增强免疫应答能力。" }] }] }] }, { "title" : "第二章", "text" : "免疫器官", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、中枢免疫器官", "alignment" : "left" }, { "text" : "（1）概念<br>（2）组成<br>（3）主要功能　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、外周免疫器官", "alignment" : "left" }, { "text" : "（1）概念<br>（2）组成<br>（3）主要功能　", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "免疫器官的分类及主要作用", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "中枢免疫器官", "alignment" : "left" }, { "text" : "外周免疫器官", "alignment" : "left" }] }, { "content" : [{ "text" : "别名", "alignment" : "left" }, { "text" : "初级淋巴器官", "alignment" : "left" }, { "text" : "次级淋巴器官", "alignment" : "left" }] }, { "content" : [{ "text" : "组成", "alignment" : "left" }, { "text" : "人类的骨髓和胸腺、禽类特有法氏囊", "alignment" : "left" }, { "text" : "淋巴结、脾脏、黏膜相关淋巴组织", "alignment" : "left" }] }, { "content" : [{ "text" : "功能", "alignment" : "left" }, { "text" : "免疫细胞发生、分化、发育和成熟场所", "alignment" : "left" }, { "text" : "成熟淋巴细胞定居场所、启动初级免疫应答的主要部位", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "黏膜相关淋巴组织是指在肠道、呼吸道及泌尿生殖道黏膜构成的一道免疫屏障，在黏膜局部抗感染免疫防御中发挥关键作用。" }] }] }] }] }, { "title" : "第三章", "text" : "免疫细胞", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、T淋巴细胞", "alignment" : "left" }, { "text" : "（1）T淋巴细胞的表面标志<br>（2）TCR复合物的组成<br>（3）T淋巴细胞亚群及其功能 <br>（4）调节性T细胞　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、B淋巴细胞", "alignment" : "left" }, { "text" : "（1）B淋巴细胞的表面标志<br>（2）BCR复合物的组成 <br>（3）B淋巴细胞亚群及其功能", "alignment" : "left" }] }, { "content" : [{ "text" : "三、自然杀伤（NK）细胞", "alignment" : "left" }, { "text" : "（1）NK细胞的表面标志<br>（2）NK细胞的受体 <br>（3）NK细胞的功能", "alignment" : "left" }] }, { "content" : [{ "text" : "四、抗原提呈细胞", "alignment" : "left" }, { "text" : "（1）抗原提呈细胞的概念<br>（2）抗原提呈细胞的种类<br>（3）外源性抗原递呈过程<br>（4）内源性抗原递呈过程<br>（5）抗原的交叉提呈", "alignment" : "left" }] }, { "content" : [{ "text" : "五、其他免疫细胞", "alignment" : "left" }, { "text" : "（1）单核巨噬细胞<br>（2）中性粒细胞<br>（3）嗜酸粒细胞 <br>（4）嗜碱粒细胞<br>（5）肥大细胞", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "免疫细胞泛指所有参加免疫应答和与免疫应答有关的细胞及其前体细胞，包括造血干细胞、淋巴细胞、单核-巨噬细胞、粒细胞和红细胞等。免疫活性细胞则特指T细胞和B细胞。" }] }, { "type" : "h1", "text" : "一、T淋巴细胞", "content" : [{ "type" : "common", "alignment" : "left", "text" : "简称T细胞，来源于骨髓中的淋巴样干细胞，在胸腺中发育为成熟T细胞，故称胸腺依赖性淋巴细胞。" }] }, { "type" : "h1", "text" : "二、B淋巴细胞", "content" : [{ "type" : "common", "alignment" : "left", "text" : "简称B细胞，由哺乳动物骨髓或禽类法氏囊中的淋巴样干细胞分化发育而来，主要定居于外周淋巴器官的淋巴小结内。B细胞不仅能产生抗体发挥体液免疫功能，也是重要的抗原提呈细胞。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "骨髓为B细胞分化、成熟的场所。胸腺为T细胞分化、成熟场所。淋巴结、脾均属于外周免疫器官，为成熟T、B细胞主要定居场所。", "content" : [{ "type" : "common", "alignment" : "center", "text" : "B细胞和T细胞表面标志", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "B细胞的表面标志", "alignment" : "left" }, { "text" : "BCR、mIg、Igα/Igβ、B细胞共受体、CD40、CD80、CD86. CD20、CD22. CD32等。", "alignment" : "left" }] }, { "content" : [{ "text" : "T细胞的表面标志", "alignment" : "left" }, { "text" : "TCR、CD3. CD4. CD8. 协同刺激分子和丝裂原结合分子等", "alignment" : "left" }] }] }] }] }] }] }, { "type" : "h1", "text" : "三、各类免疫细胞的特点及功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "免疫细胞", "alignment" : "left" }, { "text" : "特有表面标志", "alignment" : "left" }, { "text" : "功能", "alignment" : "left" }] }, { "content" : [{ "text" : "T淋巴细胞", "alignment" : "left" }, { "text" : "CD3为特有的表面标志", "alignment" : "left" }, { "text" : "Th1：分泌IL-2. IFNγ；促进CTL杀伤肿瘤和病毒感染细胞的功能，促进NK细胞的杀伤功能，增强吞噬细胞介导的抗感染免疫；促进IgG的生成，从而促进调理吞噬作用；是迟发型超敏反应中的效应T细胞<br>Th2：促进B细胞增殖分化及抗体形成，介导体液免疫应答；分泌IL-4<br>Th17：参与固有免疫及一些炎症反应<br>细胞毒性T细胞（CTL）：特异性直接杀伤靶细胞；通过Fas/FasL途径诱导靶细胞凋亡", "alignment" : "both" }] }, { "content" : [{ "text" : "B淋巴细胞", "alignment" : "left" }, { "text" : "CD20：人B细胞特有的表面标志，主要是调节B细胞发育<br>BCR：B细胞特征性表面变标志，特异性抗原受体，也是最重要的表面标志，主要是调节B细胞增殖活化", "alignment" : "both" }, { "text" : "B细胞受抗原刺激后增殖分化为浆细胞，从而浆细胞分泌抗体", "alignment" : "left" }] }, { "content" : [{ "text" : "自然杀伤（NK）细胞", "alignment" : "left" }, { "text" : "无特异性抗原受体", "alignment" : "left" }, { "text" : "非特异性直接杀伤肿瘤和病毒感染细胞的固有免疫淋巴细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "抗原提呈细胞（APC）", "alignment" : "left" }, { "text" : "专职APC：单核-巨噬细胞、树突状细胞、B细胞<br>非专职APC：内皮细胞、成纤维细胞、上皮及间皮细胞", "alignment" : "both" }, { "text" : "加工处理抗原，并将抗原信息提呈给淋巴细胞", "alignment" : "left" }] }] }] }] }, { "title" : "第四章", "text" : "免疫球蛋白", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、基本概念", "alignment" : "left" }, { "text" : "（1）免疫球蛋白（Ig）<br>（2）抗体（Ab）", "alignment" : "left" }] }, { "content" : [{ "text" : "二、免疫球蛋白的结构", "alignment" : "left" }, { "text" : "（1）免疫球蛋白的基本结构<br>（2）免疫球蛋白的功能区<br>（3）免疫球蛋白的其他成分", "alignment" : "left" }] }, { "content" : [{ "text" : "三、免疫球蛋白的类型", "alignment" : "left" }, { "text" : "（1）免疫球蛋白的类及亚类<br>（2）免疫球蛋白的型及亚型", "alignment" : "left" }] }, { "content" : [{ "text" : "四、免疫球蛋白的功能", "alignment" : "left" }, { "text" : "（1）免疫球蛋白V区的功能<br>（2）免疫球蛋白C区的功能", "alignment" : "left" }] }, { "content" : [{ "text" : "五、各类免疫球蛋白的特性和功能", "alignment" : "left" }, { "text" : "（1）IgG的特性和功能<br>（2）IgM的特性和功能<br>（3）IgA的特性和功能<br>（4）IgE的特性和功能<br>（5）IgD的特性和功能", "alignment" : "left" }] }, { "content" : [{ "text" : "六、抗体的制备", "alignment" : "left" }, { "text" : "（1）多克隆抗体<br>（2）单克隆抗体<br>（3）人源化抗体", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、基本概念", "content" : [{ "type" : "common", "alignment" : "left", "text" : "免疫球蛋白是指具有抗体活性并具有抗体化学结构的球蛋白。免疫球蛋白可分为分泌型（sIg）和膜型（mIg），前者主要存在于血液及组织液中，后者构成B细胞膜上的抗原受体（BCR）。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "免疫球蛋白和抗体两者区别联系：抗体是免疫球蛋白，但免疫球蛋白不都是抗体，免疫球蛋白涵盖的范围大。" }] }] }, { "type" : "h1", "text" : "二、各类免疫球蛋白特性和功能", "content" : [{ "type" : "common", "alignment" : "left", "text" : "根据Ig重链恒定区（C区）所含抗原表位不同，可据此将重链分为5种，对应5类Ig。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "占血清抗体比", "alignment" : "left" }, { "text" : "特点", "alignment" : "left" }, { "text" : "功能", "alignment" : "left" }] }, { "content" : [{ "text" : "IgG", "alignment" : "left" }, { "text" : "75%～80%", "alignment" : "left" }, { "text" : "唯一能通过胎盘；血清含量最高；生后3月开始产生，3～5岁达成人水平，为再次免疫应答主要抗体", "alignment" : "left" }, { "text" : "新生儿抗感染免疫；是抗体抗感染主力军", "alignment" : "left" }] }, { "content" : [{ "text" : "IgM", "alignment" : "left" }, { "text" : "5%～10%", "alignment" : "left" }, { "text" : "最早合成和分泌抗体，为初期免疫应答最早出现的抗体；检出表示新近感染；为天然的血型抗体；胚胎晚期的胎儿即可产生", "alignment" : "left" }, { "text" : "机体抗感染的先头部队；用于早期诊断；血型不符的输血，可致严重溶血反应；脐带血若检出，提示宫内感染", "alignment" : "left" }] }, { "content" : [{ "text" : "IgA", "alignment" : "left" }, { "text" : "10%～15%", "alignment" : "left" }, { "text" : "合成和分泌的部位在肠道、呼吸道、乳腺、唾液腺和泪腺等", "alignment" : "left" }, { "text" : "是黏膜局部抗感染的主要因素；婴儿从初乳中获得，为重要被动免疫", "alignment" : "left" }] }, { "content" : [{ "text" : "IgD", "alignment" : "left" }, { "text" : "0.3%", "alignment" : "left" }, { "text" : "膜结合型IgD是B细胞分化成熟的标志", "alignment" : "left" }, { "text" : "生物学功能不清", "alignment" : "left" }] }, { "content" : [{ "text" : "IgE", "alignment" : "left" }, { "text" : "0.02%", "alignment" : "left" }, { "text" : "血清中含量最少；为亲细胞抗体", "alignment" : "left" }, { "text" : "引起I型变态反应", "alignment" : "left" }] }] }] }] }] }, { "title" : "第五章", "text" : "补体系统", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、基本概念", "alignment" : "left" }, { "text" : "（1）补体的概念<br>（2）补体系统的组成", "alignment" : "left" }] }, { "content" : [{ "text" : "二、补体系统的激活", "alignment" : "left" }, { "text" : "（1）经典激活途径<br>（2）旁路激活途径<br>（3）凝集素激活途径", "alignment" : "left" }] }, { "content" : [{ "text" : "三、补体激活的调节", "alignment" : "left" }, { "text" : "（1）补体的自身调控<br>（2）补体调节因子的调控", "alignment" : "left" }] }, { "content" : [{ "text" : "四、补体的生物学功能", "alignment" : "left" }, { "text" : "（1）膜攻击复合物介导的生物学作用<br>（2）补体活性片段介导的生物学作用", "alignment" : "left" }] }, { "content" : [{ "text" : "五、补体与临床疾病", "alignment" : "left" }, { "text" : "（1）补体与疾病的发生<br>（2）补体与疾病的诊治", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、基本概念", "content" : [{ "type" : "common", "alignment" : "left", "text" : "补体（C）系统是一组存在于血清、体液及细胞表面、具有精密调控机制的蛋白质系统。补体系统由补体固有成分、补体调节蛋白、补体受体组成，其中补体固有成分中以C3含量最高，C1分子量最大，D因子含量最低、分子量最小。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "补体激活后可产生攻膜复合物（MAC），形成穿膜的亲水性通道，破坏局部磷脂双层，最终使细胞崩解。MAC的生物学效应：溶解红细胞、血小板和有核细胞；参与宿主抗细菌和抗病毒防御机制。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "补体的生物学功能：细胞毒作用、调理吞噬作用、促炎症作用、免疫粘附作用、免疫调节作用。补体裂解产物C3b与细菌或其他颗粒结合，可促进吞噬细胞的吞噬，即补体的调理吞噬作用。" }] }] }] }, { "type" : "h1", "text" : "二、补体系统激活的三条途径特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "激活物", "alignment" : "left" }, { "text" : "特点", "alignment" : "left" }] }, { "content" : [{ "text" : "经典（传统）激活途径（CP）", "alignment" : "left" }, { "text" : "主要是与抗原结合的IgG或IgM分子", "alignment" : "left" }, { "text" : "C3转化酶为C4b2a复合物<br>C5转化酶为C4b2a3b复合物", "alignment" : "both" }] }, { "content" : [{ "text" : "旁路（替代）激活途径（AP）", "alignment" : "left" }, { "text" : "某些细菌、内毒素、酵母多糖、葡聚糖等可接触表面", "alignment" : "left" }, { "text" : "C3转化酶为C3bBb<br>C5转化酶为C3bBb3b", "alignment" : "both" }] }, { "content" : [{ "text" : "凝集素（MBL）激活途径", "alignment" : "left" }, { "text" : "病原体表面的糖结构", "alignment" : "left" }, { "text" : "形成与经典途径中相同的C3转化酶与C5转化酶的级联酶促反应", "alignment" : "left" }] }] }] }] }, { "title" : "第六章", "text" : "细胞因子", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、基本概念", "alignment" : "left" }, { "text" : "细胞因子　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、细胞因子的种类", "alignment" : "left" }, { "text" : "（1）白细胞介素<br>（2）干扰素<br>（3）肿瘤坏死因子<br>（4）集落刺激因子<br>（5）趋化因子　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、细胞因子受体", "alignment" : "left" }, { "text" : "基本概念　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、细胞因子的功能", "alignment" : "left" }, { "text" : "概念　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、细胞因子与疾病", "alignment" : "left" }, { "text" : "（1）疾病的发生<br>（2）疾病的诊断<br>（3）疾病的治疗　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、基本概念", "content" : [{ "type" : "common", "alignment" : "left", "text" : "细胞因子（CK）是由经抗原活化的免疫细胞和非免疫细胞（如某些基质细胞）合成分泌的低分子量可溶性蛋白质，具有调节固有免疫和适应性免疫应答、促进造血、介导炎症反应、刺激细胞活化、增殖和分化等功能。" }] }, { "type" : "h1", "text" : "二、细胞因子的种类与功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "白细胞介素（IL）", "alignment" : "left" }, { "text" : "简称白介素，IL-2主要由活化的CD4+Th1细胞产生的细胞因子，可激活巨噬细胞吞噬杀菌、NK的杀伤肿瘤细胞和病毒感染细胞的作用，诱导Th0向Th1分化并增殖，促进CTL的分化并增强其杀伤功能", "alignment" : "left" }] }, { "content" : [{ "text" : "干扰素(IFN)", "alignment" : "left" }, { "text" : "可分为Ⅰ型和Ⅱ型干扰素，Ⅰ型包括IFN-ɑ、IFN-ß，由APC和成纤维细胞产生，有较强抗病毒转录复制作用；Ⅱ型即IFN-γ，主要由活化T细胞产生，通过激活APC功能和巨噬细胞、NK、CTL细胞功能发挥抗病毒作用。", "alignment" : "left" }] }, { "content" : [{ "text" : "肿瘤坏死因子(TNF)", "alignment" : "left" }, { "text" : "分为TNF-ɑ和TNF-β两种，主要生物学作用：①对肿瘤细胞和感染病毒细胞有生长抑制和细胞毒作用；②增强巨噬细胞、NK细胞吞噬杀死作用；③增强T细胞、B细胞增殖；④诱导血管内皮细胞表达黏附分子和分泌IL-1. IL-6等，促进炎症反应；⑤直接作用或刺激巨噬细胞释放IL-1间接作用下丘脑体温调节中枢引起发热", "alignment" : "left" }] }, { "content" : [{ "text" : "集落刺激因子（CSF）", "alignment" : "left" }, { "text" : "能刺激多能造血干细胞和不同发育分化阶段的造血祖细胞分化、增殖的细胞因子。主要包括粒细胞-巨噬细胞集落刺激因子（GM-CSF）、干细胞生成因子（SCF）、多能集落刺激因子（IL-3）和促红细胞生成素（EPO）等", "alignment" : "left" }] }, { "content" : [{ "text" : "趋化因子", "alignment" : "left" }, { "text" : "由多种细胞分泌的对不同细胞具有趋化作用的细胞因子", "alignment" : "left" }] }] }] }] }, { "title" : "第七章", "text" : "主要组织相容性复合体及其编码分子", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、基本概念", "alignment" : "left" }, { "text" : "（1）主要组织相容性抗原<br>（2）主要组织相容性复合体（MHC）　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、HLA复合体及其产物", "alignment" : "left" }, { "text" : "（1）HLA复合体的定位和结构<br>（2）HLA复合体的分类<br>（3）HLA复合体的遗传特征（多基因性、多<br>态性、单元型遗传、共显性遗传、连锁不平衡）<br>（4）HLA编码的产物　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、HLA-Ⅰ类抗原", "alignment" : "left" }, { "text" : "（1）结构<br>（2）分布<br>（3）主要功能　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、HLA-Ⅱ类抗原", "alignment" : "left" }, { "text" : "（1）结构<br>（2）分布<br>（3）主要功能　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、HLA在医学上的意义", "alignment" : "left" }, { "text" : "（1）HLA与同种器官移植的关系<br>（2）HLA与输血反应的关系<br>（3）HLA与疾病的相关性<br>（4）HLA的生理学意义", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、基本概念", "content" : [{ "type" : "common", "alignment" : "left", "text" : "移植排斥反应中发挥主要作用的抗原（移植物是否相容的主要决定者），称为主要组织相容性抗原。人的主要组织相容性抗原称人白细胞抗原（HLA）。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "主要组织相容性复合物（MHC）是一组决定移植物是否排斥，与免疫应答密切相关、紧密连锁的基因群。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "HLA复合体分为三个区域，即Ⅰ类基因区、Ⅱ类基因区和Ⅲ类基因区。HLAⅠ类基因包括B、C、A三个座位，HLAⅡ类基因由DP、DQ和DR三个亚区组成。HLA复合体具有多基因型、多态性、单元型遗传、共显性和连锁不平衡等遗传特征。" }] }] }] }, { "type" : "h1", "text" : "二、HLA-I类抗原和HLA-Ⅱ类抗原分布和主要功能", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "HLA-I类抗原", "alignment" : "left" }, { "text" : "HLA-Ⅱ类抗原", "alignment" : "left" }] }, { "content" : [{ "text" : "组织分布", "alignment" : "left" }, { "text" : "所有有核细胞表面", "alignment" : "left" }, { "text" : "APC、活化的T细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "主要功能", "alignment" : "left" }, { "text" : "识别和提呈内源性抗原肽、与辅助受体CD8结合，对CTL的识别起限制作用。", "alignment" : "left" }, { "text" : "识别和提呈外源性抗原肽，与辅助受体CD4结合，对Th的识别起限制作用。", "alignment" : "left" }] }] }] }] }, { "title" : "第八章", "text" : "免疫应答", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、基本概念", "alignment" : "left" }, { "text" : "（1）免疫应答<br>（2）免疫应答的类型<br>（3）免疫应答的过程　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、固有免疫应答", "alignment" : "left" }, { "text" : "（1）概念<br>（2）固有免疫识别<br>（3）组成<br>（4）功能<br>（5）与疾病的关系　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、适应性免疫应答", "alignment" : "left" }, { "text" : "（1）概念<br>（2）分类<br>（3）特点　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、B细胞介导的体液免疫应答", "alignment" : "left" }, { "text" : "（1）TD抗原诱导的体液免疫应答<br>（2）TI抗原诱导的体液免疫应答<br>（3）体液免疫应答的一般规律　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、T细胞介导的细胞免疫应答", "alignment" : "left" }, { "text" : "（1）T细胞活化的双识别、双信号<br>（2）Th1细胞的效应<br>（3）Th2细胞的效应<br>（4）Th17细胞的效应<br>（5）CTL的细胞毒效应　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、基本概念", "content" : [{ "type" : "common", "alignment" : "left", "text" : "免疫应答是指机体免疫系统受抗原刺激后，免疫细胞特异性识别抗原分子，发生活化、增殖、分化，并发挥以清除抗原为主的生物学效应全过程。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "免疫应答的类型分为固有免疫应答和适应性免疫应答。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "固有免疫系统主要由组织屏障、固有免疫细胞和固有免疫分子组成。适应性免疫应答是机体在接受抗原刺激后产生的针对抗原的特异性免疫应答，可分为B细胞介导的体液免疫应答和T细胞介导的细胞免疫应答。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "免疫应答发生在外周免疫器官和组织，分为三个阶段：识别阶段、活化阶段和效应阶段。" }] }] }] }] }, { "type" : "h1", "text" : "二、B细胞介导的体液免疫应答", "content" : [{ "type" : "common", "alignment" : "left", "text" : "外来抗原诱导抗原特异性B细胞活化、增殖，并最终分化为浆细胞，产生特异性抗体，存在于体液中，发挥重要的免疫效应作用，称为特异性体液免疫应答。可分为胸腺依赖性抗原（TD-Ag）和胸腺非依赖性抗原（TI-Ag）诱导的体液免疫应答。" }] }, { "type" : "h1", "text" : "三、T细胞介导的细胞免疫应答", "content" : [{ "type" : "common", "alignment" : "left", "text" : "T细胞必须同时识别抗原表位和MHC分子的沟槽两端，才能被活化，此即T细胞活化的双识别。同时T细胞的充分活化不仅需要来自抗原表位的特异性第一信号，还需要来自共刺激分子传递的第二信号。" }] }, { "type" : "h1", "text" : "四、Th1. Th2细胞的效应和CTL的细胞毒效应", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "Th1细胞", "alignment" : "left" }, { "text" : "Th2细胞", "alignment" : "left" }, { "text" : "CTL", "alignment" : "left" }] }, { "content" : [{ "text" : "表达", "alignment" : "left" }, { "text" : "CD4<sup>+</sup>", "alignment" : "left" }, { "text" : "CD4<sup>+</sup>", "alignment" : "left" }, { "text" : "CD8<sup>+</sup>", "alignment" : "left" }] }, { "content" : [{ "text" : "TCR识别的配体", "alignment" : "left" }, { "text" : "抗原肽-MHCⅡ类分子复合物", "alignment" : "left" }, { "text" : "抗原肽-MHCⅡ类分子复合物", "alignment" : "left" }, { "text" : "抗原肽-MHCI类分子复合物", "alignment" : "left" }] }, { "content" : [{ "text" : "诱导分化", "alignment" : "left" }, { "text" : "IL-12. IFN-γ", "alignment" : "left" }, { "text" : "IL-4", "alignment" : "left" }, { "text" : "IL-2", "alignment" : "left" }] }, { "content" : [{ "text" : "分泌", "alignment" : "left" }, { "text" : "IFN-γ、LTα、IL-2. IL-3. GM-CSF、FasL", "alignment" : "left" }, { "text" : "IL-4. IL-5. IL-10. IL-13. GM-CSF", "alignment" : "left" }, { "text" : "IFN-γ、LT-α、TNF-α、穿孔素、颗粒酶、FasL", "alignment" : "left" }] }, { "content" : [{ "text" : "主要参与", "alignment" : "left" }, { "text" : "特异性细胞免疫反应", "alignment" : "left" }, { "text" : "体液免疫反应", "alignment" : "left" }, { "text" : "细胞免疫反应", "alignment" : "left" }] }, { "content" : [{ "text" : "免疫保护", "alignment" : "left" }, { "text" : "胞内感染病原体", "alignment" : "left" }, { "text" : "清除蠕虫等", "alignment" : "left" }, { "text" : "病毒感染细胞、肿瘤细胞", "alignment" : "left" }] }, { "content" : [{ "text" : "参与病理应答", "alignment" : "left" }, { "text" : "迟发型超敏反应、类风湿关节炎、炎症性肠病", "alignment" : "left" }, { "text" : "哮喘等变态反应性疾病", "alignment" : "left" }, { "text" : "Ⅳ型变态反应、移植排斥反应", "alignment" : "left" }] }] }] }] }, { "title" : "第九章", "text" : "超敏反应", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、基本概念", "alignment" : "left" }, { "text" : "（1）超敏反应<br>（2）超敏反应的分型　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、Ⅰ型超敏反应", "alignment" : "left" }, { "text" : "（1）Ⅰ型超敏反应的特点<br>（2）Ⅰ型超敏反应的变应原、变应素和细胞<br>（3）Ⅰ型超敏反应的发生机制<br>（4）临床常见的Ⅰ型超敏反应性疾病<br>（5）Ⅰ型超敏反应的防治原则　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、Ⅱ型超敏反应", "alignment" : "left" }, { "text" : "（1）Ⅱ型超敏反应的发生机制<br>（2）临床常见的Ⅱ型超敏反应性疾病　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、Ⅲ型超敏反应", "alignment" : "left" }, { "text" : "（1）Ⅲ型超敏反应的发生机制<br>（2）临床常见的Ⅲ型超敏反应性疾病　", "alignment" : "left" }] }, { "content" : [{ "text" : "五、Ⅳ型超敏反应", "alignment" : "left" }, { "text" : "（1）Ⅳ型超敏反应的发生机制<br>（2）临床常见的Ⅳ型超敏反应性疾病　", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "超敏反应是指机体受到某些抗原刺激时，出现生理功能紊乱或组织细胞损伤的异常适应性免疫反应。", "content" : [{ "type" : "common", "alignment" : "center", "text" : "超敏反应的分型", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "I型超敏反应", "alignment" : "left" }, { "text" : "Ⅱ型超敏反应", "alignment" : "left" }, { "text" : "Ⅲ型超敏反应", "alignment" : "left" }, { "text" : "Ⅳ型超敏反应", "alignment" : "left" }] }, { "content" : [{ "text" : "别称", "alignment" : "left" }, { "text" : "过敏反应", "alignment" : "left" }, { "text" : "细胞毒型超敏反应", "alignment" : "left" }, { "text" : "", "alignment" : "left" }, { "text" : "", "alignment" : "left" }] }, { "content" : [{ "text" : "抗原", "alignment" : "left" }, { "text" : "可溶性抗原", "alignment" : "left" }, { "text" : "细胞性抗原", "alignment" : "left" }, { "text" : "可溶性抗原", "alignment" : "left" }, { "text" : "可溶性抗原、细胞性抗原", "alignment" : "left" }] }, { "content" : [{ "text" : "介导", "alignment" : "left" }, { "text" : "IgE抗体", "alignment" : "left" }, { "text" : "IgG、IgM抗体", "alignment" : "left" }, { "text" : "IgG抗体", "alignment" : "left" }, { "text" : "T细胞介导、CTL", "alignment" : "left" }] }, { "content" : [{ "text" : "特点", "alignment" : "left" }, { "text" : "发生快、消退快；常引起生理紊乱，不引起炎症组织损伤；有明显个体差异和遗传倾向", "alignment" : "left" }, { "text" : "有抗体、补体、吞噬细胞、NK细胞参与；引起以细胞溶解或组织损伤的病变", "alignment" : "left" }, { "text" : "以局部充血水肿坏死、中性粒细胞浸润为主的炎症反应；组织损伤重", "alignment" : "left" }, { "text" : "引起以单个核细胞浸润、组织损伤为主的炎症反应；发生较慢；其发生与抗体和补体无关", "alignment" : "left" }] }, { "content" : [{ "text" : "常见疾病", "alignment" : "left" }, { "text" : "药物过敏性休克、枯草热、支气管哮喘、食物过敏症、湿疹、皮肤过敏反应", "alignment" : "left" }, { "text" : "输血反应、新生儿溶血症、自身免疫性溶血性贫血、药物过敏性血细胞减少症、Graves病", "alignment" : "left" }, { "text" : "Arthus反应、类Arthus反应、血清病、链球菌感染后肾炎、类风湿性关节炎", "alignment" : "left" }, { "text" : "感染性迟发型超敏反应（结核性损伤）、接触性迟发型超敏反应（接触性皮炎）", "alignment" : "left" }] }] }] }] }] }] }, { "title" : "第十章", "text" : "免疫缺陷病", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、基本概念", "alignment" : "left" }, { "text" : "（1）免疫缺陷病的概念<br>（2）免疫缺陷病的分类　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、原发性免疫缺陷病", "alignment" : "left" }, { "text" : "（1）B细胞缺陷<br>（2）T细胞缺陷<br>（3）联合免疫缺陷<br>（4）吞噬细胞缺陷<br>（5）补体系统缺陷　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、获得性免疫缺陷病", "alignment" : "left" }, { "text" : "概念及种类　", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "免疫缺陷病是免疫系统先天发育不全或后天损害而使免疫细胞的发育、增殖、分化和代谢异常并导致免疫功能不全所出现的临床综合征。按病因可分为原发性免疫缺陷病和获得性免疫缺陷病。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "获得性免疫缺陷综合征是人类免疫缺陷病毒（HIV）感染和破坏CD4+T细胞，引起细胞免疫严重缺陷，导致以机会性感染、恶性肿瘤和神经系统病变为特征的临床综合征。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "B细胞、吞噬细胞或补体缺陷患者易患化脓性细菌（葡萄球菌）感染；细胞免疫缺陷者主要易患由病毒、真菌、胞内寄生菌和原虫引起的感染。DiGeorge综合征是由于先天性胸腺发育不全引起的T细胞缺陷病，患儿唇和耳等发育不良，T细胞数目降低，B细胞数目正常。" }] }] }] }] }, { "title" : "第十一章", "text" : "肿瘤免疫", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "一、肿瘤抗原", "alignment" : "left" }, { "text" : "（1）肿瘤抗原的概念<br>（2）肿瘤抗原的分类　", "alignment" : "left" }] }, { "content" : [{ "text" : "二、机体抗肿瘤免疫的效应机制", "alignment" : "left" }, { "text" : "（1）体液免疫机制<br>（2）细胞免疫机制　", "alignment" : "left" }] }, { "content" : [{ "text" : "三、肿瘤的免疫逃逸机制", "alignment" : "left" }, { "text" : "（1）与肿瘤细胞有关的因素<br>（2）与宿主免疫系统有关的因素　", "alignment" : "left" }] }, { "content" : [{ "text" : "四、肿瘤的免疫治疗", "alignment" : "left" }, { "text" : "（1）非特异性免疫治疗<br>（2）主动免疫治疗<br>（3）被动免疫治疗　", "alignment" : "left" }] }] }, { "type" : "h1", "text" : "一、肿瘤抗原", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肿瘤抗原是指细胞癌变过程中出现的新抗原、肿瘤细胞异常或过度表达的抗原物质的总称。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肿瘤特异性抗原（TSA）：只存在于某一种或几种肿瘤细胞而不存在于正常细胞的新抗原。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肿瘤相关抗原（TAA）：是指肿瘤细胞和正常组织细胞均可表达的抗原，只是其含量在细胞癌变时明显增高。此类抗原只表现出量的变化，而无严格肿瘤特异性。如癌胚抗原（CEA）、甲胎蛋白（AFP）等。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "常见肿瘤相关抗原与疾病的关系：PSA与前列腺癌、gp100和MART-1与黑色素瘤、HER-2/neu与乳腺癌、AFP与原发性肝癌、CEA与结肠癌、CTA与多种肿瘤、EBV与鼻咽癌、HBV与肝癌、HPV与宫颈癌。" }] }] }] }] }, { "type" : "h1", "text" : "二、机体抗肿瘤免疫的效应机制", "content" : [{ "type" : "common", "alignment" : "left", "text" : "细胞免疫是抗肿瘤免疫的主力，体液免疫仅起协同作用。在控制具有免疫原性肿瘤细胞方面，T细胞免疫最为重要。CD8+ CTL是抗肿瘤免疫最重要的杀伤细胞；NK细胞不需要预先致敏就能非特异性杀伤肿瘤细胞，其作用不受MHC限制，是一类在肿瘤发生早期起作用的重要效应细胞，是机体抗肿瘤的第一道防线；巨噬细胞既是抗原提呈细胞，也是杀伤肿瘤的效应细胞。" }] }, { "type" : "h1", "text" : "三、肿瘤的免疫逃逸机制", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肿瘤细胞抗原缺失和抗原调变、“漏逸”、MHCⅠ类分子表达低下、肿瘤细胞导致的免疫抑制、缺乏共刺激信号和肿瘤细胞抗凋亡等机制。宿主自身免疫功能低下或免疫耐受状态等。" }] }] }] }, { "text" : "第六篇  医学微生物学", "guide" : [{ "text" : "执业医师考试——本篇约占临床执业医师考试的1%，出题量约为6题。主要内容包括细菌、真菌和病毒三大类微生物，考点比较分散，复习重点为常见常考的病原微生物特点，其中关于细菌的内容为重点，由于占的分值较少，故无需花过多时间学习每个章节内容。" }], "content" : [{ "title" : "第一章", "text" : "微生物基本概念", "content" : [{ "type" : "common", "alignment" : "left", "text" : "三大类微生物及其特点", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "微生物类型", "alignment" : "left" }, { "text" : "特点", "alignment" : "left" }, { "text" : "种类", "alignment" : "left" }] }, { "content" : [{ "text" : "非细胞型", "alignment" : "left" }, { "text" : "最小最低等生物体，结构简单，超级寄生性", "alignment" : "left" }, { "text" : "病毒、朊粒等", "alignment" : "left" }] }, { "content" : [{ "text" : "原核生物型", "alignment" : "left" }, { "text" : "单细胞，无完整细胞核，胞质内有核糖体，但缺少内质网、线粒体等", "alignment" : "left" }, { "text" : "包括细菌、支原体、衣原体、立克次体、螺旋体和放线菌等", "alignment" : "left" }] }, { "content" : [{ "text" : "真核生物型", "alignment" : "left" }, { "text" : "多细胞或单细胞，有细胞核和各种细胞器，故易在体外生长繁殖", "alignment" : "left" }, { "text" : "真菌等", "alignment" : "left" }] }] }] }] }, { "title" : "第二章", "text" : "消毒与灭菌", "content" : [{ "type" : "h1", "text" : "一、消毒灭菌的基本概念", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "灭菌", "alignment" : "left" }, { "text" : "指杀灭物体上所有微生物的方法，包括杀灭细菌芽孢、病毒和霉菌在内的全部病原微生物和非病原微生物", "alignment" : "left" }] }, { "content" : [{ "text" : "消毒", "alignment" : "left" }, { "text" : "指杀死物体上或环境中的病原微生物，并不一定能杀死细菌芽孢或非病原微生物", "alignment" : "left" }] }, { "content" : [{ "text" : "无菌", "alignment" : "left" }, { "text" : "指不存在活菌的状态，多指灭菌的状态", "alignment" : "left" }] }, { "content" : [{ "text" : "抑菌", "alignment" : "left" }, { "text" : "抑制体内或者体外细菌的生长", "alignment" : "left" }] }, { "content" : [{ "text" : "防腐", "alignment" : "left" }, { "text" : "防止或抑制皮肤表面细菌生长繁殖的方法", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "二、常见灭菌法及其应用", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "灭菌方法", "alignment" : "left" }, { "text" : "应用", "alignment" : "left" }] }, { "content" : [{ "text" : "巴氏消毒法", "alignment" : "left" }, { "text" : "牛奶、酒类的消毒", "alignment" : "left" }] }, { "content" : [{ "text" : "煮沸法", "alignment" : "left" }, { "text" : "消毒食具、剪刀、注射器", "alignment" : "left" }] }, { "content" : [{ "text" : "流动蒸汽消毒法", "alignment" : "left" }, { "text" : "Arnold消毒器", "alignment" : "left" }] }, { "content" : [{ "text" : "间歇蒸汽灭菌法", "alignment" : "left" }, { "text" : "一些不耐高温的含糖、牛奶的培养基", "alignment" : "left" }] }, { "content" : [{ "text" : "高压蒸汽灭菌法", "alignment" : "left" }, { "text" : "一般培养基、生理盐水、手术敷料、耐湿热物品", "alignment" : "left" }] }] }] }] }, { "title" : "第三章", "text" : "细菌", "content" : [{ "type" : "h1", "text" : "一、细菌的形态与结构", "content" : [{ "type" : "common", "alignment" : "left", "text" : "细菌按基本形态分为球菌、杆菌和螺形菌三种形态。细菌的结构分基本结构和特殊结构。基本结构包括细胞壁、细胞膜、细胞质、核质，为各种细菌所共有结构；特殊结构包括荚膜、鞭毛、菌毛和芽孢等，仅某些细菌特有。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "细胞壁为包绕细胞膜周围的膜状结构，主要成分为肽聚糖，其主要功能为保持菌体固有形态和维持细胞内外的渗透压。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肽聚糖也称粘肽或胞壁质，为细胞壁特有成分，肽聚糖为细菌所特有，在革兰氏阳性（G+）与革兰氏阴性 (G-)菌中，肽聚糖的构成有所不同。其中G+菌的细胞壁肽聚糖层数较多，可达50层，肽聚糖含量占细胞壁干重50%~80%。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "细菌的特殊结构", "alignment" : "left" }, { "text" : "特点", "alignment" : "left" }] }, { "content" : [{ "text" : "荚膜", "alignment" : "left" }, { "text" : "细胞壁外的一层多糖结构，具有粘附宿主细胞核抗吞噬等致病作用，抗有害物质的损伤作用", "alignment" : "left" }] }, { "content" : [{ "text" : "鞭毛", "alignment" : "left" }, { "text" : "鞭毛是细菌的运动器官，使细菌趋向营养物质而逃避有害物质，具有抗原性并与致病性有关", "alignment" : "left" }] }, { "content" : [{ "text" : "菌毛", "alignment" : "left" }, { "text" : "普通菌毛可促使细菌粘附于宿主细胞表面而致病，性菌毛是噬菌体细胞与F<sup>+</sup>菌，并使后者获取致病物质", "alignment" : "left" }] }, { "content" : [{ "text" : "芽孢", "alignment" : "left" }, { "text" : "抵抗力强，耐高温。通常以杀死芽孢作为灭菌指标", "alignment" : "left" }] }] }] }] }] }] }, { "type" : "h1", "text" : "二、细菌的感染与免疫", "content" : [{ "type" : "h2", "alignment" : "left", "text" : "1. 细菌的毒力", "content" : [{ "type" : "common", "alignment" : "left", "text" : "细菌的毒力是由侵袭力和毒素决定的。侵袭力指细菌突破宿主的防御屏障，在体内定居、繁殖及扩散的能力。细菌毒素包括内毒素和外毒素两种。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "细菌内、外毒素的主要区别", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "细菌外毒素", "alignment" : "left" }, { "text" : "细菌内毒素", "alignment" : "left" }] }, { "content" : [{ "text" : "来源", "alignment" : "left" }, { "text" : "革兰阳性菌、少数革兰阴性菌", "alignment" : "left" }, { "text" : "革兰阴性菌", "alignment" : "left" }] }, { "content" : [{ "text" : "释放方式", "alignment" : "left" }, { "text" : "多为活菌分泌，少为细菌崩解释放", "alignment" : "left" }, { "text" : "细菌细胞壁成分，细菌崩解后释放", "alignment" : "left" }] }, { "content" : [{ "text" : "化学成分", "alignment" : "left" }, { "text" : "蛋白质", "alignment" : "left" }, { "text" : "脂多糖", "alignment" : "left" }] }, { "content" : [{ "text" : "毒性作用", "alignment" : "left" }, { "text" : "强，对组织器官有高度选择性", "alignment" : "left" }, { "text" : "弱，对组织器官无选择性", "alignment" : "left" }] }, { "content" : [{ "text" : "稳定性", "alignment" : "left" }, { "text" : "不稳定，60℃～80℃，30min可破坏", "alignment" : "left" }, { "text" : "耐热，160℃，2～4h可破坏", "alignment" : "left" }] }, { "content" : [{ "text" : "抗原性", "alignment" : "left" }, { "text" : "强，可刺激机体产生抗毒素", "alignment" : "left" }, { "text" : "弱", "alignment" : "left" }] }, { "content" : [{ "text" : "甲醛处理", "alignment" : "left" }, { "text" : "经甲醛处理可脱毒成类毒素", "alignment" : "left" }, { "text" : "不形成类毒素", "alignment" : "left" }] }] }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 菌血症、败血症、脓毒血症概念及举例", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "概念", "alignment" : "left" }, { "text" : "举例", "alignment" : "left" }] }, { "content" : [{ "text" : "菌血症", "alignment" : "left" }, { "text" : "致病菌由局部侵入血流，但并未在血流中生长繁殖，只是短暂的一过性通过血循环达到体内适宜部位后再进行繁殖而致病", "alignment" : "left" }, { "text" : "伤寒早期发生的菌血症", "alignment" : "left" }] }, { "content" : [{ "text" : "败血症", "alignment" : "left" }, { "text" : "致病菌侵入血流后，在其中大量繁殖并产生毒性物质，引起全身症状，如高热、皮肤和黏膜瘀斑、肝脾肿大等", "alignment" : "left" }, { "text" : "炭疽芽孢杆菌引起的败血症", "alignment" : "left" }] }, { "content" : [{ "text" : "脓毒血症", "alignment" : "left" }, { "text" : "是指化脓性致病菌侵入血流后，在其中大量繁殖，并通过血流扩散至宿主体内的其他组织或器官，产生新的化脓性病灶", "alignment" : "left" }, { "text" : "金黄色葡萄球菌的脓毒血症常导致转移性肝脓肿、肾脓肿", "alignment" : "left" }] }] }] }] }, { "type" : "h1", "text" : "三、病原性球菌", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "金黄色葡萄球菌", "alignment" : "left" }, { "text" : "G<sup>+</sup>菌，凝固酶阳性菌，多为致病菌，凝固酶是鉴别有无致病性的重要指标。以形成局部脓肿为主，如皮肤伤口化脓性感染疖、痈等", "alignment" : "left" }] }, { "content" : [{ "text" : "链球菌", "alignment" : "left" }, { "text" : "G<sup>+</sup>菌，致病菌主要为A群，多数呈乙型溶血。所致疾病：侵袭性疾病，如化脓性炎症；毒素性疾病，如猩红热；超敏性疾病，如风湿热和急性肾小球肾炎", "alignment" : "left" }] }, { "content" : [{ "text" : "肺炎链球菌", "alignment" : "left" }, { "text" : "G<sup>+</sup>菌，荚膜：有荚膜的肺炎链球菌的抵抗力强，具有抗吞噬作用，是主要的毒力因子。所致疾病主要为大叶性肺炎", "alignment" : "left" }] }, { "content" : [{ "text" : "脑膜炎奈瑟菌", "alignment" : "left" }, { "text" : "G<sup>-</sup>菌，所致疾病流行性脑脊髓膜炎，简称流脑，人是唯一宿主", "alignment" : "left" }] }, { "content" : [{ "text" : "淋病奈瑟菌", "alignment" : "left" }, { "text" : "G<sup>-</sup>菌，人是唯一宿主，经性接触传播", "alignment" : "left" }] }] }] }, { "type" : "h1", "text" : "四、肠道杆菌", "content" : [{ "type" : "common", "alignment" : "left", "text" : "肠道杆菌为革兰阴性菌，共有菌体O抗原、鞭毛H抗原和荚膜抗原3种抗原。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "肠道杆菌种类", "alignment" : "left" }, { "text" : "考点", "alignment" : "left" }] }, { "content" : [{ "text" : "埃希菌属", "alignment" : "left" }, { "text" : "肠出血性大肠埃希（EHEC）O157：H7血清型引起以反复出血性腹泻和严重腹痛为特征的出血性结肠炎，表现为大量血样便腹泻", "alignment" : "left" }] }, { "content" : [{ "text" : "志贺菌属", "alignment" : "left" }, { "text" : "志贺菌也称痢疾杆菌，致病物质主要为侵袭力、内毒素、外毒素，侵袭力主要与菌毛有关，内毒素作用于肠黏膜，引起炎症、溃疡、出血坏死，外毒素可引起水样腹泻", "alignment" : "left" }] }, { "content" : [{ "text" : "沙门氏菌属", "alignment" : "left" }, { "text" : "伤寒、副伤寒又名肠热症，分别由伤寒沙门氏菌、副伤寒甲、乙、丙沙门氏菌引起，肥达试验O、H凝集效价均高提示肠热症可能性较大", "alignment" : "left" }] }], "content" : [{ "type" : "common", "alignment" : "left", "text" : "肥达试验是一种直接凝集试验，是用已知的伤寒沙门菌的菌体抗原（O抗原）、鞭毛抗原（H抗原），以及副伤寒沙门菌的鞭毛抗原（H抗原），与患者血清进行定量凝集试验，检测血清中有无相应抗体及抗体的效价。O、H凝集效价均高提示肠热症可能性较大；O、H凝集效价均低提示肠热症可能性较小；O效价不高H高，预防接种或非特异性回忆反应；O效价高H不高，感染早期，其他沙门菌感染。" }] }] }] }, { "type" : "h1", "text" : "五、弧菌属", "content" : [{ "type" : "common", "alignment" : "left", "text" : "霍乱弧菌为革兰阴性菌，有菌毛和单鞭毛，运动活泼，有些菌株有荚膜，无芽孢。该菌有两类抗原，即菌体O抗原和鞭毛H抗原。霍乱弧菌的致病物质有菌毛、鞭毛及其他毒力因子和霍乱肠菌素。霍乱属于甲类烈性传染病，表现为剧烈腹泻和呕吐（米泔水样腹泻物）。" }] }, { "type" : "h1", "text" : "六、厌氧性杆菌", "content" : [{ "type" : "common", "alignment" : "left", "text" : "根据能否形成芽孢，可分为厌氧芽孢梭菌属和无芽孢厌氧菌。" }, { "type" : "h2", "alignment" : "left", "text" : "1. 厌氧芽孢梭菌", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "破伤风梭菌", "alignment" : "left" }, { "text" : "革兰氏阳性菌，严格厌氧；<br>产生两种外毒素，即破伤风溶血素和破伤风痉挛毒素；<br>防治措施：清创并对伤口用过氧化氢溶液（H<sub>2</sub>O<sub>2</sub>）冲洗创面以消除厌氧环境。破伤风抗毒素（TAT）：中和游离的破伤风外毒素", "alignment" : "both" }] }, { "content" : [{ "text" : "产气荚膜梭菌", "alignment" : "left" }, { "text" : "革兰氏阳性粗大杆菌，无鞭毛，有荚膜，厌氧；<br>能产生10余种外毒素，致病条件与破伤风梭菌相似，引起气性坏疽、食物中毒等；<br>直接涂片镜检是极有价值的快速诊断方法；<br>切除感染和坏死组织，大剂量使用青霉素等抗生素以杀灭病原菌和其他细菌，高压氧舱法", "alignment" : "both" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 无芽孢厌氧菌", "content" : [{ "type" : "common", "alignment" : "left", "text" : "属于人体内正常菌群，包括革兰阳性和革兰阴性的球菌和杆菌。无芽孢厌氧菌感染多为慢性感染过程，内源性感染为其主要感染形式。无芽孢厌氧菌单一菌或混合感染，是坏死性溃疡性牙龈炎、牙周炎、坏疽性口腔炎等口腔感染的主要原因。" }] }] }, { "type" : "h1", "text" : "七、棒状杆菌属", "content" : [{ "type" : "common", "alignment" : "left", "text" : "白喉棒状杆菌，属革兰阳性菌，无鞭毛和荚膜，不形成芽孢。致病物质主要为白喉外毒素，还有索状因子和K抗原。白喉棒状杆菌是引起人类白喉的唯一病原体。白喉的临床表现为鼻咽部急性炎症和形成基膜，并伴有全身中毒症状。注射白喉类毒素是预防白喉的重要措施。" }] }, { "type" : "h1", "text" : "八、分枝杆菌属", "content" : [{ "type" : "common", "alignment" : "left", "text" : "结核分枝杆菌因细胞壁含有大量脂质，不易着色，经齐-尼二氏抗酸染色阳性，呈红色，无鞭毛和芽孢。为专性需氧菌，培养营养要求高，生长缓慢，毒力与耐药性均可发生变异。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "结核杆菌对酸、碱、自然环境和干燥有抵抗力，但对湿热、酒精和紫外线敏感。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "结核菌素（OT）试验原理是测定机体对结核菌的迟发型超敏反应，以此判断机体有无抗结核免疫力。" }] }] }] }, { "type" : "h1", "text" : "九、支原体和衣原体", "content" : [{ "type" : "common", "alignment" : "left", "text" : "支原体是一类缺乏细胞壁、呈高度多形性、能通过滤菌器、在无生命培养基中能生长繁殖的最小原核细胞型微生物。从人体分离出的支原体有16个菌种，其中致病性支原体主要有肺炎支原体、解脲脲原体。肺炎支原体引起人类原发性非典型性肺炎即间质性肺炎，解脲支原体是引起非淋菌性尿道炎的重要病原体。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "衣原体是一类严格细胞内寄生，有独特发育周期，能通过细菌滤器的原核细胞型微生物。衣原体感染为人与人之间经空气飞沫或呼吸道分泌物传播。人类是沙眼衣原体的主要自然宿主。" }] }] }] }, { "title" : "第四章", "text" : "真菌", "content" : [{ "type" : "common", "alignment" : "left", "text" : "真菌是一大类真核细胞型微生物。细胞核高度分化，有核膜和核仁，胞浆内有完整细胞器。可分为单细胞真菌和多细胞真菌两大类。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "单细胞真菌：①酵母型真菌，由母细胞以芽生方式繁殖，不产生菌丝，如隐球菌，新生隐球菌的荚膜多糖是重要致病物质；②类酵母型真菌，也以芽生方式繁殖，形成假菌丝，如白假丝酵母菌，假菌丝和厚膜孢子是其特点。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "多细胞真菌又称丝状菌（俗称霉菌），由菌丝和孢子构成。孢子是由真菌的生殖菌丝产生的繁殖器官，再分为无性孢子和有性孢子。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "卡氏肺孢子菌对免疫缺陷或免疫功能低下者可引起机会性感染，如艾滋病患者。" }] }] }] }] }, { "title" : "第五章", "text" : "病毒", "content" : [{ "type" : "h1", "text" : "一、病毒的基本性状", "content" : [{ "type" : "common", "alignment" : "left", "text" : "病毒体主要由核酸和蛋白质组成。核心为核酸DNA或RNA，在核酸外围有蛋白质外壳，称作衣壳。病毒蛋白质是构成衣壳和包膜的主要成分。病毒体的脂质和糖类来自宿主的细胞膜，并与病毒蛋白共同构成病毒包膜。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "病毒复制的方式是以病毒基因为模板，按照碱基配对原则，进行自我复制。病毒的复制周期主要包括吸附、穿入、脱壳、生物合成及装配与释放等5个阶段。" }] }] }, { "type" : "h1", "text" : "二、病毒的感染与免疫", "content" : [{ "type" : "common", "alignment" : "left", "text" : "病毒的传播方式有水平传播和垂直传播两类。抗病毒免疫以细胞免疫为主，细胞免疫在发挥其抗病毒感染的同时，特异性细胞毒性T细胞（CTL）等，也对宿主细胞产生损伤。", "content" : [{ "type" : "common", "alignment" : "left", "text" : "干扰素（IFN）不是直接作用于病毒，而是作用于宿主细胞的基因，诱生合成20多种抗病毒蛋白。" }] }, { "type" : "h2", "alignment" : "left", "text" : "1. 病毒的感染类型", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "显性感染", "alignment" : "left" }, { "text" : "是指病毒感染后出现临床症状和体征", "alignment" : "left", "colSpan" : 2 }] }, { "content" : [{ "text" : "隐性感染", "alignment" : "left" }, { "text" : "是指病毒进入机体后，虽然不引起临床症状，但可向外界散播病毒，且可使机体获得特异性免疫力，即适应性免疫", "alignment" : "left", "colSpan" : 2 }] }, { "content" : [{ "text" : "急性感染", "alignment" : "left" }, { "text" : "是指病毒侵入机体后，在细胞内增殖，经数日乃至数周的潜伏期后发病", "alignment" : "left", "colSpan" : 2 }] }, { "content" : [{ "text" : "持续性感染", "alignment" : "left", "rowSpan" : 4 }, { "text" : "慢性感染", "alignment" : "left" }, { "text" : "指显性感染或隐性感染后，病毒未完全清除，仍持续存在于血液或组织中并不断排出体外或经输血，注射而传播给易感者，如乙肝病毒", "alignment" : "left" }] }, { "content" : [{ "text" : "潜伏感染", "alignment" : "left" }, { "text" : "指显性感染或隐性感染后，病毒基因存在于组织或细胞内，但并不能产生感染性病毒体，在某些条件下可被激活而出现临床急性发作", "alignment" : "left" }] }, { "content" : [{ "text" : "慢发病毒感染", "alignment" : "left" }, { "text" : "指病毒感染后，经很长的潜伏期，达数月、数年甚至数十年之久，才出现慢性进行性疾病。", "alignment" : "left" }] }, { "content" : [{ "text" : "急性病毒感染的迟发并发症", "alignment" : "left" }, { "text" : "急性感染后1年或数年，发生致死性的并发症，如麻疹病毒可引起亚急性硬化性全脑炎（SSPE）", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "2. 呼吸道病毒", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "正黏病毒", "alignment" : "left" }, { "text" : "仅一个流行性感冒病毒，有甲、乙、丙三型，甲型流感病毒是反复流行最为频繁和引起流感全球流行的重要病原体", "alignment" : "left" }] }, { "content" : [{ "text" : "副黏病毒", "alignment" : "left" }, { "text" : "包括副流感病毒、麻疹病毒、呼吸道合胞病毒、腮腺炎病毒、尼帕病毒和人偏肺病毒；<br>人是麻疹病毒的唯一自然储存宿主，麻疹是儿童时期最为常见的急性出疹性传染病，临床表现常有上呼吸道卡他症状和Koplik斑等典型症状；<br>腮腺炎病毒是流行性腮腺炎的病原体，只有一个血清型，引起一侧或双侧腮腺肿大，1~2周可自愈，感染者可引起睾丸炎，卵巢炎等并发症", "alignment" : "both" }] }, { "content" : [{ "text" : "冠状病毒", "alignment" : "left" }, { "text" : "SARS冠状病毒引起具有流行性的严重疾病即急性呼吸综合征，主要经飞沫传播，也可经粪-口传播", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "3. 肠道病毒", "content" : [{ "type" : "common", "alignment" : "left", "text" : "人类肠道病毒归于小RNA病毒科肠道病毒属，主要经粪-口途径传播。", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "脊髓灰质病毒", "alignment" : "left" }, { "text" : "引起脊髓灰质炎，主要通过粪-口途径传播，病毒可侵犯脊髓前角运动神经细胞，引起暂时性或永久性驰缓性肢体麻痹（遗留后遗症），故亦称小儿麻痹症", "alignment" : "left" }] }, { "content" : [{ "text" : "71型肠道病毒", "alignment" : "left" }, { "text" : "主要引起手足口病及无菌性脑膜炎", "alignment" : "left" }] }, { "content" : [{ "text" : "轮状病毒", "alignment" : "left" }, { "text" : "引起急性胃肠炎，主要传播途径为粪-口传播，多发生在深秋和初冬季节，在我国常被称为“秋季腹泻”", "alignment" : "left" }] }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "4. 肝炎病毒", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "", "alignment" : "left" }, { "text" : "甲型（HAV）", "alignment" : "left" }, { "text" : "乙型(HBV)", "alignment" : "left" }, { "text" : "丙型(HCV)", "alignment" : "left" }, { "text" : "丁型(HDV)", "alignment" : "left" }, { "text" : "戊型(HEV)", "alignment" : "left" }] }, { "content" : [{ "text" : "基因类型", "alignment" : "left" }, { "text" : "属于小RNA病毒科嗜肝RNA病毒属", "alignment" : "left" }, { "text" : "属嗜肝DNA病毒科正嗜肝病毒属；HBV归属逆转录DNA病毒，HBVDNA逆转录复制是其病毒易于变异的主要原因", "alignment" : "left" }, { "text" : "基因组为单股正链RNA（ssRNA）", "alignment" : "left" }, { "text" : "基因组为单股负链RNA（-ssRNA）", "alignment" : "left" }, { "text" : "基因组为线状单股正链RNA（ssRNA）", "alignment" : "left" }] }, { "content" : [{ "text" : "传播途径", "alignment" : "left" }, { "text" : "经粪-口途径传播", "alignment" : "left" }, { "text" : "经血液、血制品传播；母-婴传播；性接触及密切接触传播", "alignment" : "left" }, { "text" : "与HBV的传播途径相似", "alignment" : "left" }, { "text" : "与HBV有相同的传播途径", "alignment" : "left" }, { "text" : "主要经粪-口途径传播", "alignment" : "left" }] }, { "content" : [{ "text" : "传热源", "alignment" : "left" }, { "text" : "急性患者和隐性感染者", "alignment" : "left" }, { "text" : "急性和慢性乙型肝炎患者及慢性HBsAg携带者", "alignment" : "left" }, { "text" : "同乙肝", "alignment" : "left" }, { "text" : "与乙肝混合感染", "alignment" : "left" }, { "text" : "同甲肝", "alignment" : "left" }] }, { "content" : [{ "text" : "预防", "alignment" : "left" }, { "text" : "接种灭活疫苗或减毒疫苗", "alignment" : "left" }, { "text" : "接种乙型肝炎疫苗是预防HBV感染最有效的方法", "alignment" : "left" }, { "text" : "目前尚无丙型肝炎预防性疫苗", "alignment" : "left" }, { "text" : "无疫苗", "alignment" : "left" }, { "text" : "目前无戊型肝炎疫苗", "alignment" : "left" }] }, { "content" : [{ "text" : "特点", "alignment" : "left" }, { "text" : "HAV的显性感染或隐性感染可诱导机体产生抗-HAV的IgM和IgG抗体，前者出现在进行期和恢复早期，后者出现在恢复期，并可维持多年，对病毒的再感染有免疫力。甲肝患者预后良好，不会转为慢性，亦无病毒携带者。预防以为主导措施", "alignment" : "left" }, { "text" : "1）病毒感染后可产生细胞免疫和体液免疫，病毒抗原致敏的CTL是彻底清除HBV的最重要环节；<br>2）HBsAg是检查HBV感染的主要标志，HBeAg可作为体内有HBV复制及血清具有强传染性的一个标志；<br>3）“大三阳”：HBsAg（+）、HBeAg（+）、抗HBc(+)；“小三阳”：HBsAg（+）、抗HBe（+）、抗HBc(+)", "alignment" : "both" }, { "text" : "丙型肝炎患者恢复后，仅有低水平免疫力，且免疫力不牢固", "alignment" : "left" }, { "text" : "病毒复制必须有HBV或其他嗜肝DNA病毒辅助获得包膜，才能复制增殖，故称作缺陷性病毒，故HDV必须有HBV相辅助，即混合感染，才能感染人体", "alignment" : "left" }, { "text" : "机体病后可获得一定免疫力，但不够稳固，儿童患过成人后可再次感染", "alignment" : "left" }] }] }] }, { "type" : "h2", "alignment" : "left", "text" : "5. 其他病毒", "content" : [{ "type" : "table", "rows" : [{ "content" : [{ "text" : "流行性乙型脑炎病毒", "alignment" : "left" }, { "text" : "主要传播媒介三带喙库蚊，蚊子既是传播媒介又是重要的储存宿主。猪是主要的传染源和储存宿主", "alignment" : "left" }] }, { "content" : [{ "text" : "出血热病毒", "alignment" : "left" }, { "text" : "汉坦病毒是最重要的引起出血热的病毒，可引起人兽共患病性疾病肾综合征出血热，主要经皮肤黏膜伤口、消化道及呼吸道由鼠到人传播", "alignment" : "left" }] }, { "content" : [{ "text" : "狂犬病毒", "alignment" : "left" }, { "text" : "是弹状病毒科狂犬病毒属中能引起急性脑组织病变的嗜神经病毒，经患病动物咬伤经伤口进入", "alignment" : "left" }] }, { "content" : [{ "text" : "朊病毒（朊粒）", "alignment" : "left" }, { "text" : "为传染性蛋白粒子的简称，是一种疏水性糖蛋白粒子，引起传染性海绵状脑病，为一种中枢神经系统致死性慢性退化性疾病，所致的疾病为进行性痴呆和震颤病、克-雅病", "alignment" : "left" }] }] }] }] }] }] }] }